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One approach to studying the mechanism of exo- and endocytosis is
to identify and characterise the proteins that present in the membranes of
secretory vesicles that are not involved in the biosynthesis of their contents,
and which display a wide tissue distribution.
The aim of this project was the characterisation of the membrane
proteins of bovine adrenal chromaffin granules in order to determine their
possible roles in either mediating exocytosis or in the organisation and
intracellular movement of the granule. The characterisation was carried out
by using mouse monoclonal antibodies that were raised against granule
membrane-derived protein fractions. Such an approach was chosen to
overcome the biochemical problems one would face if each antigen were to be
individually purified and studied.
To obtain monoclonal antibodies against these components, antigen
fractions enriched in them, but devoid of the abundant and immunogenic
proteins of catecholamine biosynthesis (such as dopamine /3-monooxygenase
and cytochrome b561) were required for immunising mice. These were
generated first by using the phase separation property of the non-ionic
detergent Triton X-114 to obtain a fraction that was enriched in membrane
glycoproteins, and second by the liberation of tryptic peptides from
chromaffin granule membranes that had been washed free of cytosolic and
lumenal contaminants. Another method used was to obtain a fraction of
proteins that bound to chromaffin granule membranes in the presence of
elevated concentrations of free Ca2+.
Identification of the mouse monoclonal antibodies required the
development of rapid and sensitive methods of screening the hybridoma
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supernatants. Procedures for immuno-dot and enzyme-linked immuno¬
sorbent assays were developed to identify and characterise the antibodies.
Using these approaches several monoclonal antibodies were obtained.
One of these, cgm80, recognised a protein of molecular weight 78 - 94-kDa and
pi 4 - 5, and was determined to be against the integral membrane protein
glycoprotein II, the structure and function of which have not been
characterised. Other monoclonal antibodies included dbhl and cgm67 , which
were respectively directed against dopamine /3-monooxygenase and a protein
of molecular weight 67-kDa and pi 5.4 - 6.2. Using these antibodies, the cgm67
antigen was studied in detail, and was found to be an integral chromaffin
granule membrane protein. Its susceptibility to the enzymes endoglycosidase
F and neuraminidase showed that it was N-glycosylated. Limited trypsin
digestion of chromaffin granules and their membranes was used to
determine its structure and transmembrane topology. Such treatments
liberated a 39-kDa soluble fragment of the antigen which corresponded to the
whole of its cytoplasmic domain. This domain was shown to contain both
the epitope for the monoclonal antibody cgm67 and a calmodulin-binding
site. The 39-kDa fragment was purified, the sequence of its N-terminal 20
amino acids determined and found to be identical to a sequence within the rat
synaptic vesicle protein p65. The cgm67 antigen was therefore termed bovine
p65. The structure and in vitro properties of bovine p65 has suggested that
this protein performs an important function during exocytosis, possibly by
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It is well established that most proteins that are secreted from
eukaryotic cells move by vesicular transport from the endoplasmic reticulum
to the Golgi apparatus to the plasma membrane, in vesicles. The process of
secretion, which depends on the the type of cell, can be categorised as either
"constitutive" or "regulated" [Kelly, 1985; Burgess & Kelly, 1987]. The
constitutive pathway is the general route in all cells for the transport of
molecules that are constantly needed at the cell's exterior such as growth
factors, extracellular components and enzymes. It is also used for the
biogenesis of all the organelles along the secretory pathway including the
plasma membrane. The secretory vesicle, the organelle involved in the final
stages of secretion, transports these molecules from the trans-Golgi network
to the cell surface at rates that keep pace with their synthesis. In contrast,
regulated secretion occurs only in specialised secretory cells such as those
found in endo- and exocrine cells, as well as in neurones. These cells contain
specialised vesicles known as "secretory granules" which can selectively
concentrate their contents many-fold and store them in close proximity to the
plasma membrane until required. The release of the contents to the cell's
exterior then occurs by exocytosis which is triggered by a specific external
secretory stimulus in response to a change in the physiological state of the
organism.
It is assumed that the regulated pathway has evolved from the
constitutive pathway by the superimposition of specific control and targeting
elements, since if these are perturbed, secretion occurs by default through the




about the contents of secretory granules and how these are accumulated, the
biochemistry of granule movement and membrane fusion are not
understood. It is assumed that these events must be regulated by proteins
that are present in the membranes of the granules, although none of the few
membrane proteins which have been identified so far have been assigned an
exact role. Nevertheless, the proteins of the granule membrane provide a
starting-point for the investigation of the molecular mechanism of exocytosis.
The aim of this study was to characterise, by means of immunological
techniques, the membranes of secretory vesicles from the adrenal medullary
chromaffin cell ("chromaffin granules"), to further our understanding of the





1.2 The adrenal chromaffin cell
Chromaffin cells comprise the bulk of the adrenal medulla, a
neuroendocrine tissue derived from the neural crest. They are regarded as
modified post-ganglionic sympathetic neurones which secrete catechol¬
amines, neuropeptides and proteins in response to neural stimulation by the
pre-ganglionic cholinergic nerves that come from the spinal cord [Malmejac,
1964; Carmichael, 1986] (Figure 1.1). Early studies by Blashko and Welsh
(1953) and Hillarp et al. (1953) established that these secretory products are
sequestered in subcellular compartments, now known as chromaffin
granules, and subsequent studies by Douglas showed that they are released to
the cells' exterior by a mechanism analogous to stimulus-contraction in
skeletal muscle [Douglas & Rubin, 1961n]. Consequently the chromaffin cell
became an established model for the study of regulated secretion because of
the ease with which its abundant and dense granules can be purified.
Furthermore the availability of primary cultures [Fenwick et al., 1978] and of
a transformed rat cell line (PC12) [Greene & Tischler, 1976] has allowed the
investigation of the molecular events occurring during biogenesis and
exocytosis of the granules.
1.3 The chromaffin granule
Chromaffin granules, the secretory vesicles of chromaffin cells, are
the re-usable shuttles for the molecules that are released from these cells by
regulated secretion; a typical chromaffin cell contains up to 20,000 granules
[Phillips, 1982; Phillips & Pryde, 1986]. Although regarded as a homogeneous


















terms of size and content [Coupland, 1968; Kryvi et al., 1979; Terland et al.,
1979]. This is because the adrenal medulla is primarily composed of two
different cell types - the adrenaline- and noradrenaline-storing chromaffin
cells. These two types of cells are clearly distinguishable in electron
micrographs, those secreting noradrenaline containing the denser-looking
granules in comparison to those that secrete adrenaline [Coupland et al., 1964;
Coupland & Hopwood, 1966].
In this Chapter, chromaffin granules will be considered as a single
population simply because there have not been many studies on the
properties of the two types of granules. Therefore, the physical parameters of
granules presented in Table 1.1 are only mean values, and serve to illustrate
their magnitude.
[a] Contents of the chromaffin granule :
The matrix of the chromaffin granule is composed of a remarkably
high concentration of secretory products. These are summarised in Table 1.2.
The physiologically best-characterised and most abundant constituents of
chromaffin granules are the catecholamines. Within the granule their total
concentration is estimated to be around 550 mM; this is a typical feature of
regulated secretory vesicles where active transport drives the accumulation of
small molecules. The pathway of synthesis of catecholamines has long been
established [Kirshner, 1975] and is initiated in the cytosol with the
hydroxylation of L-tyrosine into L-dopa (Figure 1.2). This reaction, which is
catalysed by the enzyme tyrosine hydroxylase (EC 1.14.16.2), is the rate-
limiting step of catecholamine synthesis, and is regulated by substrate and
co-factor availability as well as multi-site phosphorylation of the enzyme.
The product dopa is then converted into dopamine by the cytosolic enzyme





Morphometric Analysis of Bovine Chromaffin Cells'^'
The adrenal chromaffin cell
Diameter of a chromaffin cell 16 |tm
Surface area of a spherical cell 800 |im2
The adrenal chromaffin granule
Average diameter of a chromaffin granule 0.28 |im
Surface area of a granule 0.25 |im2
Approximate number of granules in a cell 30,000
Volume of cell occupied by granules 15 %
Total area of granule membrane in one cell 7,400 |im^
a From Phillips & Pryde (1986), see also Phillips (1982).
b These are approximate values and they differ for adrenaline and noradrenaline-storing
chromaffin cells e.g. average number of granules per adrenaline-storing cells is 23,000





Matrix components of chromaffin granules
Matrix small molecules Approx no. of molecules per granule'7
Adrenaline 1.7 xlO6
Noradrenaline 7.1 x 105
Dopamine 2.1 x 104
ATP 5.8 x 105
Other nucleotides 2.3 x 105
Ascorbic acid 1.0 xlO5
Na+ 9.4 x 104
Ca2+ 4.1 xlO4
Mg2+ 2.0 xlO4
Enkephalins 7.5 x 103
Neuropeptide Y 5.0 x 102
Neurotensin 7.2 x 102
Substance P 3.0 x 102








about 4 mg per mg of membrane
protein (chromogranin A family
composes -50% of it).
Matrix glycosaminoglycans pmol sugar/granule protein'1
Chondroitin sulphate 2.6
Heparin sulphate 0.1
a Mean values converted to number of molecules per granule from values taken from Winkler
& Westhead (1980). N.B. Chromaffin granules are heterogeneous and adrenaline and
noradrenaline granules differ [Terland et al. 1979; Bolstad et al. 1980]. Values for inorganic
cations from Krieger-Brauer & Gratzl (1982). 1 mg total chromaffin granule protein is
equivalent to 5.8 x 1044 vesicles [Schilling & Gratzl, 1988].





Catecholamine biosynthesis in adrenal chromaffin cells

























OF ADRENAL CHROMAFFIN CELL









Schematic representation of the ion and small molecule translocators
















and adrenaline requires the active uptake of cytosolic dopamine into the
granules via an amine transporter and, once in the granule, the enzyme
dopamine/3-monooxygenase catalyses its conversion into noradrenaline.
This enzyme requires molecular oxygen and catalyses a redox reaction in
which two electrons are transferred from ascorbic acid via the two copper ions
of dopamine /1-monooxygenase to dopamine. The ascorbic acid is regenerated
from its oxidised form (semidehydro ascorbate) by non-enzymatic
dismutation followed by reduction by electrons supplied from the
transmembrane protein cytochrome b561 [Skotland et al., 1980; Diliberto &
Allen, 1980]. About three-quarters of the chromaffin cells of the bovine
adrenal medulla contain adrenaline-storing granules and the other quarter
contain noradrenaline-storing granules. In the cells with adrenaline-storing
granules, noradrenaline leaves the granule and is converted into adrenaline
by the cytosolic enzyme phenylethanolamine N-methyl transferase (PNMT,
E.C.2.1.1.28). The adrenaline is then taken up into the granule via the amine
carrier and stored until its release from the cell.
Another constituent of the chromaffin granule is ATP, which is
present at around 150 mM. Although the actual reason for the presence of
ATP in the granules is not known, it is thought to play an important role in
reducing of the osmotic stress caused by the high concentration of
catecholamines through ion pairing with Na+ and molecular stacking with
catecholamines [Kopell & Westhead, 1982]. Both ATP and a wide range of
other nucleotides are taken up into the granule by an atractyloside-sensitive
nucleotide-translocase, driven by the membrane potential [Aberer et al., 1978;
Weber & Winkler, 1981].
The chromaffin granule also contains secretory proteins and
neuropeptides at concentrations of 180 mg/ml. The molecular mechanism by




increasingly acidic condition and Ca2+ concentrations have been proposed to
aggregate these proteins during the budding of the granules from the
trans-Golgi network [Wallach & Schramm, 1971; Amsterdam & Jamieson,
1974; Palade, 1975; Huttner et al., 1990]. Despite the high concentration of
these intragranular proteins, there are a relatively few different types, the
most prominent being chromogranin A. This protein, which constitutes
about 7% of the total bovine adrenal medullary and 50% of the intragranular
protein, belongs to a group of acidic glycoproteins that are homologous to the
secretory proteins found in a wide range of endocrine secretory granules
[Cohn et al., 1982; O'Connor & Frigon, 1984; Kruggel et al., 1985]. Structural
studies of chromogranin A have revealed a high content of glutamate,
extensive O-glycosylation and almost no defined tertiary structure [Smith &
Winkler, 1967; Sharp & Richards, 1977; Gerdes et al., 1989]. Electrophoretic
studies show that chromogranin A which has an apparent molecular weight
of 75-kDa (the actual polypeptide molecular weight being 48-kDa), is
proteolysed into a family of peptides. These properties are also features of two
related proteins, chromogranin B (secretogranin I) and chromogranin C
(secretogranin II) which share homology particularly around the
disulphide-bonded loops near the amino-terminus as well as at the
carboxy-terminus [Smith & Winkler, 1967; Kiang et al., 1982; Benedum et al.,
1986 & 1987]. The function of chromogranins is not known. They were
initially thought to play a role in catecholamine storage but this seems
unlikely in view of their wide distribution in secretory granules. More
recently, Galindo et al. (1991) have suggested that chromogranins may be the
precursor to biologically active peptides, since part of the primary sequence of
chromogranin A is homologous to the peptide pancreastatin which regulates
secretion from pancreatic [3-cells [Tatemoto et al., 1986]. Pancreastatin which
inhibits secretion from pancreatic [3-cells has been shown to have similar




Such peptides have not however been isolated from chromaffin cells but if
they have a physiological existence, they may be part of a mechanism to
switch off secretion following exocytosis.
Other secretory proteins present in chromaffin granules are the
soluble forms of dopamine /3-monooxygenase and glycoprotein III, and
various neuropeptide precursors. Dopamine /3-monooxygenase constitutes
some 3 to 4% of the total soluble content of bovine chromaffin granules.
Membrane-bound forms of dopamine /3-monooxygenase and glycoprotein III
are also present (see Section 1.4 for more detail). The enkephalin and
dynorphin precursors are better characterised [Lemaire et al., 1984], The
enkephalin precursors are proteolytically processed resulting in a family of
peptides of up to 28-kDa [Patey et al., 1984; Fischer-Colbrie & Frischenschlager,
1985]. The proteases that carry out the processing of these precursors are also
present in the matrix of the granules, and to date three have been identified: a
cobalt-stimulated carboxypeptidase ("H" or "E") and two trypsin-like
endopeptidases [Fricker & Snyder, 1982; Hook & Eiden, 1984; Lindberg et ai,
1984]. Both bovine and rat carboxypeptidase H have been cloned and
sequenced and shown to exist in two isoforms, identical with the
previously-identified glycoproteins ] and K [Gavine et al., 1984; Fricker et al.,
1986; Rodriguez et al., 1989]. Recent experiments with cultured chromaffin
cells have demonstrated that some peptides derived from proenkephalin and
chromogranin A may be processed extracellularly [Watkinson et al., 1990].
Among the proteins reported to be present in the granule matrix in
minor amounts is acetylcholinesterase; a membrane-bound form of this
enzyme has also been reported [Gratzl et al., 1981]. However, the location of
this enzyme is controversial and its presence in the granules may be as a
consequence of contaminating endoplasmic reticulum and plasma




Mizobe et al., 1984; Burgun et al., 1985]. Another less-well characterised
minor constituent of the chromaffin granule matrix is the acidic 10-kDa
copper-containing protein isolated by Grigoryan et al. (1981) and Mikaelyan et
al. (1987). The structure and function of this protein is unknown, however,
studies of its aminoacid composition and antigenicity have revealed that it is
a member of the neurocuprein family of protein that have been identified in
mammalian brain. The in vivo role of this protein in chromaffin granules is
not clear, there have been reports that it binds catecholamine and, in its
reduced form, participates in adrenochrome detoxification. The apo-form of
this protein has also been reported to be a potent inhibitor of dopamine
/1-monooxygenase [Grigoryan et al., 1981; Mikaelyan et al.,1987]. Resembling
other proteins of the chromaffin granule matrix, this protein also appears to
be present in both soluble and membrane-bound forms, its membrane anchor
has been proposed to be an extended hydrophobic tail [Mikaelyan et al.,1987].
Some 3 - 4% of the chromaffin granule matrix consists of proteo¬
glycans, which is typical of regulated secretory vesicles (Table 1.2). Their
glycosaminoglycan components are thought to consist mainly of dermatan
sulphate and chondroitin 4-6 sulphate [Kiang et al., 1982; see Falkensammer
et al., 1985 for review]. The protein core of the proteoglycans were initially
thought to be immunologically similar to that of chromogranin A, despite
differences observed in their peptide maps [Banerjee & Margolis, 1982;
Kilpatrick et al., 1983]. These differences were attributed to the different
glycosyl contents of the two proteins. However, the recent demonstration
that the antibodies used in the comparison of the peptide maps were directed
towards their glycosyl chains and not towards the polypeptides suggested that
the protein core may indeed be dissimilar [Gowda et al., 1990].
The final constituents of the chromaffin granule matrix are the ions.




bound ATPase I complex (Figure 1.3; see Section 1.4 for details of ATPase I).
The accumulation of protons results in a lumenal pH of about 5.2 and
generates a membrane potential of around -60 mV (inside positive). This
membrane potential is the used for the uptake of small molecules and other
ions as summarised in Figure 1.3. Other cations include Ca2+. Although its
total concentration in the granule is around 20 mM, only 10 pM is free, the
rest being sequestered in chromogranin A/ATP complexes [Bulenda & Gratzl,
1985; Reiffen & Gratzl, 1986]. It is thought that accumulation of Ca2+ by the
granules could be used as a mechanism for the long-term removal of Ca2+
from the cell. The uptake of Ca2+ into the granules is mediated through the
ruthenium red-sensitive Na+/Ca2+ antiporter. Although a link between this
antiporter and the proton gradient was established by Haigh and Phillips
(1990) via a H+/Na+ antiporter, the distribution of Ca2+ and Na+ suggest that
these anions do not equilibrate with protons. Magnesium ions are also
present in the granules at around 5 mM, mostly complexed to ATP.
The anionic composition of the granules is less well defined: chloride
ions are thought to cross the granule membrane passively driven by the
membrane potential. It has been suggested that a mechanism analogous to
the bicarbonate/chloride exchanger of erythrocytes may be present in
chromaffin granule membranes to prevent the lysis of granules as a result of
CP uptake. It has also been suggested that CT uptake into chromaffin granules
may be mediated through a CT channel analogous to that present in the
membranes of coated vesicles and the Golgi apparatus [Xie et ai, 1989a;
Barasach et al., 1991].
[b] Lipid composition of the chromaffin granule membrane :
The membrane composition of the chromaffin granule has to be





Lipid composition of chromaffin granule membranes"













contents. Consequently this membrane is highly impermeable to ions and
small molecules [Johnson & Scarpa, 1976]. Chromaffin granule membranes
also have a high lipid to protein ratio (about 2 gmol phospholipid per mg of
protein). The lipid composition is summarised in Table 1.3. Among the
lipids, sphingomyelin and cholesterol are particularly abundant (e.g. 0.6 (imol
cholesterol/pmol phospholipid) [Winkler, 1976]. Chromaffin granule
membranes also have an usually high content of lysophosphatidylcholine
(approximately 20% of the total phospholipid) [Da Prada et al., 1972] which has
been postulated to play an important role in the fusion between membranes
[Howell & Lucy, 1969]. However only 10% of this phospholipid is in the outer
leaflet of the lipid bilayer of the chromaffin granule membrane [Voyta et al.,
1978; de Oliveira-Filgueiras, 1979]. In contrast, phosphatidylethanolamine,
together with phosphatidylinositol, is enriched in the outer leaflet [Buckland
et al., 1978]; the latter is in the correct orientation for the generation of inositol
phosphates through the action of phospholipase C. It is interesting to note
that phosphatidylinositol appears to be phosphorylated by a component of the
chromaffin granule membrane [Phillips, 1973] and the product of this
reaction, phosphatidylinositol 4,5-bisphosphate (PIP2) is implicated in the
regulation of actin filamentation by proteins such as villin and severin
during exocytosis (see Section 1.5[c] and Matsudaira & Janmey, 1988 for
review).
The other lipid component of the chromaffin granule membranes is
the gangliosides which compose 2 - 3% of the phospholipids. Three different
species of GM3 comprises around 95% of the gangliosides [Dreyfus et al., 1977;
Serkine et al., 1984]. As expected the oligosaccharide moieties of the





[c] Membrane proteins of chromaffin granules :
About 20% of the proteins of chromaffin granules are membrane-
bound. These proteins mediate many of the granules' functions, such as the
biosynthesis and accumulation of catecholamines, its interaction with
cytoplasmic factors and targeting to and from the plasma membrane. It is
therefore not surprising to find that when preparations of chromaffin granule
membranes are analysed by electrophoresis and Coomassie-blue staining,
about 60 bands are detected [Abbs & Phillips, 1980]. Among these proteins, the
two best-studied components of catecholamine biosynthesis, dopamine
/3-monooxygenase and cytochrome b561 constitute about half the protein
content [see Winkler & Fischer-Colbrie, 1990]. The proton translocating
ATPase I complex, which has a fundamental role in the bioenergetics of the
granule, has also been characterised [Percy et ai, 1985; Cidon & Nelson, 1986].
Characterisation of the rest of the proteins has been complicated by not
knowing whether many of the peripheral proteins found in the chromaffin
granule membrane preparation are true components of it. Washing the
membranes at pH 11 with sodium carbonate removes these adherent
proteins, leaving about 40 polypeptides detectable on two-dimensional gels by
Coomassie-blue staining. This is still an underestimate of the number of
integral membrane proteins since about half of these are glycoproteins that
are poorly stained. Lectin-binding provides a better means of visualising
most but not all of these glycoproteins [Gavine et al., 1984; Apps et ah, 1985;
Pryde & Phillips, 1986]. The low abundance of some proteins means that they
can only be visualised by specific antibodies (e.g. SV2, p65, p38), or else their
presence is indicated by activities present in chromaffin granule membrane
preparations (e.g. Na+/H+ antiporter). In short, the proteins of the chromaffin






Chromaffin granule membrane proteins"













Identifiable on gels but function unknown: Not identifiable on gels and function unknown:
Glycoprotein II p65
Glycoprotein III Synaptophysin (p38)
Glycoprotein IV Synaptobrevin (pi 8)
Glycoprotein H SV2
a Adapted from Winkler et al. (1986).




An interesting, yet unresolved, feature of some of these membrane
proteins is their dual distribution as both membrane-bound and soluble
proteins. Within this group of proteins are dopamine /3-monooxygenase,
glycoprotein III and carboxypeptidase H. These proteins will be discussed in




1.4 Membrane proteins of the chromaffin granule
The proteins of the chromaffin granule membrane may be
categorised into two groups depending on their abundance. The more
abundant proteins such as dopamine /1-monooxygenase, cytochrome and
carboxypeptidase H are needed for the biosynthesis and accumulation of the
granules' "cargo", whereas the minor constituents, although their functions
are not known, appear to be needed for the molecular organisation and
intracellular transport of granules. The members of the former group are
present only in those cells which store and secrete the products which they
make and their abundance is consistent with the high concentration of these
products (see Section 1.3[a] and Table 1.2). The low abundance and wider
tissue distribution of the latter group, on the other hand, suggests that they a
involved in a more general (housekeeping) function and may not be required
in as many copies per granule as the biosynthetic proteins.
[a] Maior proteins of the chromaffin granule membrane :
As described in Section 1.3[a], the major constituent of the chromaffin
granule is catecholamines. Two chromaffin granule membrane proteins that
are involved in their biosynthesis are dopamine /Tmonooxygenase and
cytochrome b561, which together constitute around 50% of the total membrane
protein. Dopamine /3-monooxygenase (EC 1.14.17.1), a copper-containing
enzyme, catalyses the conversion of dopamine to noradrenaline in the
chromaffin granule. It is a glycoprotein of about 300-kDa consisting of four
subunits of 72- and 75-kDa, arranged as two pairs of disulphide-linked dimers
[Hortnagl et al., 1972]. It is present in large dense core vesicles of sympathetic




Hokfelt et al., 1975] but its presence in small dense-core vesicles is
controversial (see Winkler & Fischer-Colbrie, 1990). The protein is N-
glycosylated, each tetramer carrying about six oligosaccharides (two high-
mannose and four complex biantennary) which show microheterogeneity
[Margolis et al., 1984] and it therefore binds both concanavalin A and wheat
germ agglutinin [Gavine et al., 1984].
The conversion of dopamine to noradrenaline by dopamine
/3-monooxygenase is a redox reaction requiring molecular oxygen and
electrons (see Section 1.3[a] ). Electrons for this reaction originate from the
cytosol and are transported into the granule via the haem -containing
integral membrane protein cytochrome b561 [Njus et al., 1983], which accounts
for around 20% of the total protein content of chromaffin granule
membranes [Terland & Flatmark, 1980«; Apps et al., 1984; Winkler, 1976]. This
protein has been cloned and sequenced from cow [Perin et al., 1988]; it is
composed of 273 aminoacids and has an apparent molecular weight of 28-kDa
on SDS-gels. It is predicted to cross the chromaffin granule membrane six
times with both its N- and C- terminal domains exposed to the cytoplasm and
is not glycosylated; both predictions are in agreement with earlier studies by
Abbs & Phillips (1980). Recent studies have suggested that the N-terminus
may be fatty acylated and thus be attached to the membrane, however the
physiological significance of this is not clear [Kent & Fleming, 1990].
Cross-linking and redox titration studies have suggested that cytochrome b561
forms oligomers in the granule membrane [Apps et al., 1984],
As a supplier of electrons for granules, cytochrome b561 is present in
both large dense-core and small dense-core vesicles of sympathetic neurones
[Asamer et al., 1971], as well as in the secretory granules of anterior and
posterior pituitary [Pruss & Shepard, 1987]. It is also present in the secretory




endocrine cells of the pancreas [Weiler et al., 1989]. Cytochrome fr561 has also
been reported to be present in heart muscle cells [Pruss & Shepard, 1987].
Among the other major proteins of the chromaffin granule
membrane that are involved in the biosynthesis of intragranular contents is
carboxypeptidase H. Previously known as carboxypeptidase E or
enkephalin-convertase, carboxypeptidase H (EC 3.17.10) is involved in the
biosynthesis of enkephalin. It removes C-terminal arginines and lysines
from the partially-processed proenkephalin [Hook et al., 1982; Fricker, 1986].
Carboxypeptidase H has been shown to be the same protein as the previously
identified glycoproteins J and K of the chromaffin granule membrane [Wood
et al., 1984; Laslop et al., 1986]. It displays a broad tissue distribution, and as
well as in the adrenal medulla, it is present in pituitary, pancreas, endocrine
cells of the gastrointestinal tract as well as in various regions of the brain
[Lynch et al., 1986,1987,1988; Hook et al, 1985].
One common feature of the biosynthetic enzymes such as dopamine
/3-monooxygenase and carboxypeptidase H is that they are present in both
membrane-bound and soluble forms in approximately equal amounts.
Another chromaffin granule protein, "glycoprotein III" with unknown
function, is also present in two forms [Winkler & Fischer-Colbrie, 1990;
Palmer & Christie, 1990]. The reasons for this dual distribution is not known;
their genes have been cloned and sequenced [Lamouroux et al.,
1987 (D/3H); Fricker et al., 1986 & Rodriguez et al., 1989 (CpH); Palmer & Christie,
1990 (GpIII) ], and no apparent differences were found which could result in
the two forms. It is possible that during evolution, the membrane-binding
property of these proteins initially served as a sorting mechanism at the
trans-Golgi network (such as that proposed for chromogranin A by Huttner et
al., 1990), and since then it evolved as a mechanism to preventing their loss




/3-monooxygenase and glycoprotein III have been shown to recycle into new
granules after exocytosis [Phillips et al., 1983; Patzak et al., 1984; Hunter &
Phillips, 1989],
The mode of attachment of these proteins to the chromaffin granule
membrane is a controversial issue and three different models have been
proposed: (l) uncleaved signal sequence, (2) phospholipid anchors, and (3)
conformational change induced by the environment of the protein. Most
studies have been carried out on dopamine /1-monooxygenase - there is
evidence for the presence of both an uncleaved signal sequence [Skotland et
al., 1977; Taljanidisz et al., 1989] and affinity for phophatidylserine [Taylor &
Fleming, 1989]. For glycoprotein III, membrane binding may be dependent on
the lumenal milieu - this is suggested by the homology of this protein to
glycoprotein 2 of rat Sertoli cells which can aggregate red blood cells [Palmer &
Christie, 1990; Jenne & Tschopp, 1989; Laine & Esser, 1989]. Whatever the
mechanism of attachment, it is not clear how it results in an equal
distribution of these proteins between the two forms. It must also be stressed
that these proteins were not accessible to extragranular reagents [Abbs &
Phillips, 1980].
The accumulation of the catecholamines and ions from the cytosol
into chromaffin granules is dependent on the membrane potential and the
pH gradient maintained by the ATPase I complex, a proton pump originally
identified by Hillarp in 1962. ATPase I belongs to the vacuolar type of proton
pumps which occurs in the membranes of intracellular acidic compartment,
and is related to, but distinct from, the mitochondrial F-type ATP synthase
[Pederson & Carafoli, 1987; Forgac, 1989; Moriyama & Nelson, 1989a,b]. The
electrogenic translocation of protons into the granules is linked to cytosolic
ATP hydrolysis and results in a pH gradient of 1.7 units and a membrane




accumulation of catecholamines as well as transport of Na+ and Ca2+ ions into
the granule.
ATPase I is a multisubunit complex of about 500-kDa. Although its
exact subunit composition is controversial, it is generally regarded to be
composed of six subunits of apparent molecular weights 120-, 72-, 57-, 40-, 33-
and 16-kDa [Percy et al., 1985; Cidon & Nelson, 1986; Perez-Castiniera & Apps,
1990]. In intact granules, the 120-, 72-, 57-, 40- and 33-kDa subunits are all
accessible to treatment by impermeant reagents such as N-hydroxysuccini-
midyl biotin, suggesting that they are exposed to the cytoplasm. Washing the
membranes at pH 11 fails to remove the 120- and 16-kDa subunits, and these
are the only subunits that are labelled with TID, a hydrophobic probe which
reacts with those the regions of membrane proteins in contact with the
phospholipid bilayer. Therefore the only membrane-spanning polypeptides
of the complex are the 120- and 16-kDa subunits [Apps et al., 1989]. The
120-kDa subunit is thought to be the only glycosylated polypeptide of the
complex [Apps et al., 1989; Gillespie et al., 1991].
The 16-kDa subunit is thought to form a hexameric proton-
translocating channel. Its sequence is highly homologous to other channel
complex proteins such as the 15-kDa proteolipid of the mediatophore in
Torpedo electric organs and the 16-kDa gap junction protein [Mandel et al.,
1988; Leitch & Finbow, 1990; Birman et al., 1990]. Proteins of this nature are
implicated in the formation of fusion pores that are necessary for fusion of
lipid bilayers [Aimers, 1990], but there is no evidence that the ATPase 16-kDa
subunits perform such a function.
Most of the subunits of V-type ATPases have now been cloned and
sequenced [Wang et al., 1988; Manolson et al., 1988]. The results, confirmed by
biochemical studies, suggest that the subunit of 67-72-kDa contains the




nucleotide binding site and the 16-kDa subunit comprises the proton channel.
The functions of the other polypeptides, including the largest, trans¬
membrane subunit of 120-kDa remain unknown.
Although ATP is required for exocytosis, a direct role of the ATPase
can be excluded because the ATPase can operate with a broad range of
nucleotides whereas exocytosis is specific for ATP; and because the Km for the
ATPase is about 10-fold less that which is required for exocytosis.
Furthermore, agents that inhibit the ATPase activity and those that dissipate
the pH or potential gradients do not effect exocytosis [Holtz et al., 1983; Knight
& Baker, 1985].
The other ATPase activity present in chromaffin granule membrane
as well as in bovine brain clathrin-coated vesicle membranes and secretory
granules of the pituitary is due to a vanadate-sensitive ATPase II [Percy et al.,
1985; Xie et al., 1989b; Russell, 1984]. In contrast to the ATPase I complex,
ATPase II is a single polypeptide with an apparent molecular weight of
140-kDa by gel filtration and 120-kDa by SDS-gels [Percy et al., 1985; Moriyama
& Nelson, 1988a]. It is of unknown function, however Zachowski et al. (1989)
have suggested that it may be involved in aminophospholipid translocation
within the granule membrane.
Another major protein of the chromaffin granule membrane of
unknown function is glycoprotein II. Glycoprotein II is a heterogeneous
component of granule membranes with a pi of 4.2-4.7 and an apparent
molecular weight of 80- to 100-kDa. [Pryde & Phillips, 1986; Winkler et al.,
1986]. It is extensively glycosylated with galactose, N-acetylglucosamine and
sialic acid moieties and it has therefore been identified by lectin blotting
[Gavine et al., 1984]. It is present in both endocrine and exocrine secretory
vesicles [Obendorf et al., 1988] as well as in lysosomes [Weiler et al., 1990] but




detergent lithium di-iodosalicylate has provided a rapid way of isolating it
[Christie & Palmer, 1990]. Its N-terminal aminoacid sequence shows that it is
enriched in cysteine and acidic aminoacids [Christie & Palmer, 1990]. Its
orientation in the granule membrane is not known but it is accessible to
extragranular reagents [Abbs & Phillips, 1980]. Unlike dopamine /3-mono-
oxygenase, glycoprotein III and carboxypeptidase H, it does not appear to be
present in a soluble form in the matrix.
Minor proteins of the chromaffin granule membranes that are also
present in other secretory vesicle membranes :
An increasing number of secretory vesicle membrane proteins that
are not involved the biosynthesis of vesicular contents and that display wide
tissue distributions are being identified with the use of immunological
techniques. These proteins appear to be present in both hormone-storing
dense core vesicles (such as in the adrenal and pituitary glands), and in small
synaptic vesicles. Their functions are not known but their wide tissue
distribution, highly conserved structures and their in vitro activities strongly
imply that they are involved in secretory vesicle organisation and trafficking.
Although they appear to be abundant components of synaptic vesicles, their
presence in chromaffin granules is masked by the abundance of the
biosynthetic enzymes, secretory protein and peptides. As a consequence, in
preparations of chromaffin granule membranes, they may only be visualised
with the aid of specific antibodies. Among these proteins are SV2, p65, p38






As a consequence of raising and using monoclonal antibodies to
characterise synapses at a molecular level, p65 was the first secretory vesicle
membrane protein to be found to have wide tissue and species distribution
and not to be involved in the biosynthesis of vesicular contents [Matthew et
al, 1981].
Using rat brain synaptic junctional complexes as an antigen to
prepare monoclonal antibodies, Matthew et al. (1981) obtained two antibodies,
asv30 and asv48. Immunocytochemical analysis at the electron microscope
level demonstrated that the epitope of the antigen recognised by these
antibodies was present on synaptic vesicle membranes in all nerve terminals
of the central nervous system, as well as on the secretory vesicle membranes
of pituitary (anterior and posterior) and adrenal medulla [Matthew et al., 1981;
Fournier & Trifaro, 1988«]. Cell lines derived from the above tissue such as
AtT20, GH3 and PCi2 also possessed this antigen; the localisation of the antigen
at higher resolution, as well as its accessibility to antibody-coated acrylamide
beads, demonstrated that the epitope recognised by these antibodies was
exposed to the cytoplasmic side of vesicles [Matthew et al., 1981; Lowe et al.,
1988; Floor & Feist, 1989]. When the antigen was analysed by
immunoblotting, its molecular weight was found to be 65-kDa in all
vertebrate species tested and the antigen was hence termed "p65" [Matthew et
al., 1981]. The immunoreactivity of these monoclonal antibodies with p65
from different species, the similar molecular weights of different intact p65
and the correspondence of the proteolytic fragments suggested that p65 was a
common, yet evolutionally- conserved protein of secretory vesicles in neural
and endocrine tissue. However, p65 was not detected in exocrine tissue such
as pancreas or in salivary glands and liver [Matthew et al., 1981].




it carries out an important function, to date this function remains obscure.
As with other secretory vesicle membrane proteins such as SV2,
synaptophysin and synaptobrevin, the lack of in vitro assays which
reconstitute exocytosis, and not knowing which stage of the exocytic pathway
to study remain barriers to determining the function of p65. However, the
discovery that p65 binds calmodulin, a protein which regulates the function
of other proteins in response to the levels of intracellular Ca2+ concentrations,
has been an important step in implicating p65 as a component of the secretory
machinery of regulated secretory cells [Fournier & Trifaro, 1988a; Trifaro et al.r
1989]. Previous studies on calmodulin-binding proteins present in bovine
chromaffin granule membranes had identified two proteins of 50/53- and
65/69-kDa which displayed Ca2+-dependent calmodulin binding [Geisow et al.,
1982; Hikita et al., 1984; Bader et al., 1985]. It was subsequently shown by
Fournier & Trifaro (1988a) that the 65/69-kDa chromaffin granule calmodulin-
binding protein also bound asv48, the monoclonal antibody originally used to
identify p65 [Matthew et al., 1981], and that this protein was also present in
chromaffin cell plasma membranes [Fournier & Trifaro, 1988;'], confirming
previous observations by Matthew et al. (1981). These findings suggested that
p65 may be involved in the docking of secretory vesicles to the plasma
membrane preceding membrane fusion and discharge of the vesicular
contents.
The recent cloning and sequencing of the cDNA encoding p65 from
rat, human and Drosophila has allowed Perin et al. and others to predict the
structure of p65 [Perin et al., 1990, 1991a &1991/0; these findings are supported
by biochemical evidence [Tugal et al., 1991; Perin et al., 1991/']. According to
these predictions, in both rat and human, p65 is an integral membrane
glycoprotein of secretory vesicles, consisting of 421 aminoacids.




vesicle membrane once and has a large cytoplasmic domain consisting of 343
aminoacids. The cytoplasmic domain appears to be important in the function
of p65 as it is highly conserved - comparison of the human and rat sequences
reveals that only two aminoacids are different in this domain (residues 190
and 375; see appendix I for sequences). Within the cytoplasmic domain, there
are two regions in tandem showing 39% homology to the regulatory C2
domain of protein kinase C (PKC) [Perin et nl., 1990]. These two domains are
only slightly more homologous to each other than they are to protein kinase
C, and these differences are conserved across species, suggesting that they are
not functionally equivalent. The cytoplasmic domain of p65 has been shown
to bind acidic phospholipids with diacylglycerol backbones, and to agglutinate
red blood cells [Perin et nl., 1990]. These functions have been assigned to the
PKC-like domains since recombinant cytoplasmic domain constructs which
contain only one such repeat retain phospholipid-binding but fail to
agglutinate red blood cells [Perin et nl., 1991b].
As well as binding acidic phospholipids, it is suggested by Perin et nl
(1991a) that the PKC-like domains of p65 may also bind Ca2+, because PKC
isoenzymes that lack this domain do not require Ca2+ for activation
[Nishizuka, 1989] and that Ca2+ binding may be physiologically important in
the regulation of p65. Perin et nl do not have direct evidence in support of
this claim nor for their dismissal of the importance of Ca2+-calmodulin
binding to p65 [Siidhof & Jahn, 1991]. Irrespective of whether p65 binds Ca2+
directly or is activated by Ca2+-calmodulin, it appears that the function of p65
is regulated by changes in intracellular Ca2+ concentration; it has also been
reported recently that the activity of p65 may be modulated by its
phosphorylation state [Petrenko et nl., 1991] (see Section 1.6[b] ).
The intralumenal (N-terminal) domain of p65 is the least conserved




residues are different in this domain, as compared 2 out of 343 in the
cytoplasmic domain. In Drosophila, this domain is 47 aminoacids longer
than its mammalian counterpart [Perin et al., 1991n]. Recently, an isoform of
p65 has been cloned from mouse which is has the same overall structure,
however it is expressed only in the certain regions of brain and not in
neuroendocrine glands [Geppert et al., 1991]. The intravesicular domain of
this isoform is also divergent (46% homologous to the more widely
distributed isoform). The only constant feature of the intravesicular domain
is that it is N-glycosylated [Tugal et al., 1991; Perin et al., 1991b].
The p65 gene has been located in chromosome 12 (12cen-q21) in
humans and chromosome 23B in Drosophila [Perin et al., 1991a]- The 3'
region of p65 mRNA appears to 87% conserved in rat and human with a
region containing 22 consecutive copies of GTs, this region is not translated.
The long untranslated 5' regions of p65 mRNA is also unusual - in
Drosophila, this region contains five consecutive copies of CAGs [Perin et al.,
1991«]. These observations remain unexplained but illustrate that p65 must
be involved in an important function.
One such function of p65 suggested by all investigators is in the
docking of vesicles to the plasma membrane [Fournier & Trifaro, 1988; Perin
et al., 1991b; Sudhof & Jahn, 1991]. There are three lines of evidence in
support of this: first is that p65 is the only protein which is present in both
secretory vesicle membranes and in plasma membrane [Fournier & Trifaro,
1988]; the second is that p65 has been suggested to form homooligomers [Perin
et al., 1991b;]; and thirdly, p65 can bind phospholipids in membranes [Perin et
al., 1990]. It may be that during exocytosis, p65 initially docks secretory
vesicles to the plasma membrane with its phospholipid-binding activity and
then forms an oligomeric fusion pore such as that suggested by Aimers






Originally named synaptin, synaptophysin is a major constituent of
synaptic vesicle membranes and has a wide distribution in the nervous
system as well as in endocrine glands [see Winkler & Fischer-Colbrie, 1990,
and references therein], Synaptophysin is a glycoprotein of 38-kDa and has pi
ranging from 4.5 to 5.8 [Rehm et nl., 1986; Johnston et nl., 1989; Obendorf et nl.,
1988], but under non-reducing conditions it forms homooligomers and has an
apparent molecular weight of 76-kDa on SDS-gels [Rehm et nl., 1986; Jahn &
Maycox, 1988].
The primary structure of synaptophysin is known and, like p65, it is
highly conserved [Buckley et nl., 1987; Leube et nl., 1987; Siidhof et nl., 1987], It
consists of 307 aminoacids with membrane topology showing four
hydrophobic transmembrane domains, its N-terminus as well as its larger
C-terminal domain both being exposed to the cytoplasm. The primary
sequence of synaptophysin shows homology to the connexons of gap
junctions which form oligomeric cell to cell channels. If this homology is
also functional, then together with its Ca2+-binding activity [Rehm et nl., 1986],
synaptophysin might be involved in the formation an exocytic fusion pore
[Breckenridge & Aimers, 1987; Aimers, 1990]. The formation of such pores is
supported by the in vitro observations that synaptophysin forms hexameric
voltage- sensitive channels in lipid bilayers [Thomas et nl., 1988]. Recent
identification of an oligomeric 36-kDa plasma membrane protein,
"physophilin" (suggested to be the "receptor" of synaptophysin during
exocytosis), has strengthened synaptophysin's putative role as the exocytic
fusion pore [Thomas & Betz, 1990]. Synaptophysin has also been




the actual function of synaptophysin is unknown.
One obstacle to determining the function of synaptophysin has been
the uncertainty of its subcellular localisation. In neurones, synaptophysin is
clearly present in synaptic vesicles [Navone et al., 1986; De Camilli & Navone,
1987], but its localisation in neuroendocrine cells has been controversial. The
centre of this controversy is whether, in neuroendocrine cells, synaptophysin
is present in membranes of large dense-core vesicles (such as chromaffin
granules) or in small synaptic vesicle-like vesicles, or both. The presence of
synaptophysin in small synaptic vesicle-like vesicles in endocrine cells has
been taken to imply that there may be two parallel pathways of exocytosis in
cell which display regulated secretion [De Camilli & Navone, 1987; De Camilli
& Jahn, 1990]. However, careful biochemical analysis of the intracellular
distribution of synaptophysin in chromaffin cells by Obendorf et al., (1988)
and Fournier et al., (1989) has shown that synaptophysin is indeed present in
chromaffin granules (see also Lowe et al., 1988) as well as in a population of
vesicles which band around 0.85 - 1.00 M sucrose. These vesicles have not
been characterised but are probably the 50 nm synaptic vesicle-like vesicles
observed by Navone et al., (1986) and may hold the clue to the function of
synaptophysin. Other membrane proteins such as SV2, p29 and synapto-
brevin have also been reported to be enriched in these small synaptic
vesicle-like vesicles [Baumert et al., 1989].
The discrepancies about the localisation of synaptophysin appear to be
as a result of the the low relative abundance of this protein in membranes of
chromaffin granules. Schilling & Gratzl (1988) have determined that the copy
number of synaptophysin per vesicle is around 20 in both chromaffin granule
and synaptic vesicles. Since chromaffin granule membranes have a more
complex composition than synaptic vesicles, the relative amount of




vesicle membranes and is spread over 30-times the membrane surface area
[Schilling & Gratzl, 1988; Obendorf et ah, 1988; Fournier et ah, 1989]. As a
consequence, immunocytochemical methods used by Navone et al., (1986)
may not be sensitive enough to determine the presence of synaptophysin in
chromaffin granules.
(iii) SV2 :
This glycoprotein, with an apparent molecular weight of 100-kDa, was
initially identified by the use of monoclonal antibodies raised against
cholinergic vesicles of Torpedo californica [Buckley & Kelly, 1985]. Its
function and structure are not known but it has a wide distribution in large
dense-core secretory vesicles of neural and endocrine cells, as well as in cell
lines derived from the latter (PC12 and GH3). As well as being present in these
vesicles, SV2 has also been identified in small synaptic vesicle-like vesicles of
endocrine cells which are devoid of typical chromaffin granule marker
proteins such as dopamine /1-hydroxylase and cytochrome fr561 but which
contain synaptophysin [Floor & Feist, 1989; Winkler et al., 1991]. It is thought
to be a transmembrane protein since the epitope of the monoclonal antibody
used for its identification is present on the cytoplasmic side of secretory
vesicles and it is glycosylated [Buckley & Kelly, 1985].
(iv) p29 & synaptobrevin (pl8) :
These recently-identified synaptic vesicle membrane proteins are also
present in endocrine tissue such as adrenal medulla and the pituitary
[Trimble et al., 1988; Baumert et al., 1989; Baumert et al., 1990]. Immuno-




synaptic vesicles in neurones and in the small synaptic vesicle-like vesicles of
chromaffin cells, which also contain synaptophysin. These proteins have not
been detected in the membranes of chromaffin granules using immunocyto-
chemical techniques, but as with the subcellular distribution of synaptophysin
discussed above (Section 1.4(b)(ii) ), this may be because of their low relative
abundance in the granule membrane.
The functions of these proteins are not known, although p29 is a
substrate for tyrosine kinase [Baumert et al., 1990], and synaptobrevin, like
p65, is proposed to span the vesicle membrane once with the larger part of the
protein exposed to the cytoplasm. Resembling p65, synaptobrevin is proposed
to be present in isoforms [Elferink et al., 1989].
(v) svp25:
Svp25 is the latest synaptic vesicle membrane glycoprotein to be
identified from the electric organ of Torpedo californica [Volknandt et al.,
1990]. Its function has not been determined, although it is phosphorylated in
vitro, binds Ca2+ and forms hexameric oligomers suggesting a role either in
ion transport into the synaptic vesicle or in the formation of an exocytic
fusion pore. Unfortunately, the polyclonal antibodies raised against
denatured svp25 did not cross-react with mammalian synaptic vesicle
proteins despite the presence of a protein of the same molecular weight in the
latter preparation. It therefore remains to be seen whether this protein is




1.5 Proteins associated with chromaffin granules
Preparations of chromaffin granule membranes contain extrinsic
proteins of extra-granular origin which co-purify with them. These proteins,
which are summarised in Table 1.5, originate from both the lumen of the
granule and from the cytosol. For some of these proteins, the nature of their
association with the granule membrane is not known, but for others their
binding is reversible and dependent on molecules such as Ca2+, ATP and GTP
which are intracellular messengers of exocytosis (see Section 1.6). This section
will review the possible role of these proteins in exocytosis.
[a] Calcium-dependent granule-binding proteins :
Since the discovery that Ca2+ is an important factor for exocytosis
[Douglas & Rubin, 1961a], there has been substantial research to identify
proteins which can couple changes in the intracellular concentrations of Ca2+
to the exocytic machinery.
Calmodulin is a well-characterised 17-kDa acidic protein which
regulates the function of many cellular proteins in response to changes in
intracellular levels of Ca2+, and therefore its role in exocytosis has been
investigated. Calmodulin is present in chromaffin cells comprising around
0.01 to 0.04% of the total cellular protein [Kuo & Coffee, 1976; Hikita et al.,
1984], Although its direct involvement in secretion is not yet proven, many
of its properties suggest its role in secretion. For example, when chromaffin
cells are challenged with secretagogues, around 25% of the cytosolic
calmodulin becomes membrane-bound predominantly to the granules
[Hikita et al., 1984], Furthermore, the inhibition of exocytosis by calmodulin
antagonists (e.g. trifluoperazine) and by anti-calmodulin antibodies





Proteins associated with chromaffin granule membranes"




cytosolic e.g. synexin, calpactin,
caldesmon and other members of




Creutz et al. (1978),
Creutz et al. (1983),
Geisow & Burgoyne (1982),
Geisow & Burgoyne (1983),
Geisow et al. (1982),
Hikita et al. (1984),
Martin et al. (1987).
Terbush et al. (1988).






Aunis & Perrin (1984),
Bader & Aunis (1983),
Bader et al. (1986),
Jockusch et al. (1977),
Fowler & Pollard (1982),
Rodriguez Del Castillo et al. (1990),
Sakurai et al. (1990 & 1991).
GTP-binding proteins cytosolic - Rab3A Matteoli et al. (1991).
Chromogranins
(A, B and C)
lumen of chromaffin granules Pryde & Phillips (1986).




involved in the secretory process [Kenigsberg et al., 1982; Brookes & Treml,
1983; Kenigsberg & Trifaro, 1985]. Similar biochemical evidence has been
obtained with anterior pituitary cells, sea urchin oocytes and in the
unicellular organism Paramecium. [Conn et ah, 1981; Steinhardt & Alderton,
1982; Momanyezi et al., 1987], However, there have also been reports that
both calmodulin agonists and anti-calmodulin antibodies had no effects on
saponin- and streptolysin-permeabilised chromaffin cells [Brook & Treml,
1984; Ahnert-Hilger et al., 1989]. It must be pointed out that because
calmodulin regulates many intracellular processes, it is difficult to distinguish
between the general effects of the above reagents as opposed to their effects at
the site of exocytosis.
A more direct way of demonstrating the role of calmodulin in
secretion has been by studying its interaction at the chromaffin granule
membrane. Chromaffin granules show Ca2+-dependent calmodulin binding.
The binding capacity of chromaffin granule membranes for calmodulin is low
but highly specific: reported biding parameters are Bmax= 3.3 pmol/mg, Kd=31
nM [Burgoyne & Geisow, 1981], and Bmax = 30 pmol/mg, Kd = 13 nM [Hikita et
fl/.,1984]. The granular receptors of calmodulin have been identified as two
proteins of 50/53-kDa and 65/69-kDa, and binding to both of these is
dependent Ca2+. The 65/69-kDa protein has been identified as the integral
membrane glycoprotein p65 which has a wide tissue distribution; the identity
of the 50/53-kDa protein is not known but it could be a membrane-bound
proteolytic product of p65 [Geisow & Burgoyne, 1983; Bader et al., 1985; Tugal
et al., 1991]. Calmodulin also binds in a Ca2+-independent manner to
chromaffin granule membrane proteins of 21- and 24/25-kDa but these have
not been characterised [Geisow et al., 1982; Hikita et al., 1984],
In the presence of elevated Ca2+ concentrations, calmodulin is able to




granule membrane [Geisow & Burgoyne, 1983] and among these is the actin-
and phospholipid-binding protein, caldesmon, whose possible function in
exocytosis is discussed below.
Other cytosolic proteins have also been shown to bind reversibly to
chromaffin granule membranes in a Ca2+-dependent manner and have
therefore been implicated in the mechanism of exocytosis. These proteins
have been collectively named as "annexins" or "chromobindins" [Creutz et
al., 1988; Geisow et al., 1987; Burgoyne & Geisow, 1989]. Annexins are a group
of seven Ca2+- and lipid-binding proteins which contain either four or eight
copies of a conserved 17-aminoacid sequence and a variable N-terminal
region characteristic of each protein [Geisow et al.r 1987, Burgoyne & Geisow,
1989; Kretsinger & Creutz, 1986]. Synexin was the first annexin to be
identified on the basis of its ability to aggregate and fuse chromaffin granules
[Creutz et al., 1978; Creutz, 1981; Creutz et al., 1988; Burns et al., 1989].
Compared to the other annexins, synexin has an extended N-terminal region
[Burns et al., 1989]. A model has been proposed for the fusogenic action of
synexin in which it inserts itself into the membrane and forms a channel
[Pollard et al., 1988; Burns et al., 1989]. However, these in vitro activities
require a free Ca2+ concentration of around 10 - 100 pM, much higher than
that suggested to be required in permeabilised cell experiments [Baker &
Knight, 1981; Kao & Schneider, 1986; see also Burgoyne, 1984].
The best evidence for the role of annexins in exocytosis has been for
the 36-kDa annexin, calpactin. Unlike other annexins, calpactin exists in
association with an 11-kD polypeptide, the calpactin light chain, as p362-pll2
heterotetramers [Gerke & Weber, 1984; Zokas & Glenney, 1987; Burgoyne &
Morgan, 1990]. In the heterotetrameric form, calpactin has been shown to
aggregate chromaffin granules at Ca2+ concentrations of around 1-2 pM [Drust




acid (and 2 mM Mg2+), calpactin can promote membrane fusion [Drust &
Creutz, 1988], the significance of this activity is that arachidonic acid has been
shown to be produced when bovine chromaffin cells are stimulated [Frye &
Holz, 1984]. In the monomeric form, calpactin can also aggregate chromaffin
granules but as with synexin, this requires Ca2+ concentration of around 10-
100 jiM, implying that the binding of the light chain lowers the Ca2 +
dependence of calpactin in aggregating granules [Drust & Creutz, 1988]. The
N-terminal "tail" of calpactin appears to be important in its function since the
proteolytic peptide of calpactin without the first 27 aminoacids does not bind
the light chain or lipid bilayers [Drust & Creutz, 1988; Ali et al., 1989].
Heterotetramer formation by calpactin is regulated by both Ca2+ and by
phosphorylation. In cultured chromaffin cells, phosphorylation of calpactin
parallels nicotine stimulation. The kinase(s) which carry out this
phosphorylation in vivo are not known, but calpactin heavy chain contains
phosphorylation sites for pp60c~src, protein kinase C, cAMP- and
calmodulin-dependent protein kinases [Johnsonn et al., 1986; Gerke, 1989]. In
vitro results show that tetramer formation is inhibited by phosphorylation at
serine25 by protein kinase C, but not at tyrosine23 by pp60c"src [Johnsonn et al.,
1986; Powell & Glenney, 1987], Tyrosine phosphorylation appears only to
inhibit the phospholipid-binding activity of calpactin [Powell & Glenney,
1987]. When phosphorylation of the heavy chain is blocked by the binding of
antibodies against the N-terminal domain of calpactin in
digitonin-permeabilised bovine chromaffin cells, a small increase in
Ca2+-dependent exocytosis is observed [Burgoyne & Morgan, 1990].
The most conclusive evidence for the role of calpactin (and other
annexins) in exocytosis has come from experiments investigating the
function of the consensus repeat sequence. When a peptide containing the




into digitonin-permeabilised bovine chromaffin cells, exocytosis was
inhibited [Ali et al., 1989; Ali & Burgoyne, 1990]. Furthermore, addition of
calpactin to digitonin-permeabilised cells from which cytosolic factors have
leaked out (and consequently lost their ability to secrete) restored some of
their Ca2+-dependent exocytosis (Burgoyne & Morgan, personal communi¬
cation; see Section 1.5[e]).
Calpactin (and other other annexins) have been localised just beneath
the plasma membrane [Burgoyne et al., 1986; Burgoyne & Cheek, 1987] and
calpactin filaments which cross-link granules to the plasma membrane have
been identified [Nakata et al., 1990]. In view of the subcellular localisation
and in vitro properties of calpactin, it has been suggested that it is involved in
the final stages of exocytosis by mediating the binding and possibly the fusion
of the granules with the plasma membrane [Burgoyne, 1991].
Caldesmon (or p70), another Ca2+-
calmodulin-dependent actin cross-linking protein [Burgoyne et al., 1986].
Caldesmon-actin association is inhibited at micromolar Ca2+ concentrations,
and it is suggested that this might lead to the opening up of the actin network
in the periphery of the cell during exocytosis (see Section 1.5[c]). Caldesmon
has a similar subcellular distribution as calpactin, just beneath the plasma
membrane [Burgoyne et al., 1986]. The possession of these properties suggests
that caldesmon may also play an important role in the mechanism of
exocytosis.
"Chromobindins" are a larger group of calcium-dependent granule-
binding proteins which have been described by Creutz et al. (1983).
Chromobindins not only include members of the annexins, but also proteins
such as calmodulin, protein kinase C and a phosphatidylinositol-specific
phospholipase [Summers & Creutz, 1985; Creutz et al., 1985]. Seven




toroidal complex ("chromobindin A") on chromaffin granule membranes
with ATPase activity but the exact role of this complex is unknown [Martin &
Creutz, 1987].
[b] Secretory vesicle-binding phosphoproteins and kinases :
The requirement of ATP for exocytosis suggests that the exocytic
machinery of cells could be regulated by phosphorylation (see also Section
1.6[b] ). To date, the best evidence for the involvement of phosphoproteins in
exocytosis relates to the cytosolic synaptic vesicle and cytoskeleton-binding
proteins of the synapsin family (synapsin la, lb, Ila, lib) [see De Camilli &
Navone, 1987; Burgoyne, 1990 and Slidhof & Jahn, 1991 for reviews].
Synapsin I was first discovered as a major endogenous substrate for cAMP-
dependent protein kinase in mammalian brain, but it is also phosphorylated
by Ca2+-calmodulin-dependent protein kinase II [Johnson et ai, 1972; Llinas et
al., 1985]. Phosphorylation of synapsin I by Ca2+-calmodulin-dependent
protein kinase II parallels neurotransmitter release and promotes its
dissociation from both synaptic vesicles and from the cytoskeleton [De
Camilli & Greengard, 1986; Schlieber et al., 1986]. When dephospho-, but not
phospho-synapsin I is microinjected into the preterminal digits of giant squid
axon, neurotransmission is strongly inhibited [Llinas et al., 1985]. This
observation correlates with the actin-bundling properties of synapsins Ia/b
[Petrucci & Morrow, 1987; Bahler & Greengard, 1987], It is proposed that
dephospho-synapsin cross-links synaptic vesicles to the cytoskeletal network
in resting cells, and upon stimulation, it dissociates allowing the movement
of vesicles towards the plasma membrane. The speed of synaptic release
implies that this mechanism probably prepares the vesicles for exocytosis




phosphoproteins of the same size as synapsin, there is uncertainty whether
synapsin is present in chromaffin granules [Burgoyne & Geisow, 1981 & 1982].
However, a related phosphoprotein (protein III, consisting of 55- and 74-kDa
polypeptides) is present in chromaffin granule membranes and its
phosphorylation increases upon stimulation [Burgoyne & Baines, 1987;
Haycock et al., 1988].
The discovery of tyrosine kinase pp60c~src as a component of
chromaffin granule membranes in association with a 38-kDa protein has
suggested a possible role of this kinase in the phosphorylation of calpactin
upon its binding to chromaffin granule membranes, and therefore in the
regulation of exocytosis (see Section 1.6[b]) [Parsons & Creutz, 1986; Grandori
& Hanfusa, 1988]. Protein kinase C is another kinase which also binds to
chromaffin granule membranes [Terbush et al., 1988], its involvement in
secretion will be discussed in Section 1.6[b].
[c] Cytoskeletal and cytoskeleton-organising proteins :
In resting chromaffin cells, granules are prevented from interacting
with the plasma membrane by a dense cortical cytoskeletal network
composed primarily of F-actin and fodrin. This cytoskeletal barrier is
apparent in electron micrographs of resting chromaffin cells, as a distinct
400-nm zone devoid of granules just beneath the plasma membrane [Geisow
& Burgoyne, 1982, 1986].
For exocytosis to take place, this network must be rearranged allowing
granules access to the plasma membrane. The requirement for this
rearrangement has been implied from experiment where the cytoskeletal
network is perturbed by drugs or antibodies. For example, treatment of




B, which induce actin disassembly, decrease the Ca2+-dependency of secretion,
whereas phalloidin, which stabilises F-actin, inhibits secretion [Lelkes et al.,
1986]. Furthermore, following the stimulation of chromaffin cells, the sites of
exocytosis appear to be devoid of F-actin [Vitale et al., 1991].
There is increasing evidence that some of the proteins involved in
the regulation of the cytoskeleton are peripheral components of chromaffin
granules. As the action of these proteins appear to be under the control of
factors or events similar to those implemented in the regulation exocytosis
such as intracellular concentration of Ca2+, inositol phospholipids and protein
phosphorylation, they appear to be required for exocytosis [Matsudaira &
Janmey, 1988; Vandekerckhove, 1990].
Among these cytoskeletal regulatory proteins present on chromaffin
granules is a-actinin [Jockusch et al., 1977; Bader & Aunis, 1983]. The non-
muscle isoform of a-actinin is a 100-kDa Ca2+-regulated actin cross-linking
protein. In the absence of Ca2+, a-actinin forms antiparallel homodimers
which cross-link actin filaments. In the presence of micromolar Ca2 +
concentration however, this complex dissociates. This behaviour of a-actinin
is consistent with biochemical observations (see Burgoyne, 1984) and the
hypothesis that the peripheral actin barrier must be disassembled during
exocytosis [Cheek & Burgoyne, 1986].
Other granule-associated actin-binding cytosolic proteins are the
annexins caldesmon and calpactin I (also known as calpactin and p36; see
Section 1.5[a], Geisow et al., 1987 and Burgoyne &Geisow, 1989). Caldesmon is
a 70-kDa Ca2+-calmodulin regulated protein which cross-links granules to
F-actin [Burgoyne et al., 1986; Vandekerckhove, 1990]. This interaction is
inhibited at micromolar Ca2+ concentrations, thus allowing the dissociation of
granules from the actin network in preparation for exocytosis. The




this requires millimolar Ca2+ concentrations.
Although not detected in chromaffin granule preparations, other
actin-binding proteins such as villin and gelsolin may be crucial in the
mechanism of exocytosis [Matsudaira & Janmey, 1988; Vandekerckhove,
1990]. Gelsolin-like proteins have been identified which cross-link F-actin at
resting Ca2+ concentrations in chromaffin cells [Bader et al., 1986, Sakurai et
al., 1990; Sakurai et al., 1991]. Micromolar Ca2+ concentrations induce the
actin-severing activity of villin and gelsolin which would allow granule
movement to the plasma membrane. Furthermore, the actin-severing
activity of these proteins is inhibited by phosphatidylinositol 4,5-bisphosphate
(PIP2, see Matsudaira & Janmey, 1988). Since this phospholipid is generated in
the chromaffin granule membrane by phosphatidylinositol kinase [Phillips,
1973] this could provide a switch-off mechanism. The role of actin-severing
proteins have also been implicated in exocytosis from sea urchin oocytes.
Recently a Ca2+-dependent actin severin protein, scinderin, which is different
from gelsolin has been purified from bovine adrenal medulla [Rodriguez Del
Castillo et al., 1990]. The distribution of this protein as measured by
immunofluorescence has suggested that scinderin has a role in the final
stages of exocytosis [Vitale et al., 1991].
Fodrin, the spectrin homologue presentkchromaffin cells, has also
been implied in the mechanism of exocytosis [Aunis & Perrin, 1984]. When
anti-a-fodrin antibodies were introduced into permeabilised chromaffin cells,
they resulted in the inhibition of secretion [Perrin et al., 1987]. This effect is
explained by previous observations that specific antibodies prevent Ca2+-
dependent proteolysis of fodrin which in turn would prevent the dissociation
of the granules from the cytoskeletal network [Siman et al., 1985]. In
chromaffin cells, fodrin is present just beneath the plasma membrane; this




exocytosis [Perin & Aunis, 1985; Langley et al., 1986].
Chromaffin granules have also been shown to bind tubulin with
high affinity (Kd = 30 nM, Bmax = 0.4 nmol/mg protein) but its significance is
not clear [Bernier-Valentin et al., 1983]. It has been shown recently that
secretory granules are targeted towards the tips of neurone-like projections of
endocrine cells using microtubules [Kreis et al., 1989] and that microtubules
are involved in the targeting of pre-lysosomal vesicles [Gruenberg et al., 1989].
Since microtubules appear to organise the subcellular localisation of
organelles, tubulin-binding by chromaffin granules could a part of this
mechanism. However, microtubule-disrupting drugs apparently do not
inhibit final stages of exocytosis in chromaffin cells, but inhibit the formation
of new granules (see Burgoyne, 1984 and Burgess & Kelly, 1987).
[d] GTP-binding proteins :
There is increasing evidence that GTP is required for the final stages
of the exocytic process as well as for vesicular transport through the secretory
pathway (see Section 1.6[d]; Balch,1989; Bourne et al., 1990 and Balch, 1990].
This section will review some of the "G-proteins" that are implicated in the
mechanism of exocytosis and that are components of chromaffin granule
membranes.
From both biochemical and genetic evidence it has been established
that low-molecular weight GTP-binding proteins of 20- to 25-kDa, related to
the ras oncogene superfamily, are involved in the specific intracellular
targeting of secretory vesicles. The common feature of these proteins is that
GTP hydrolysis acts as a functional switch such that only the GTP-bound form
of the protein associates with the secretory vesicle membrane. As shown in





Proposed mechanism of action for small molecular weight GTP-binding








a See Sections 1.5[d] & 1.6[c] for text.
KEY:
GTP : Guanine triphosphate
GDP : Guanine diphosphate
Pi : Inorganic phosphate
GTPaseAP : GTP-hydrolysis activating protein




to the correct acceptor membrane. The interaction of the two correct
compartments induces GTP hydrolysis, possibly by the interaction of a
GTPase-activating protein, resulting in the return of the G-protein to the
cytoplasm for another cycle [Plutner et al., 1990]. The yeast Sec4 and Yptl
proteins are examples of such proteins, their mammalian counterparts (rab,
rac, ral, rho and rap) have also been identified
(see Balch, 1990 and Bourne et al., 1990 for reviews). By analogy
with the different localisation of Sec4 and Yptl in yeast cells (i.e. secretory
vesicles and the Golgi apparatus respectively), the diversity of the
mammalian counterparts suggests that these proteins also function at
different stages of both constitutive and regulated secretory pathways. It has
recently been shown that chromaffin granules and synaptic vesicles contain
such proteins (Rab3A), and that their subcellular localisation appears to
change during exocytosis [Burgoyne & Morgan, 1989; Fischer von Mollard et
al., 1991; Matteoli et al., 1991].
Their close homology with ras suggests that these low-molecular
weight GTP-binding proteins associate with vesicle membranes through a
post-translationally added lipid-anchor, and that this is essential for their
function [Mcllhinney et al., 1990; Walworth et al., 1989; Pfanner et al., 1990].
This has also been demonstrated by Molenaar et al. who showed that mutant
forms of ras which ras lack their C-terminal cysteine to which the lipid
anchor is attached, are non-functional forms of the protein.
Since GTP-hydrolysis is an obligatory step for the release of small G
proteins from the donor/acceptor membrane complex prior to another round




inhibits secretion (see Section 1.6[d] ). However, in neutrophils for example,
such GTP analogues have been found to act synergistically with, and even to
obviate the requirement for Ca2+ [Barrowman et al., 1986; Cockcroft et al.,
1990]. This response, typical of the better-known 40- to 50-kDa heterotrimeric
GTP-binding proteins [Casey & Gilman, 1988] led to the hypothesis that
exocytosis could be under the control of such a G-protein, termed Ge
[Gomperts, 1990], possibly linked to an as yet uncharacterised second
messenger [Burgoyne, 1987]. The subcellular location of Ge is not clear but it
could be an integral part of secretory vesicles [Gomperts, 1986].
[e] Other cytosolic vesicle-binding proteins :
The development of the permeabilised chromaffin cell assay has been
an important step in studying the final stages of regulated exocytosis (see
Section 1.8(a)). However, the loss of cytosolic factors from the cells into the
bathing medium has been a limitation of the assay, resulting in "running-
down" of the secretory responsiveness of the cells. Recently Morgan and
Burgoyne have used this very limitation to isolate three cytosolic factors
which appear to regulate exocytosis [Morgan & Burgoyne, personal commu¬
nications]. These factors have been named EXOl, EX02 (the two stimulatory
factors) and SIP, the inhibitory factor. EXOl, the better characterised factor,
has a native molecular weight of 70-kDa and runs at 29-kDa on SDS-gels.
When EXOl is reintroduced into permeabilised "ran-down" cells, it restores
about 60% of the original secretory response of the cells, however, if EXOl is
incubated with tetanus toxin, it can no longer restore the secretory
responsiveness of the cell. The inhibitory effect of tetanus toxin may be
reversed if EXOl/tetanus toxin complex is run down a gel filtration column,




neurotoxin from Botulinum does not appear to have any effect on EXOl.
EXOl isolated from cytosol treated with the phorbol ester PMA enhances the
stimulatory effect of EXOl, and this effect is sensitive to staurosporine
suggesting an involvement of protein kinase C in the regulation of EXOl.
EX02, the 54-kDa stimulatory factor is less well characterised. The
stimulatory effect of EX02 is additive to that of EXOl, together they can
restore nearly 100% of the secretory response of a run-down permeabilised
chromaffin cell. Both trypsin- and NEM-treatment of cytosol abolishes the
stimulatory effects of EXOl and EX02. The inhibitory factor SIP is not
characterised. The exact functions of EXOl, EX02 and SIP, and how it will fit
into our current knowledge of the control of exocytosis remains to be
established.
Studies using in vitro systems reconstituting the intracellular
secretory pathway (other than the permeabilised chromaffin cell system) has
identified three components that are required for the fusion of intra-Golgi
vesicles. These are firstly, an N-ethylmaleimide-sensitive factor (NSF, the
Secl8 protein) [Wilson et al, 1989]; secondly, a set of proteins required for the
binding of NSF to the donor membranes termed a-, (3-, y-SNAPs [Clary et al.,
1990]; and thirdly, a 25-kDa cytosolic protein that acts at a late prefusion step,
termed POP [Wattenberg et al., 1990]. In addition a late step in membrane
fusion has been shown to be dependent on fatty acyl coenzyme A [Pfanner et
al., 1990]. These complexes have been shown to to function in other
intracellular transport steps [Beckers et al., 1989; Diaz et al., 1989]. Although
not yet identified in chromaffin cells, homologous proteins could be
involved in the late stages of exocytosis.
Other proteins exhibiting reversible binding to secretory vesicles are
the "coat proteins" involved in the membrane budding from both




characterised coat protein is clathrin which associates with vesicles during
membrane budding at the trans-Golgi network (TGN); during vesicle
biogenesis and at the plasma membrane during endocytosis [Pierce &
Robinson, 1990]. The clathrin-vesicle association is mediated through the
adaptins HA1 or HA2, depending on which membrane the vesicle are
budding from [Pierce & Robinson, 1990]. The other set of coat proteins are the
COPs which only bind to inter-Golgi vesicles [Hurtley, 1991; Robinson, 1991].
Since the interaction between coat proteins and vesicles are stage-specific,
there must be some component in vesicle membranes which directs this
specificity. The nature of this specificity nor the components of the vesicle
membrane involved in this interaction are established.
[f] Plasma membrane proteins which bind to chromaffin granules :
The final stages of exocytosis involves the docking of secretory
vesicles to the plasma membrane and studies have been directed to
determine if this interaction is mediated by proteins present in the plasma
membranes. A 51-kDa protein has been identified through its in vitro ability
to bind chromaffin granules [Meyer & Burger, 1989], and specific antibodies
against this protein were shown to inhibit exocytosis in both chromaffin cells
and in patch-clamped chromaffin cells indicating its possible involvement in
secretion [Schweizer et al., 1989]. However, the interaction of this protein
with chromaffin granules was Ca2+-independent. It has recently been shown
that this protein is a member of the cytochrome P-450 family of proteins and
therefore possibly not involved in exocytosis. Another plasma membrane
protein of 36-kDa ("physophilin") from rat brain synaptosomes has been
demonstrated to bind to the integral vesicle membrane protein,




ATP, GTPyS, and like the 51-kDa plasma membrane protein, by Ca2+. Since
exocytosis requires these factors, further work is needed to establish the roles
of these proteins in exocytosis.
The chromaffin granule membrane protein p65 has also been
localised to the plasma membrane [Matthew et al., 1981; Fournier & Trifaro,
1988b]. The self-aggregation property of this protein suggests that it may be
involved in vesicle docking at the plasma membrane, and unlike the 51-kDa
protein and physophilin, the action of p65 appears to be regulated by the
concentration of Ca2+(see Section 1.4[b](i)).
[g] Lumenal proteins :
Chromaffin granule membrane preparations washed at pH 11 with
sodium carbonate liberate proteins that originate in the lumen of the granule.
These include the chromogranin family and also dopamine /3-mono-
oxygenase. The significance of the affinity of the chromogranins for the
chromaffin granule membrane is not clear but there is accumulating
evidence to suggest that this membrane-binding ability may be an important
factor in the mechanism by which these proteins are sorted and accumulated




1.6 Factors regulating exocytosis
Exocytosis requires the coupling of an external stimuli to the
intracellular machinery responsible for vesicular targeting and fusion. The
combined use of "permeabilised" cells, in vitro systems, advanced Ca2 +
imaging systems and genetic approaches have implicated factors such as Ca2+,
ATP, guanine nucleotides, inositol phosphates and arachidonic acid in
stimulus-secretion coupling. The roles of these factors are not yet completely
defined since they elicit different responses in different cells. This has raised
the possibility that alternative pathways of exocytic control may have
evolved, and that different cells do not utilise the same pathway. This section
will review the evidence for the involvement of these factors in the
regulation of exocytosis from bovine chromaffin cells.
[a] Role of calcium ions in exocytosis :
The essential requirement of calcium ions for exocytosis from
regulated secretory cells such as the chromaffin cell has been known since the
initial whole-gland perfusion studies of Douglas and Rubin (196la, 1961b).
These results have since been confirmed by more sophisticated experiments
on populations of chromaffin cells which have been either permeabilised so
that the cytoplasmic Ca2+ concentrations could be manipulated (Knight &
Baker, 1982; Holz et al., 1983; Dunn & Holz, 1983), or loaded with
Ca2+-sensitive fluorescent dyes to monitor intracellular fluxes of free Ca2+. It
is now agreed that the intracellular free Ca2+ concentration in resting cells is
in the order of 0.05 - 0.1 |iM, increasing to lOpM on stimulation (depending
on the secretagogue) and that the Ca2+ dose-response for exocytosis is




The advent of fluorescent dyes such as quin-2 and fura-2 that respond
to free Ca2+ concentrations has been an important step in determining the
role of Ca2+ in exocytosis from intact cell [Tsien et al., 1982; Grynkiewicz et al.,
1985]. This technique has been further refined by the development of
enhanced video-imaging systems which can continuously monitor the
cytosolic Ca2+ levels within single cells. Single cell imaging has resolved
discrepancies observed in the levels of Ca2+ that is required for secretion from
cell populations [Burgoyne, 1984; Burgoyne & Cheek, 1985; Kao & Schneider,
1986], and has also given a great deal of information about the spatial
distribution of the Ca2+ fluxes [O'Sullivan et al., 1989; Cheek et al., 1989]. It is
now agreed that, in bovine chromaffin cells, the entry of external Ca2+ is an
essential factor for exocytosis, an event which is initiated in vivo by the
binding of acetylcholine to its nicotinic receptor. The stimulation of the
nicotinic receptor results not only in the entry of Ca2+ through itself but also
in membrane depolarisation, and consequent opening of voltage-gated Ca2+
channels [Holz et al., 1982; Kilpatrick et al., 1982], Imaging experiments in
which fibroblasts have been co-cultured with chromaffin cells to determine
the latters' exocytic response [Cheek et al., 1989] have shown that following
nicotinic stimulation, although the increase in the cytoplasm Ca2 +
concentration is eventually uniform, it is the initial subplasmalemmal ring
of Ca2+ that results in exocytosis. This is consistent with the hypothesis that
the final stages of exocytosis involve events in the periphery of the cell such
as the breakdown of actin barrier and granule docking followed by the fusion
of the granules with the plasma membrane. Furthermore the proteins that
have been implemented in the control of these events, such as calpactin (see
Section 1.5[a] ), are all present in the subplasmalemmal region of the cell.
Further evidence for this hypothesis is the inability of muscarinic agonists




exocytosis. Despite the importance of the subplasmalemmal Ca2+ in the
exocytic response of bovine chromaffin cells, the initial free Ca2 +
concentration in this region, as determined by fura-2 imaging, is only around
50 nM above the basal level, a value far below that required in permeabilised
cells. This discrepancy is thought to be because of the limitations in the
spatial and temporal resolution of the imaging system and the inability of
fura-2 to measure Ca2+ concentration above 100 jiM which is thought be
reached immediately beneath the plasma membrane during exocytosis. This
therefore raises the important question of what exactly is the "physiological"
Ca2+ concentration which is required for exocytosis. The answer to this
remains unsolved. Another unsolved problem is the identity of the
intracellular receptors for Ca2+. Although Ca2+ is certainly the main signal for
exocytosis in all cell types, it seems likely that there is no single Ca2+-receptor
involved in the control of exocytosis and that Ca2+ mediates the action of both
cytosolic proteins (annexins, a-actinin etc.) and secretory vesicle membrane
proteins such as p65. The latter is a likely candidate for such a receptor in the
secretory vesicle membrane since it has recently been suggested that its
tandem protein kinase C like-domains may bind Ca2+ directly [Petrenko et al.r
1991]; this is in addition to the possible ability of p65 to bind Ca2+-calmodulin
[Fournier & Trifaro, 1988n],
M Protein phosphorylation and the role ofATP in exocytosis :
Many biochemical processes are controlled by reversible phospho¬
rylation of key proteins, an event requiring the enzymatic transfer of the
terminal phosphate of ATP to the regulated protein by kinases and its
removal by phosphatases in response to changes in the cellular environment.




process which has been predicted to be fast enough to control exocytosis
[Zieseniss & Plattner, 1985; Aimers, 1990]. It is therefore not surprising that
the phosphorylation states of secretory cell proteins have been investigated.
Upon stimulation, both cytosolic and chromaffin granule membrane proteins
change their phosphorylation state [Cote et al., 1986; Gutierrez et al., 1988;
Burgoyne & Geisow, 1981, 1982], however the relevance of these events in the
control of exocytosis has not been established so far.
In digitonin-permeabilised bovine chromaffin cells, there is a small
component of Ca2+-dependent exocytosis in the absence of ATP and
pretreatment of cells with metabolic inhibitors abolishes this response [Holz
et al., 1989]. Furthermore, the presence of millimolar ATP retards the
rundown of secretory responsiveness of these cells [Morita et al., 1988; Holz et
al., 1989; Ali & Burgoyne, 1990]. These observations suggest that ATP is not
essential for the late stages of exocytosis but it is needed to maintain the cell in
a primed state. Morphological studies on the intracellular distribution of
chromaffin granules suggest that a sub-population which is in close proximity
to the plasma membrane (and possibly docked to it), may be the primed
granules that represent the ATP-independent component of exocytosis
[Burgoyne et al., 1982]. It should be pointed out that in sea urchin oocytes, in
Paramecium and in alpha-toxin permeabilised PC12 cells where some
granules are already docked to the plasma membrane, ATP is not required for
exocytosis [Terbush et al., 1988; Thastrup et al., 1990]. Maintainance of this
primed state may involve the turnover of the phosphorylation states of
inositol phosphates and proteins, and in the case of proteins, dephos-
phorylation may be the key event which triggers exocytosis. Polyphospho¬
inositides have been implicated in the control of exocytosis, a role that is
different from the generation of diacylglycerol and IP3. Evidence for this is




pretreatment of digitonin-permeabilised bovine chromaffin cells [Eberhand et
al., 1990], and the observation that there is a decrease in the polyphospho¬
inositide levels in cells that are incubated in the absence of ATP. Eberhand et
al. suggest that polyphosphoinositides could be a substrate for a protein (such
as calpactin) in attachment to membranes. The regeneration of phosphatidyl-
inositol 4,5-bisphosphate (PIP2) may also be important in priming further
rounds of exocytosis by regulating the cytoskeleton; phosphatidylinositol
kinase (E.C. 2.7.1.67), the enzyme involved in the formation of PIP2 is present
in the membranes of chromaffin granules [Phillips, 1973].
Another mechanism by which ATP may prime cells is as a substrate
for protein-seryl phosphorylation, and this implies that dephosphorylation
may be a key step in the mechanism of exocytosis. The evidence for this
comes not from chromaffin cells, but from Paramecium in which the
dephosphorylation of a cytosolic 65-kDa protein (parafusin) correlates with
exocytosis [Zieseniss et al., 1985]. This event has been postulated to be
regulated by a Ca2+-calmodulin dependent phosphatase related to calcineurin,
because the microinjection of Ca2+-calmodulin-calcineurin complex enhances
exocytosis, whereas microinjection anti-calcineurin antibodies inhibits it
[Momayezi et al., 1987], It has also been shown that dephosphorylation of
parafusin in the presence of elevated Ca2+ levels changes its subcellular
distribution from soluble to membrane-bound, a behaviour similar to that of
calmodulin and protein kinase C [Satir et al., 1989]. Further evidence that
dephosphorylation may be involved in the final stages of exocytosis comes
from the inhibitory effect of ATP on exocytosis from Paramecium "ghosts"
despite its requirement in the intact organism [Vilmart-Seuwen et al., 1986].
The yeast and mammalian homologues of parafusin have been identified,
and its wide tissue distribution implies that it may mediate an important role




Very recently it has been shown that the secretory vesicle membrane
protein p65 can be phosphorylated in vitro and that this is inhibited by the
receptor for the black widow spider venom neurotoxin (a-latrotoxin)
[Petrenko et nl, 1991]. Since the physiological effect of this toxin is to enhance
neurotransmitter release, the authors concluded that exocytosis could be
mediated by the dephosphorylated form of p65. However, these results
should be treated with caution since the authors do not specify whether they
are using toxin-receptor complex or just the receptor to inhibit the
phosphorylation of p65 and the latter was phosphorylated by an unidentified
endogenous kinase.
The priming effect of ATP could also be as a result of its "switch-off"
effect on exocytosis. It has been established that following nicotinic
stimulation of intact cells, calpactin is serine-phosphorylated at its N-terminal
tail [Johnsson et al., 1986; Creutz et al., 1987; Gerke, 1989]. This induces p36
monomer formation, thus releasing it from both granule membranes and the
cytoskeleton. Furthermore, phosphorylation of calpactin at its N-terminal
tyrosine (reside 23) by pp60c~src, a known component of chromaffin granule
membranes, reduces the affinity of calpactin for phospholipids. Analogously
to the cyclic role of low molecular weight GTP-binding proteins such as sec4
and rab3A (see Section 1.5[d] and Figure 1.4), the releasing step could be
important in recycling calpactin for another round of granule exocytosis.
Although the activity of pp60c"src has been shown to decrease upon
stimulation of cells, increase in the tyrosine phosphorylation of a number of
proteins is detected under the same conditions [Ely et al., 1990; Oddie et al.,
1989]. In particular, changes in the phosphorylation state of the protein pp42
precedes catecholamine release but the exact role of tyrosine or serine
phosphorylation in the control of exocytosis remain unknown.




ATP in exocytosis, and the activation of exocytosis by phospholipase C
treatment of permeabilised-chromaffin cells (resulting in diacylglycerol
production which activates protein kinase C) has led to the investigation of
the role of this kinase in the secretory response. The results obtained in such
studies have not been conclusive, for example, although in intact bovine
chromaffin cells the activation of protein kinase C by phorbol ester treatment
has little effect on secretion [Brocklehurst et al., 1985; Burgoyne & Norman,
1984; Knight & Baker, 1983], similar treatment reduces the requirement of
Ca2+ for exocytosis in permeabilised cells [Knight & Baker, 1983; Pocotte et
al.,1985]. Inhibition of protein kinase C by staurosporine or sphingosine, by
long-term down-regulation or with its pseudosubstrate also has very little
effect on Ca2+-dependent exocytosis from digitonin-permeabilised bovine
chromaffin cells [Morgan & Burgoyne, 1990; Burgoyne et al., 1988; Terbush &
Holz, 1990], but the treatment of cytosol with the phorbol ester PMA enhances
the ability of EXOl to activate exocytosis, and this is sensitive to staurosporine
(see Section 1.5[e] ). It therefore seems that protein kinase C does not have an
essential, but only a regulatory role in the exocytosis from digitonin-
permeabilised bovine chromaffin cells. However, the substantial stimulatory
effect on exocytosis of protein kinase C activation in many other cells [Rink et
al., 1983; Wilson, 1990; Bittner & Holz, 1990], together with its ability to
phosphorylate the proteins implicated in Ca2+-dependent exocytosis [Lee &
Holz, 1986] suggests that protein kinase C activation may represent a parallel
pathway of exocytic regulation.
[c] Role of other second messengers in the control of exocytosis :
GTP is emerging as an important factor in the control of vesicular




ensures the correct interaction between intracellular compartments,
including the interaction of secretory vesicles with the plasma membrane
[Balch, 1990; Bourne et al., 1990; Downward, 1990; Matteoli et al., 1991], The
evidence for the role of GTP in the control of the last stages of exocytosis has
come from the use of non-hydrolysable analogues of GTP such as GTPyS
which acts as a functional block and allows the identification of the steps
involved. Molecular cloning and sequencing of proteins involved in the
secretory pathway, through the comparison of sequences, has also been
important in identifying those steps regulated by GTP. Such studies have
identified a family of low molecular weight GTP-binding proteins such as
Sec4 (yeast) and Rab3A (neurones) which are homologous to the oncogene
product p21™s (see Section 1.5[d] and above reviews). Studies in which the
effects of GTPyS, GDP-(3-S and GMP.PNP have been studied in permeabilised
chromaffin cells has suggested the role of GTP in regulated secretion through
mediating the functions of both low molecular weight GTP-binding proteins
and a putative G-protein termed Ge [Gomperts, 1990; Burgoyne, 1991], the
function of the latter protein, Ge , is appears to be independent of Ca2+.
Cyclic nucleotides such as cAMP and cGMP have been implicated in
the control of exocytosis since cholinergic and muscarinic stimulations
(respectively) of chromaffin cells transiently increase their levels [Morita et
al., 1987; Schneider et al., 1979]. Attempts to identify the role of cAMP in the
control of exocytosis have produced conflicting results due to the difference in
experimental parameters such as concentrations of forskolin and the length
of time which cells have remained in culture [see Burgoyne, 1991 for review].
cGMP on the other hand has been reported to modulate nicotine-stimulated
exocytosis, inhibiting exocytosis at high nicotine concentrations but
stimulating it at low nicotine concentrations [Nakaki et al., 1988; Derome et




agents such as atrial naturietic peptide, 8-bromo-cGMP or with nitroprusside
increases the sensitivity of chromaffin cells to nicotinic stimulation
[O'Sullivan & Burgoyne, 1990]. Nitroprusside is known to generate nitric
oxide which is been regarded as another modulator of exocytosis since it can
stimulate secretory response in perfused rat adrenals [Dohi et al., 1983]. It has
been reported that nitric oxide synthase, which catalyses the formation of
nitric oxide, is present in nerve terminals innervating the adrenal medulla
and its activity is stimulated in response to elevated Ca2+ levels [Bredt et al.,
1990]. This implies that co-release of acetylcholine and nitric oxide from the
synapses will lead to the rise of intracellular Ca2+ and cGMP levels in
chromaffin cells. However, cGMP has no effect on the intracellular
concentration of Ca2+ in intact cells, it does not stimulate Ca2+-dependent
secretion from permeabilised chromaffin cells and its role in secretion is
currently unclear [Knight & Baker, 1982; O'Sullivan & Burgoyne, 1990].
Arachidonic acid and other cis-unsaturated fatty acids have also been
implicated in the regulation of exocytosis by the findings that they induced
fusion of granules aggregated by synexin or calpactin in the presence of Ca2+
and are produced during stimulation of cells [Drust & Creutz, 1988; Frye &




1.7 Endocytosis and recycling of secretory vesicle membranes
With around 20,000 granules per cell, about 90% of the total
membrane surface area of chromaffin cells is the chromaffin granule
membrane (see Table 1.1). Upon stimulation, a release of 10% of the total
cellular catecholamine content would result in doubling of the plasma
membrane surface area, which unless rectified would clearly be lethal to the
cell. Furthermore, in contrast to the rapid turnover of the soluble secretory
components of chromaffin granules, there is little synthesis of the membrane
components such as dopamine /3-monooxygenase and cytochrome b561
[Winkler & Westhead, 1980; Falkensammer et al., 1985]. A pathway of
membrane retrieval must therefore exist not only to avoid enlargement of
the plasma membrane but also to account for the slow turnover of the
granule membrane proteins. Such a pathway would be consistent with
hypothesis that secretory vesicles are reusable shuttles for the transportation
of the secretory components, and that their membrane components are
extensively reutilised after exocytosis [Winkler, 1977],
Following exocytotic stimulation, chromaffin granule membrane
components such as dopamine/Fmonooxygenase and glycoprotein III are
exposed on, and subsequently retrieved from the cell surface by endocytosis
[Phillips et al., 1983; Patzak et al., 1984; Hunter & Phillips, 1989]. This is
supported by ultrastructural observations which show that membrane
retrieval utilises coated vesicles that are also involved in the uptake of
endocytic ligands such as transferrin and LDL [Nagasawa & Douglas, 1972;
Patzak & Winkler, 1986; Patzak et al., 1987].
The intracellular destination of endocytic cargo is initially to the
endosome, an acidic compartment where endocytosed ligands dissociate from




compartment in which they are co-localised with enzymes such as
sialyltransferase, presumed to be the trans-Golgi network (TGN). Chromaffin
granule membrane proteins are also thought to recycle through the
endosomes to the TGN, where upon arrival, they are sorted into immature
granules. Patzak and Winkler (1986) have shown this for glycoprotein III,
which when immunolabeled at the cell surface, is subsequently localised in
the newly formed chromaffin granules although some was also found in
lysosomes. The exact route of recycling of chromaffin granule membrane
proteins is not clearly established since this process appears to be effected by
the length of time cells are cultured prior to experimentation [Patzak &
Winkler, 1986; Patzak et ni, 1987], and through the lack of specific molecular
probes for chromaffin granule membranes.
Cells efficiently concentrate the molecules destined to be endocytosed
in clathrin-coated pits while excluding plasma membrane proteins from
them. Studies on the control of this mechanism have shown the importance
not only of the cytoplasmic domains of endocytosed proteins, but also of a
group of cytosolic protein known as adaptins [Pearse & Robinson, 1990;
Hurtley, 1990]. The selectivity of endocytosis of chromaffin granule
membrane proteins therefore appears to be through the interaction of their
cytoplasmic domains with adaptins. Integral membrane proteins of the
chromaffin granule membrane such as p65, synaptophysin and synaptobrevin
(see Section 1.4[b] ) all have large cytoplasmic domains which may interact
with adaptins, yet it is mysterious how proteins such as dopamine /3-mono-
oxygenase and glycoprotein III, which do not possess such domains (see
Section 1.4[a]) are endocytosed and recycled. One possible explanation of this
is that some integral membrane proteins of chromaffin granules may have
roles in the organisation and targeting of such proteins. This is supported by




in the plasma membrane before being endocytosed [Burgoyne et al., 1982;
Phillips et al., 1983]. Current research into the role of chromaffin granule
membrane proteins is focussed on their function in exocytosis, but their
possible role during endocytosis must not be ignored. It is therefore possible
that proteins such as SV2, p65, synaptophysin, synaptobrevin and
glycoprotein II may have a role in the recycling of secretory vesicle membrane
proteins.
1.8 Approaches to the study of secretion from cells
[a] In vitro assays, cell-free systems and permeabilised cells :
An important strategy of scientific research is to isolate and
simplify the event under investigation so that each of its components can be
identified and studied. In the field of intracellular traffic, such a strategy has
led to the development of in vitro systems or "cell-free" assays which can
reconstitute various stages of the secretory and endocytic pathways [Balch et
al., 1984; Davey et al., 1985]. Such systems have revealed factors that are
required for intracellular transport such as ATP, GTP, Ca2+ and fatty acylation
[Balch et al., 1984; Melangon et al., 1987; Beckers & Balch, 1989; Pfanner et al.,
1990], and also proteins such as N-ethylmaleimide sensitive factor (NSF), a-,
(3-, y- SNAPs and POP which mediate it [Malhotra et al., 1988; Wilson et al.,
1989; Clary et al., 1990; Wattenberg et al., 1990]. Studies in yeast genetics have
shown that NSF is encoded by the seel8 gene and that the GTP is required by
the SEC4gene product (see Balch, 1989 and 1990 for reviews).
A factor in the success of such in vitro systems has been the ease with




undergo when they move from one compartment to another. In contrast,
reconstitution of the late stages of intracellular traffic has been hampered by
the difficulty of isolating pure plasma membrane fractions as "inside out"
vesicles and by the absence of a biochemical event to monitor membrane
fusion. Although a cell-free system has been developed [Nadin et ai, 1989],
on the whole such attempts have been unsuccessful.
A different and highly successful approach has been the development
of permeabilised chromaffin cells by Baker and Knight (1981, 1982). This
technique utilises electrical discharge to perforate the plasma membrane
permitting bypass of signal transduction at the plasma membrane level and
allowing the cytoplasmic conditions to be manipulated. Furthermore the use
of detergents such as digitonin to make larger holes in cells has allowed the
introduction of antibodies and peptides into cells in order to study their
effects. Such studies have shown the requirement of calpactin and fodrin in
exocytosis [Perrin et «/., 1987; Drust Creutz, 1978; Ali et al.r 1989] and recent
studies in introducing essential components which have leached out from
permeabilised cells may identify more (see Section 1.5[e] ).
[b] Monoclonal antibodies as tools :
Antibodies are products of the immune system of higher eukaryotes,
their role being to tag foreign molecules and initiate their specific degradation
by the phagocytic cells. Their specific affinity for almost any type of biological
molecule has made them indispensable tools in biological research because
they provide probes for the molecule of interest and allow its detection
against a complex background of other molecules. The introduction of
monoclonal antibody technology by Kohler and Milstein in 1975 has greatly




biological of systems because monoclonal antibodies, unlike polyclonal
antisera, can be raised against a complex mixture of molecules without the
need to purify the individual components to homogeneity. This is especially
important in the investigation of complex biological systems such as
multiprotein complexes, cell surface antigens and intracellular organelles
where many of the proteins present do not have a known functional assay
that can be used in their isolation and study.
Since many of the functions of the secretory vesicles are carried out by
proteins that are intrinsic to its membrane, a powerful technique in
elucidating the mechanism of exocytosis has been to raise monoclonal
antibodies against the proteins of secretory vesicle membranes in order to
identify them. Such studies on synaptic vesicles from brain identified
proteins such as SV2, p65, synaptophysin, p29 and synaptobrevin (see Table
1.6 and Section 1.4). Because of the more complicated composition of
chromaffin granules, there have been no such attempts in chromaffin cells. It
was the aim of this study to combine the advantages of both chromaffin cells
(Section 1.2) and monoclonal antibody production to produce antibodies that
recognise components of the chromaffin granule membrane so that they





Application of monoclonal antibodies in the investigation of subcellular
organelle membranes
Organelle Antigen Reference
Golgi complex 135-kDa Golgi antigen (Rat liver)
110-kDa antigen (Cultured Fibroblast)
103-108 & 180-kDa antigens (Rat
autoimmune antibodies to acinar cells)
Cytoplasmically oriented antigens
Burke et al. (1982),
Lin & Queally (1982),
Smith et al. (1984).
Chicheportiche etnl. (1984)
Clathrin coated vesicles Clathrin heavy chain antibodies
(Pig brain)
Louvard et al. (1983).
Exocrine secretory vesicles Insulin secretory vesicles
50, 80 &110-kDa antigens
Grimaldi et al. (1987).




Pruss & Shepard (1987).
This study.
This study.







Buckley & Kelly (1985).
Matthew et al. (1981),
Obata et al. (1987).
Buckley et al. (1985),
Leube et al. (1987)
Sudhofetn/. (1987)
Baumert et al. (1990).
Trimble et al. (1988).
Lysosome lysosomal membrane antigens Croze et al. (1984)
Plasma membrane Chromaffin cells (54-kDa antigen)
Hepatocytes
Bohner et al. (1985)







2.1 Chemicals, biochemicals and other materials
[a] Chemicals :
All common laboratory chemicals were of highest grades, purchased
either from Sigma Chemical Co. Ltd. (Poole, Dorset, U.K.) or BDH (Poole,
Dorset, U.K.) unless specified.
Acetic, hydrochloric and ortho-phosphoric acids of AnalaR grade were
purchased from BDH, Poole, Dorset, U.K.
DMSO and DMF were purchased from Sigma Chemical Co. Ltd., Poole,
Dorset, U.K.
Methanol, ethanol, propan-l-ol and butan-2-ol were purchased from
BDH, Poole, Dorset, U.K.
[b] Biochemicals :
Amberlite (XAD-2), ATP (di-sodium), BSA, benzamidine, 4-chloro-
1-naphthol, deoxycholic acid (sodium salt), dithiothreitol, EDTA (di-sodium),
Hepes, Mes, leupeptin, pepstatin, PMSF, poly L-lysine, SDS, TLCK, Trisma
base, Triton X-100, Tween-20 were purchased from Sigma Chemical Co. Ltd.,
Poole, Dorset, U.K.
Acrylamide (Electran), bromophenol blue, N,N'methylene-bisacrylamide
(Electran) and Nonidet P40, polyacrylamide (carboxy-modified) and TEMED
were purchased from BDH, Poole, Dorset, U.K.




Instruments Ltd., South Croydon, Surrey, U.K.
Iodogen (Pierce) was purchased from ICN Flow, High Wycombe, Bucks,
U.K.
Coomassie blue G-250, Ponceau S and urea were purchased from Serva,
Heidelberg, Germany.
Enhanced chemiluminescence kit and Hyperfilm-MP autoradiography
film was purchased from Amersham International, Amersham, Oxfordshire,
U.K.
Triton X-114 was purchased from Fluka, Buchs, Switzerland.
Lectins were purchased from Sigma Chemical Co. Ltd., Poole, Dorset, U.K.
[c] Antibodies :
Biotin-, horse radish peroxidase- and urease-linked anti-mouse IgG
(whole molecule) and anti-mouse IgM (p-chain specific) were purchased from
Sigma Chemical Co. Ltd., Poole, Dorset, U.K.
Samples of the monoclonal antibody "asv48" were generously given by
Dr. John L. Bixby (University of Miami, School of Medicine, Miami, USA.)
and Prof. Robert D. Burgoyne (University of Liverpool, Dept. of Physiology,
Liverpool, U.K.).
Samples of anti-cytochrome fo561 polyclonal antibody was generously
given by Dr. David K. Apps (Department of Biochemistry, University of
Edinburgh Medical School, Edinburgh, U.K.) and samples of anti-glycoprotein
II polyclonal antibody was generously given by Dr. R. Fischer-Colbrie





Calmodulin-agarose, neuraminidase (EC 3.2.1.18, type X) and trypsin (EC
3.4.21.4) were purchased from Sigma, Poole, Dorset, U.K.
Endoglycosidase F (EC 3.2.1.96) and streptavidin were purchased from
Boehringer, Mannheim, Germany.
[e] Tissue culture materials :
RPMI-1640 was purchased from Flow, High Wycombe, Bucks., U.K.
Aminopterin and hypoxanthine-thymidine media supplement were
purchased from Sigma Chemical Co. Ltd., Poole, Dorset, U.K.
Myoclone foetal calf serum was purchased from Gibco BRL, Paisley, U.K.
Tissue culture plates (Falcon) and other plastics (Falcon) were purchased
from Beveridge Ltd., Edinburgh, U.K.
Polyethylene glycol 1500 (46%, Hepes-buffered and sterile) was purchased
from Boehringer, Mannheim, Germany.
[f] Cell lines :
NS-0 myeloma cell line was a generous gift of Dr. Jeff Haywood
(Department of Biochemistry, University of Edinburgh Medical School,
Edinburgh, U.K.).
[g] Protein purification and sequencing equipment :
Protein purification was performed using the Gilson FPLC system.
C-18 reverse phase and phenyl-TSK columns were purchased from
Anachem, Luton, Bedfordshire, U.K.
High pressure liquid chromatography (HPLC) was performed on Applied





Sequencing was performed on the ABI pulsed liquid sequencer model
477A using automated Edman degradation and the PTH-amino acids were
separated by HPLC (ABI model 120A) using a C-18 reverse phase column (5|u,
220 x 2.1 mm).
[h] Other materials :
Dialysis tubing (Gallenkamp) was purchased from Fisons, Loughborough,
Leicestershire, U.K.
ELISA plates (Falcon) were purchased from Beveridge Ltd., Edinburgh,
U.K.
Nitrocellulose (Schleicher & Schuell, 0.45|im) was purchased from





2.2 Preparation of subcellular fractions and organelles
[a] Adrenal medullary homogenate :
Fresh bovine adrenal glands were obtained from the local
slaughterhouse. The medullae dissected from 40 glands were placed in 400 ml
of 0.3 M sucrose containing 10 mM Hepes-NaOH (pH 7.2) and when required
2 mM EDTA, 0.1 mM phenylmethylsulphonyl fluoride (PMSF) and 1 mM
benzamidine at 0°C. The dissected glands were passed through a stainless
steel mincer followed by homogenisation by five passes of a motor-driven
Teflon/glass homogenizer.
[b] Crude chromaffin granules and the mitochondrial fraction :
The homogenate was centrifuged at 1,500 gav (Beckman Instruments,
JA-14 rotor) for 5 minutes at 4°C to remove intact cells, nuclei and debris. The
resultant post-nuclear supernatant was centrifuged at 19,000 gav in the same
rotor for 30 minutes at 4°C to pellet the granules from the cytosol and
microsomes. Crude granules were then resuspended in 150 ml of the same
buffer and washed free of soluble contaminants by centrifugation at 18,000 gav
(Beckman Instruments, JA-20 rotor) for 20 minutes at 4°C.
The pellets, consisting of a pink inner ring of chromaffin granules
and an upper fluffy layer of mitochondria, were resuspended by gentle
homogenisation to 120 ml in the homogenisation buffer and were layered
over six 50 ml "cushions" of 1.6 M sucrose containing 10 mM Hepes-NaOH




60 minutes at 4°C. By this procedure, the mitochondria were trapped at the
0.3/1.6 M sucrose interface while the dense granules pelleted.
[c] Chromaffin granule membranes :
The pellet of granules was lysed by homogenisation in 10 mM
Hepes-NaOH (pH 7.2), 0.1 mM PMSF and 1 mM benzamidine at 0°C followed
by dilution to 210 ml. The membranes were pelleted by centrifugation at
161,000 gav for 20 minutes and further purified by resuspending them to 40 ml
with the lysing buffer and layering them over three 50 ml cushions of 1.0 M
sucrose in 10 mM Hepes-NaOH (pH 7.2) followed by centrifugation at 161,000
gav for 30 minutes at 4°C. The pure chromaffin granule membranes were
collected from the 0.3/1.0 M sucrose interface and washed free of sucrose by
centrifugation at 161,000 gnv for 20 minutes at 4°C and finally resuspended in
10 mM Hepes-NaOH (pH 7.2), 1 mM DTT to a protein concentration of 10
mg/ml and stored at -70°C.
[d] Adrenal medullary mitochondrial membranes :
Mitochondria from the 0.3/1.6 M sucrose interface (Section 2.2[b] )
were lysed by homogenisation in 10 mM Hepes-NaOH (pH 7.2), 0.1 mM PMSF
and 1 mM benzamidine at 0°C followed by dilution to 210 ml. The
membranes were pelleted by centrifugation at 161,000 gnv (Beckman
Instruments, Ti-45 rotor) for 20 minutes and further purified using six
continuous 0.5-1.6 M sucrose gradients by centrifugation at 207,000 gav.
(Beckman Instruments, SW-41 rotor) for 16 hours. The membranes were




TL-100.3 rotor) for 10 minutes at 2°C, resuspended in 10 mM Hepes-NaOH
(pH 7.2) and stored at -70°C.
[e] Adrenal medullary microsomal membranes :
The supernatant from the 19,000 gav centrifugation of the
homogenate (Section 2.2|b]) was further cleared of granules and mitochondria
by centrifugation as above for 20 minutes. The resultant supernatant was
then layered onto 20 ml cushions of 1.4 M sucrose in 10 mM Hepes-NaOH
(pH 7.2) and centrifuged at 161,000 gnv (Beckman Instruments, Ti-45 rotor) for
60 minutes at 4°C. The microsomes were collected from the 0.3/1.4 M sucrose
interface. This method not only prevented the aggregation of the vesicular
structures, but also enabled the residual chromaffin granules and
mitochondria to be cleared from the microsomes. The microsomes were
stored at -70°C.
[f] Adrenal medullary cytosol :
Cytosol was generally prepared for the isolation of Ca2+-dependent
chromaffin granule-binding proteins that are implicated in the mechanism of
exocytosis, the subcellular distribution of which depends on the levels of
intracellular Ca2+ concentrations (see Chapter 1). Therefore to minimise the
loss of these proteins into the pellet fraction, cytosol was prepared in the
presence of 5 mM EDTA; otherwise the both the addition of EDTA and the
ammonium sulphate precipitation step described below were omitted.
The adrenal medullae were dissected and processed as in the




centrifugation of the homogenate was further cleared of granules,
mitochondria and microsomes by centrifugation at 161,000 gav (Beckman
Instruments, Ti-45 rotor) for 60 minutes at 4°C. The cytosolic fraction was
fractionated by addition of solid ammonium sulphate. The protein fraction
that precipitated between 55 and 90% saturation was redissolved in 10 mM
Hepes-NaOH (pH 7.2). To remove ammonium sulphate and other ions and
molecules from this preparation, it was dialysed against 100-volumes of 10
mM Hepes-NaOH (pH 7.2) over 24 hours with 5 changes of buffer and stored
frozen at -70°C.
[g] Preparation of calcium-dependent chromaffin granule-binding protein :
Chromaffin granule membranes were incubated at 1 mg protein per
ml of cytosolic fraction (both prepared as described above) in the presence of
20 pM CaCl2, 1 mM MgATP, 0.2 mM PMSF and 1 mM benzamidine at 37°C
for 30 minutes. The chromaffin granule membranes were then pelleted by
centrifugation at 161,000 gnv (Beckman Instruments, Ti-45 rotor) for 20
minutes at 4°C and washed twice by resuspension to one-tenth original
incubation volume in 10 mM Hepes-NaOH (pH 7.2) containing 10 pM CaCl2
and 1 mM MgATP and centrifuged at 207,000 gnv (Beckman Instruments,
Ti-70.1 rotor) for 15 minutes at 4°C. The final pellet was resuspended to the
same volume in 10 mM Hepes-NaOH (pH 7.2) containing 5 mM EGTA and
centrifuged as described above. The resultant supernatant was dialysed
against two changes of 100-volumes of ImM Hepes-NaOH (pH 7.2) containing




[h] Preparation of synaptosome membranes from rat fore-brain :
Rat cerebral cortex (approximately 1 g wet weight) was homogenised
in 10 ml of 0.32 M sucrose in 10 mM Hepes-NaOH (pH 7.2) at 4°C and
centrifuged at 4000 gav (Beckman Instruments, JA-20 rotor) for 10 minutes at
4°C. The supernatant was removed and layered onto a 4 ml cushion of 1.2 M
sucrose in 10 mM Hepes-NaOH (pH 7.2) and centrifuged at 160,000 gav
(Beckman Instruments, Ti-70.1 rotor) for 15 minutes at 4°C. Partially purified
synaptosomes were collected from the 0.32/1.2 M sucrose interface and
layered onto 4 ml cushions of 0.8 M sucrose in 10 mM Hepes-NaOH (pH 7.2)
and centrifuged at the same conditions as the previous spin. The pellet
consisting of purified synaptosomes was harvested in 10 mM Hepes-NaOH
(pH 7.2) and lysed in 20 ml of the same buffer by homogenisation to obtain
broken membranes. The membrane pellet was harvested following
centrifugation at 160,000 gav, resuspended in 10 mM Hepes-NaOH (pH 7.2) and
stored at -70°C.
2.3 Treatment of Subcellular Organelle Membranes with Reagents
[a] Washing membranes at pH 11 :
Membranes were resuspended at a protein concentration of 1 mg/ml
by gentle homogenisation in 0.1 M Na2C03 (pH 11) containing 1 mM EDTA
and 0.2 mM PMSF and incubated on ice for 30 minutes with occasional
agitation (Higgins, 1984; Howell & Palade, 1982). The membranes were then
recovered from the solution by centrifugation at 412,000 gav (Beckman




Hepes (pH 7.2), at a protein concentration of about 5 mg/ml. The supernatant
from the above centrifugation step was recentrifuged at the same conditions.
Both the membranes and the supernatant were then dialysed twice against
1000-volumes of 10 mM Hepes (pH 7.2) containing 0.1 mM PMSF over 24
hours.
Ib] Fractionation of membrane proteins ivith Triton X-114 :
The Triton X-114, pre-condensed by the method of Bordier (1981) was
made up as a 10% (w/v) solution for this procedure. Membranes in Tris-
buffered saline (TBS, pH 7.4) were resuspended to a protein concentration of 4
mg/ml by gentle homogenisation in the presence of 2% (w/v) cold Triton
X-114 at 0°C and incubated on ice for further 5 minutes. The solubilised
membranes were then centrifuged at 412,000 gnv (Beckman Instruments,
TL-100.3 rotor) for 15 minutes at 2°C to remove the insoluble precipitate
formed by the hydrophobic proteins, termed "PI". The PI pellet was washed
twice at 0°C by resuspension to its original volume in the presence of 2% (w/v)
Triton X-114 in TBS, then resuspended in one-fifth original volume of TBS.
The supernatant left after the removal of PI was layered over 1 ml
cushions of 0.25M sucrose/TBS/0.06% (w/v) Triton X-114 in conical glass
centrifuge tubes. The tubes were incubated at 30°C for 5 minutes to separate
the detergent phase followed by centrifugation at 2,500 gav (swing-out bench
centrifuge, top speed) for 5 minutes at room temperature. The supernatant
("aqueous phase") was removed from above the cushion. The cushion was
then carefully removed, the "detergent-rich" phase recovered and resus¬
pended to its original volume in ice-cold TBS.




procedure was repeated twice with intermediate incubations on ice for 5
minutes. Finally, the detergent phase was resuspended to one-fifth original
volume in ice-cold TBS for further use.
The residual detergent in the aqueous phase was removed by dialysis
against 100-volumes of TBS containing 1% (w/v) Amberlite XAD-2, 0.2 mM
PMSF, 1 mM benzamidine at 4°C for 5 days with two changes of buffer. The
dialysed faction was diluted with 3-volumes of TBS and centrifuged at 412,000
gav (Beckman Instruments, TL-100.3 rotor) for 15 minutes at 2°C. The pellet
(the "glycoprotein-rich" fraction) was resuspended by homogenisation in
lOmM Hepes-NaOH (pH 7.2) with 0.1% (v/v) Triton X-100. All fractions were
stored at -70°C.
[c] Labelling proteins with biotin :
Membrane proteins were resuspended in 100 mM bicarbonate buffer
(pH 9.5) at a protein concentration of about 2 mg/ml. Soluble proteins were
either dialysed into the same buffer or were centrifuged through a Biogel
P6-DG mini-column equilibrated with the same buffer. Fresh biotin-N-
hydroxysuccinimide (NHS-Biotin) ester stock in DMF was added to a final
protein:NHS-biotin ratio of 2:1 (w/w) for up to 1 hour at room temperature
while gently stirring. The reaction was terminated by the addition of Tris-HCl
(pH 7.0) to final concentration of 200 mM. Membrane proteins were washed
free of NHS-Biotin by centrifugation and resuspension in 10 mM
Hepes-NaOH (pH 7.2); soluble proteins were centrifuged through a Biogel
P6-DG mini-column equilibrated with 10 mM Hepes-NaOH (pH 7.2) or




[d] Deglycosylation of membrane glycoproteins :
Deglycosylatiort was carried out using endoglycosidase F (EC 3.2.1.96,
Boehringer) and desialylation with neuraminidase (EC 3.2.1.18, Sigma, type
VI). For deglycosylation with endoglycosidase F, 100 pg of the Triton X-114
aqueous fraction of chromaffin granule membranes were lyophilised and
resuspended with the following reagents to give a final protein concentration
of 1.6 mg/ml: 50 mM Mes-NaOH (pH 6.5), 0.5% (w/v) deoxycholate, 1% (v/v)
Triton X-100 and 33 units/ml endoglycosidase F. The digestion was carried
out at 37°C for 6 hours in the presence of 5 mM benzamidine, 200 pM PMSF,
5 pg/ml leupeptin, 5 pg/ml pepstatin, 50 pM TLCK and 15 mM EDTA (pH
6.5). The samples were lyophilised, resuspended in [xl] SDS-sample buffer
and analysed by SDS-polyacrylamide gel electrophoresis followed by
immuno-blotting.
For endoglycosidase treatments that were to be analysed by two-
dimensional electrophoresis, the aqueous fraction of chromaffin granule
membranes was dialysed for 16 hours against two changes of 1000-volumes of
5 mM Mes-NaOH pH 6.5 containing 0.1% (v/v) Triton X-100, 100 pM PMSF
and 1 mM benzamidine at 4°C. The reaction was carried out as above and the
samples were dialysed for 2 hours against two changes of 600-volumes of 1
mM Hepes-NaOH (pH 7.2) containing 0.1% (v/v) Triton X-100 and the above
protease inhibitors at 4°C using a BioRad micro-dialyser. The dialysed
samples were lyophilised, resuspended in two-dimensional electrophoresis
sample buffer and analysed by immunoblotting.
For digestion with neuraminidase, 100 pg of the Triton X-114
aqueous phase were lyophilised and resuspended to a final concentration of
1.6 mg/ml in 50 mM Mes-NaOH pH 5.5 with 0.2% (v/v) Triton X-100 and the




reaction buffer to a concentration of 10 units/ml) was added to a final
concentration of 1 unit/ml and the reaction mixture was incubated at 37°C for
5 hours. The samples were lyophilised, resuspended in [xl] SDS-sample
buffer and analysed by SDS-polyacrylamide gel electrophoresis followed by
immunoblotting.
For neuraminidase-treated samples that were to be analysed by
two-dimensional electrophoresis, 0.1% (v/v) Triton X-100, 100 pM PMSF and 1
mM benzamidine were added to the aqueous phase and dialysed for 16 hours
against two changes of 1000-volumes of 5 mM Mes-NaOH pH 5.5 containing
0.1% (v/v) Triton X-100, 100 pM PMSF and 1 mM benzamidine at 4°C.
Aliquots of 50 pg of the dialysed aqueous phase were lyophilised and
resuspended to a protein concentration of 0.5mg/ml as above. Neuramini¬
dase (Sigma type X, resuspended in the reaction buffer to a concentration of 40
units/ml) was added to a concentration of 10 unit/ml and incubated as above.
The reaction was terminated by dialysis for 2 hours against two changes of
600-volumes of 1 mM Hepes-NaOH (pFl 7.2) containing 0.1% (v/v) Triton
X-100 and the above protease inhibitors at 4°C using a BioRad micro-dialyser.
The dialysed samples were lyophilised, resuspended in two-dimensional
electrophoresis sample buffer and analysed by immunoblotting.
[e] Protease digestion of intact chromaffin granules and membranes :
The crude granule fraction and chromaffin granule membranes
resuspended in 10 mM Flepes-NaOFl (pH 7.2) to 1 mg of protein per ml with
were treated with trypsin, papain or pronase at various concentrations at 20°C
for up to 60 minutes. The digestions were stopped with the addition of the




leupeptin, 5 pg/ml pepstatin, 20 mM EDTA and 200 pM PMSF. In the case of
purified chromaffin granule membranes, the soluble peptides were separated
from the membrane-bound peptides by centrifugation at 412,000 gnv (Beckman
Instruments, TL-100.3 rotor) for 15 minutes at 2°C. The resulting pellet was
washed twice by resuspension and centrifugation in 10 mM Hepes-NaOH (pH
7.2) containing the same protease inhibitors. The supernatant fraction was
recentrifuged as above to remove any residual membrane-bound proteins.
With crude intact granules, the digestion was terminated as above. The
reaction mixture was then placed on top of a 2 ml cushion of 1.6 M sucrose,
10 mM Hepes-NaOH (pH 7.2) and centrifuged at 412,000 gav for 15 minutes at
2°C. The upper layer (0.3 M sucrose) containing the soluble peptides was
removed and recentrifuged to pellet any membranes and mitochondria. The
granule pellets were resuspended in 3 ml of 10 mM Hepes-NaOH pH 7.2
containing the protease inhibitors, and the membranes were then pelleted
and washed twice. The resultant membrane fractions were then denatured by
the addition of hot [x4] acidic SDS-sample buffer (0.2 M potassium biphthalate,
0.2 mM EDTA, 20% (w/v) SDS, 40% (v/v) glycerol, 0.015% (w/v) bromophenol
blue, pH 4.0) in the presence of 10 mM DTT. The soluble fractions were
lyophilised and taken up in one-tenth original volume of [xl] SDS-sample
buffer (pH 4.0, as above). The samples were then analysed by
immunoblotting.
[f] Calmodulin-affinity chromatography of protein fractions obtained from
chromaffin granule membranes :
Triton X-100 (0.1% (v/v) final), 0.2 mM PMSF and 1 mM benzamidine




membranes which was dialysed against three changes of 1000-volumes of
ImM Hepes-NaOH (pH 7.2), 0.05% (v/v) Triton X-100, 0.2 mM PMSF and 1
mM benzamidine over 18 hours. Tryptic supernatant of chromaffin granule
membranes was dialysed without Triton X-100 under the same conditions.
Both preparations were concentrated five-fold by rotary evaporation. The
Triton X-114 aqueous fraction at a protein concentration of 5 mg/ml or tryptic
supernatant at a concentration of 1 mg/ml in 10 mM Hepes-NaOH pH7.2
were incubated with one-tenth final volume of packed calmodulin-agarose in
the presence of 100 pM CaCl2 for 20 minutes at room temperature on a
rotating platform. The incubation was terminated by pelleting the
calmodulin-agarose in a microcentrifuge for 1 minute. The pellet was then
washed three times with 10 mM Hepes-NaOH (pH 7.2) containing 100 pM
CaCl2. Bound proteins were eluted by resuspending the final pellet in 10 mM
Hepes-NaOH, 5 mM EGTA (pH 7.2) followed by centrifugation as above. The
supernatant was then lyophilised and taken up either in urea-containing






[a] SDS-polyacndamide slab gel electrophoresis:
Proteins were analysed on 10% acrylamide gels, unless otherwise
stated, in the presence of SDS (Douglas & Butow, 1973) and with the
discontinuous buffer system of Laemmli (1970). The dimensions of the gels
were either 135 x 125 x 1.5 mm or 85 x 90 x 0.75 mm.
(i) Separating gel : Acrylamide stock for the gels were from a 30:0.8%
mixture of acrylamide/N,N' bis-acrylamide. The gel mix contained the
required percentage of acrylamide/N,N' bis-acrylamide mixture in 375 mM
Tris HC1 (pH 8.8), 0.1% (w/v) SDS, and 0.5% (w/v) polyacrylamide (Mr 250,000)
added to improve the mechanical strength of the gel. Gels were chemically
polymerised with 0.05% (v/v) TEMED and 0.1% (w/v) ammonium persulphate.
Butan-2-ol (water-saturated) was layered onto the unpolymerised gel solution
to ensure a flat top and was washed away after the gel polymerised.
(«) Stacking gel : A stacking gel containing 4.5% (w/v) of the
acrylamide/N,N' bis-acrylamide mixture in 125 mM Tris-HCl (pH 6.8), 0.1%
(w/v) SDS and 0.5% (w/v) polyacrylamide (Mr 250,000) was poured on top of
the polymerised separating gel. The pH difference between the two gels and
electrode buffer produced stacking of the proteins.
(Hi) Electrode buffer : The electrode buffer contained 50 mM Tris base,
380 mM glycine and 0.1% (w/v) SDS. The buffer was stored in a five-fold
concentrated form.
(iv) Sample preparation for SDS-polyacrylamide gel electrophoresis:
Samples were prepared by different methods depending on whether the gel
was to be stained or to be used for immunoblotting. In some cases, samples




Hepes-NaOH (pH 7.2) at 4°C for 2-8 hours before to sample preparation.
SDS-saniple buffer: Samples were loaded onto SDS-polyacrylamide
gels in 50 mM Tris-HCl (pH 6.8), 5% (w/v) SDS, 0.2 mM EDTA, 10% (v/v)
glycerol and 0.001% (w/v) bromophenol blue in the presence of 10 mM DTT.
The SDS-sample buffer was stored in a four-fold ( [x4] ) concentrated form
without DTT.
For stained gels: Membranes derived from subcellular organelles
were diluted up to 3 ml with distilled water and pelleted by centrifugation at
412,000 gnv (Beckman Instruments, TL-100.3 rotor) for 15 minutes at 2°C. The
supernatants were discarded and the pellets were taken up in [xl] SDS-sample
buffer. Samples requiring delipidation were treated with approximately 100-
volumes of acetone:ethanol (1:1) at -20°C for 60 minutes followed by
centrifugation at 15,000 gnv (Beckman Instruments, JA-20 rotor, in Corex glass
centrifugation tubes with rubber adapters) for 20 minutes at 4°C. The
supernatants were discarded and the pellets were taken up in [xl] SDS-sample
buffer.
For immunoblotted gels: Subcellular organelle membranes were
generally resuspended in 1 mM Hepes-NaOH (pH 7.2) to protein concen¬
trations above 4 mg/ml and directly dissolved in the [xl] SDS-sample buffer to
give the required protein concentration. In some cases, the samples were
lyophilised. The lyophilised samples were dissolved in one-fourth final
volume of 7 M urea, followed by one half-final volume of [x2] SDS-sample
buffer (with 20 mM DTT) and finally one-fourth final volume of distilled
water. This method particularly suited preparations of the more hydrophobic
proteins such as bovine chromaffin granule p65.
(v) Running conditions : The larger dimension gels were run at




constant current for up to 2.5 hours.
(vi) Fixing and staining gels : Proteins were fixed in the separating gel
with 10% (v/v) acetic acid and 20% (v/v) methanol for 30 minutes and stained
with 0.25% (w/v) Coomassie Brilliant Blue R250 in 50% (v/v) methanol, 7.5%
(v/v) acetic acid for 5 minutes on a shaking platform. Gels were destained in
10% (v/v) methanol, 7% (v/v) acetic acid for 2-10 hours; polyurethane foam
pieces were placed in the destaining solution to aid the destaining process.
Gels requiring sensitive detection were silver-stained using the
method of Wray et al. (1981) after fixation and three one-hour washes in 50%
(v/v) methanol with 5 minute intermediate washes in distilled water.
All fixation, washing and staining steps were carried out at room
temperature on an orbital mixer.
[b] Tzoo-dimensional electrophoresis :
Two-dimensional electrophoresis was carried out essentially by the
method of O'Farrell (1975).
(i) Isoelectric focusing : The isoelectric focusing gel mixture was
composed of 4.5% (w/v) acrylamide, 0.06% (w/v) bis-acrylamide, 9.5 M urea, 2%
Nonidet P-40 and 1.8% (v/v) ampholytes pH 3-10. The mixture was poured
into glass tubes (130 x 2 mm internal diameter) to a height of 110 mm and
was polymerised with 0.04% (w/v) ammonium persulphate.
Samples of soluble proteins were generally desalted by dialysis
against two changes of 1000-volumes of 2 mM Hepes-NaOH (pH 7.2) at 4°C for
2-8 hours. Membrane protein preparations were generally resuspended in 2
mM Hepes-NaOH (pH 7.2) after ultracentrifugation. Both types of sample




bis-acrylamide but containing 0.5% (v/v) mercaptoethanol and 0.001% (w/v)
bromophenol blue.
The samples were loaded from the cathodic (basic) end of the gel.
The cathode buffer was 1% (v/v) ethanolamine and the anode buffer was 0.5%
(v/v) orthophosphoric acid. The gels were focused initially by increasing the
voltage across the tubes while maintaining a current of 0.2 mA per tube, then
run at 400 V for 16 hours. Finally the proteins were focused at 800 V for 1
hour before the gels were removed from the tubes. The isoelectric focusing
gels were incubated in soaking buffer (50 mM Tris-HCl (pH 6.5), 3% (w/v) SDS,
10% (v/v) glycerol and 0.001% (w/v) bromophenol blue) for 20 minutes before
loading onto the second dimension.
(ii) Second dimension : The focusing gels were attached on top of a
SDS-polyacrylamide gel (135x125x1.5 mm) using 1% (w/v) agarose dissolved in
the soaking buffer and the gel was run as described earlier. Gels requiring
staining in Coomassie blue were fixed for 3 hours with three changes of the
fix solution followed by an overnight incubation in two-dimensional gel fixer





2.5 Binding of Proteins onto Nitrocellulose Membranes
[a] Electrophoretic transfer of protein :
The SDS-polyacrylamide gel containing separated proteins and a
sheet of nitrocellulose (0.45 |im) of similar size were sandwiched in tight
contact and placed in buffer containing 20 mM Na2HP04/ 0.02% (w/v) SDS and
20% (v/v) methanol with the nitrocellulose oriented towards the anode.
Proteins were transferred with a current of 0.8 A over 2 hours.
[bl Dot-blots:
Non-denatured proteins were applied onto a sheet of nitrocellulose
previously incubated in distilled water for 5 minutes, using a BioRad
Bio-Dot® microfiltration apparatus by passive filtration to allow for
quantitative binding of proteins. For screening of monoclonal antibodies, up
to 30 pg of protein were loaded onto each dot at a protein concentration of 0.2
mg/ml in TBS. Samples of intracellular organelle membranes at a protein
concentration of 0.2 mg/ml were solubilised with 0.05% (v/v) Triton X-100
before application onto the nitrocellulose. For samples of unknown protein
concentrations such as column fractions, up to 250 pi could be applied per dot.





2.6 Detection of Proteins Bound to Nitrocellulose with Antibodies
and Lectins
After protein transfer, nitrocellulose sheets were washed briefly with
three changes of distilled water and stained for 5 minutes with Ponceau S
(0.4% (w/v) in 2% (w/v) TCA) to assess the efficiency of transfer. The
nitrocellulose was destained initially with distilled water, then with TBS for
10 minutes. Non-specific sites on the nitrocellulose were blocked by
incubation in 0.5% (v/v) Tween-20 in TBS for 60 minutes on an orbital mixer.
After binding of the samples, dot-blots were washed briefly with
three changes of TBS and the non-specific sites were blocked as above.
[a] Immunoblots :
For detection of proteins with monoclonal antibodies, the sheet of
nitrocellulose containing the bound samples was incubated with culture
supernatant at 1:2 to 1:20 dilutions in 1 mg/ml (w/v) BSA in TBS with 0.1%
(w/v) sodium azide for up to 16 hours on a rocking platform at room
temperature. Blots were incubated with polyclonal antibodies at 1:100 to
1:1000 dilutions in 1 mg/ml BSA in TBS with 0.1% sodium azide for 2 hours
as above.
Non-specifically bound monoclonal antibodies were washed from
the nitrocellulose with two 5-minute washes in TBS, two in 0.1% (v/v)
Tween-20 in TBS and one in TBS over 25 minutes. The blots were then
incubated in 1:500 to 1:1000 dilution of biotinylated secondary antibody in TBS
containing lmg/ml BSA for 2 hours followed by the above wash protocol.
The secondary antibody used was compatible with the class of primary




blots were incubated in 125I-labelled streptavidin (10 Bq/(il) for 1 hour. The
blots were washed as above and dried in a 50°C oven. The antigen-antibody
complexes were visualised following autoradiography at -70°C between
intensifying screens. In some cases, the blots were visualised using
"enhanced chemiluminescence" (ECL). For this procedure the blots were
incubated with horseradish peroxidase-linked second antibodies (diluted 1 in
2000 - 10000 in azide-free TBS containing lmg/ml BSA) followed by the same
wash protocol as above. Finally the blots were washed with 10 ml of 1:1
mixture of the two ECF reagents and the chemiluminescence was detected
using autoradiography film.
Cb] Lectin blots :
Lectin overlays of proteins were carried out essentially as described
for immunoblots. The blots were incubated with either 125I-labelled lectin (at
10 Bq/gl) or unlabelled lectin (10 (ig/ml) for 16 hours. For the procedure
using concanavalin A, see Clegg (1982). The wash protocols for the lectin
blots were the same as immunoblots and the complexes were visualised




2.7 Screening Procedures for Monoclonal Antibodies
[a] Enzyme-linked immunosorbent assay :
ELISA plates (Falcon) were pre-coated with 100 pi of poly L-lysine (17
kDa) at 20 gg/ml in 10 mM Mes-Tris buffer (pH 6.5) for 1 hour at room
temperature. The poly L-lysine was replaced with the antigen, diluted in
lOmM Mes-Tris buffer, pH 6.5 (see Chapter 3, Table 4.2 for concentrations).
The wells were coated with the antigen for 90 minutes at room temperature.
To block the non-specific sites of the wells and to remove excess antigen, the
wells were incubated with veronal buffer (50 mM sodium barbitone, 85 mM
NaCl, 5 mg/ml BSA and 0.1 mg/ml sodium azide, pH 8.0) for 60 minutes and
washed with the same buffer twice.
Culture supernatants (with 0.1% (w/v) azide) were placed in the wells
and incubated for at least 3 hours at room temperature. Unbound immuno¬
globulins were washed away with 3 changes of PBS over 3 minutes. To detect
bound immunoglobulins, the wells were incubated with urease-linked anti-
mouse IgG and IgM antibodies at a dilution of 1:750 in 1 mg/ml BSA in PBS
for 2 hours. The wells were washed once with PBS and twice with distilled
water and incubated with the urease substrate (0.1% (w/v) urea, 0.008% (w/v)
bromocresol purple, 0.2 mM EDTA adjusted to pH 4.8) pre-equilibrated to
37°C for up to 30 minutes while constantly agitating the plate. The bound
urease activity was assayed spectrophotometrically at 570nm using a Dynatech
ELISA plate reader.
[b] Dot-blotting assay :
Nitrocellulose sheets were set up in 96-well format as described in




with 0.5% (v/v) Tween-20 in TBS for 1 hour. The nitrocellulose membrane
was placed back into the dot-blotting apparatus with the position of the dots
corresponding to the wells. The apparatus was sealed to the atmosphere and
the wells were incubated with the culture supernatants for up to 5 hours and
processed as described for immunoblotting (Section 2.6[a]).
lb] Western blotting :
Samples for analysis were separated by SDS-polyacrylamide gel
electrophoresis and transferred onto nitrocellulose membranes as described
in Sections 2.4[a] and 2.5[a] except that the nitrocellulose membranes were cut
into 7.5 mm strips before transfer and placed in contact with the gel as usual.
The strips with the transferred proteins were placed in a BioRad incubation
tray, blocked as above and incubated with a minimum of 2 ml of the culture
supernatants. Culture supernatants of smaller volume were incubated with




2.8 Generation and Maintainance of Hybridoma Cell Lines
[a] Immunisation protocol :
Mice (6 to 10 weeks old) were injected subcutaneously with lOOpg of
the antigen at a protein concentration of 1 mg/ml in Freund's complete
adjuvant. Three weeks after the first immunisation, a similar dose of the
antigen was injected intraperitoneally and this was repeated up to twice more
at three-weekly intervals. Three days before the fusion, one of the mice was
immunised once more with 50 pg of the antigen intravenously.
[b] Media and conditions for culturing myelomas and hybridomas :
Myeloma and hybridoma cell lines were cultured in RPMI-1640
media with 25 mM Hepes-NaOH (pH 7.2) and supplemented with 0.1 mM
hypoxanthine, 16 pM thymidine, 50 units/ml penicillin, 50 pg/ml
streptomycin, 10 mM NaHCC>3, 0.1 mM /3-mercaptoethanol and 15% (v/v)
myoclone foetal calf serum (RPMI/HT/FCS). This media was further
supplemented with 0.5 pM aminopterin for the culture and selection of
hybridomas for at least 1 week after the fusion.
Both myeloma and hybridoma cell lines were cultured at 37°C in a
sterile incubator containing 5 % (v/v)C02, 100% humidity.
[c] Fusion and cell culture protocols :
The spleen of an immunised mouse was removed under sterile
conditions and disrupted into a cell suspension in serum-free RPMI/HT




centrifugation at 500 gav for 5 minutes at room temperature and finally
resuspended in 15 ml of the same medium. Myeloma cells (NS-0) were
cultured in RPMI/HT media containing 15% foetal calf serum and passaged
into two 75 cm2 flasks approximately 40 hours before the fusion. NS-0 cells
were harvested in log growth and washed as above and resuspended in 5 ml
serum-free RPMI/HT medium equilibrated to 37°C. The lymphocyte and
NS-0 cell concentrations were determined using a haemocytometer. The
NS-0 culture supernatant was retained and mixed with a suspension of
thymus (feeder T-cells) cells obtained from a 6 to 8 week old non-immune
mouse.
The NS-0 and the spleen cells were mixed in a ratio of 1:5 and the
mixture centrifuged at 500 gav for 5 minutes at room temperature. The
supernatant was removed and the cells were resuspended in 1 ml sterile 46 %
polyethylene glycol (Hepes buffered PEG-1500, equilibrated to 37°C) over 30
seconds whilst gently agitating. The PEG was diluted using serum-free
RPMI/HT medium 90 seconds after the start of the fusion, initially at a rate of
0.5 ml over 1 minute, followed by 2 ml over 2 minutes and finally 10 ml over
2 minutes. The fusion mixture was centrifuged at 500 gav for 5 minutes at
room temperature and the cells were resuspended in 60 ml of the T-cells in
RPMI/HT media containing 15% foetal calf serum and 0.5 pM aminopterin at
37°C.
The fusion mixture was dispensed into six 96-well culture plates.
The cells were fed with RPMI/HT media containing 15% foetal calf serum
and 0.5 pM aminopterin at 3 days after the fusion and cultured for a further 4-
6 days before the hybridoma cell density was sufficient to remove the culture
supernatants for immunoassays.




transferred into 24-well plates at about 50 to 80% confluency and the culture
supernatants were assayed again. The immunoreactive cells were then
transferred into 25 cm2 flasks. The cells were harvested for freeze-down in log
growth and the remainder of the cells were allowed to grow to confluency.
The supernatants of the confluent cells were harvested and stored at 4°C in
the presence of 0.1% (w/v) sodium azide.
[d] Cloning of hybridoma cell lines :
Hybridoma cell lines producing antibodies of the required specificity
were cloned by limiting dilution. To aid cell growth in the wells with low
number of cells, 100 pi of mouse thymus (feeder) cells in RPMI/HT media
containing 15% foetal calf serum and lpM aminopterin were placed into the
wells of sterile 96-well tissue culture plates; usually three plates were prepared
for each cell line. Into column "1" wells of each cloning plate, 100 pi of
hybridoma cells, at a density of 10000/ml were dispensed, mixed and 100 pi of
the mixture was transferred into the wells in column "2". Such 1 in 2
dilutions were made across the plate.
After three days in culture, 50 pi of fresh RPMI/HT media
containing 15% foetal calf serum was placed into each well without disturbing
the cell colonies. The number of colonies in each well was determined after
a further two days in culture days; wells with up to 3 colonies were chosen to
be screened for antibody production. Cells originating from a single colony
and producing the desired antibodies were expanded to flasks and were
harvested at log growth to be frozen down for long-term storage in liquid
nitrogen. The remainder of these cells were taken through another round of




[e] Long-term storage of hybridoma and myeloma cell lines :
(i) Freezing doivn cells : Exponentially-growing cells were shaken off
from culture flasks and centrifuged at 500 gav for 5 minutes at room
temperature. The pellet of cells was resuspended in 1ml ice cold foetal calf
serum with 10% (v/v) DMSO and transferred into 2 ml sterile screw-top vials.
The vials were kept on ice until they were wrapped up in a polystyrene box
and placed at -70°C. Within 1 week, the vials were transferred into liquid
nitrogen where they were kept until required.
(ii) Thaiving-out cells : The vials were removed from liquid
nitrogen, rapidly thawed out at 37°C and transferred into a sterile tube
containing 10 ml RPMI/HT media with 15% foetal calf serum. The cells were
washed by centrifugation 500 gnv for 5 minutes at room temperature and
resuspension in the same medium. The resuspended cells were placed in a
25cm2 flask containing a lawn of mouse thymus cells and cultured as usual.
[e] Storage of hybridoma and myeloma supernatants :
Hybridoma cell line supernatants were kept with the addition of





[a] Protein concentration determination :
Protein concentration estimations were performed according to the
method of Bradford (1976) using BSA as the standard.
|b] Dialysis tubing :
Dialysis tubing was boiled in distilled water/EDTA for 1 hour prior
to use. The tubing was washed with distilled water and stored in 50% (v/v)
ethanol at 4°C until required.
[c] 125I-labelling proteins :
Streptavidin was labelled with 125I using the iodogen method of
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CHAPTER 3
The generation of polypeptides from chromaffin granule membranes for the
production of monoclonal antibodies
3.1 Introduction
One of the approaches used to elucidate the mechanism of exocytosis
has been to search for integral components of secretory vesicle membranes
that are involved in the secretory process. However, progress has been slow
because of our limited knowledge of the composition of secretory vesicle
membranes as well as not knowing what kinds of molecules to look for.
One way of tackling such a problem has been to raise monoclonal
antibodies against the components of secretory vesicle membranes. Such an
approach, which overcomes the need to purify each component, has been
successfully applied to the study of synaptic vesicle membrane proteins (see
Section 1.8(b) ). Probably as a consequence of their more complicated
composition, there have not been reports of such attempts with chromaffin
granules. It was the aim of this study to apply to the well-studied chromaffin
cell the advantages of monoclonal antibody production (Sections 1.2 & 1.8(b) )
to produce antibodies that recognise components of the chromaffin granule
membrane so that these antibodies might be used to investigate the functions
of the membrane proteins.
Despite the advantages offered by monoclonal antibodies in the study
of individual components of a complex mixture, the success of obtaining the




The generation of polypeptides from chromaffin granule membranes for the production of monoclonal antibodies
(1) Maximisation of the chances of the immune system of the immunised
animal recognising and responding to the proteins of interest;
(2) Establishing sensitive and efficient methods of screening for the antibody-
producing hybridomas.
A particular difficulty in producing monoclonal antibodies against the
components of the chromaffin granule membrane is that about half of the
total protein content of the these membranes is accounted for by just two
proteins; dopamine /3-monooxygenase and cytochrome b561/ both of which are
involved in the well-studied pathways of catecholamine biosynthesis
[Winkler & Westhead, 1980; Terland & Flatmark, 1980]. Furthermore,
preparations of these membranes also include a substantial amount of
"contaminants" both from within the granule and from the cytoplasm (see
Chapter 1, Section 1.5 and Table 1.5 for a list of these proteins). The
intragranular component chromogranin A, together with the major
membrane proteins dopamine /1-monooxygenase and cytochrome b5^, are
highly immunogenic. Consequently even when mice are immunised with
whole chromaffin cells, antibodies are raised against these proteins [Pruss &
Shepard, 1987].
The chances of raising monoclonal antibodies against the minor
components of the chromaffin granule membrane which might be involved
in vesicle organisation and trafficking would be maximised by techniques that
allow their partial isolation and enrichment. One such technique, used in
this study, has been the fractionation of membrane proteins by phase
separation in the detergent Triton X-114 [Bordier, 1981; Pryde, 1986]. Another
method has been the isolation of tryptic peptides from chromaffin granule
membranes previously washed with EDTA and sodium carbonate (pH 11).
The specific membrane-binding properties of some of the cytosolic proteins
ill
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that "contaminate" chromaffin granule preparations have also been exploited
in the preparation of proteins for raising monoclonal antibodies [Geisow &
Burgoyne, 1982; Creutz etal., 1983].
The fractionation of chromaffin granule membrane proteins with the
non-ionic detergent Triton X-114 has been an important technique in
providing material for both the production and characterisation of
monoclonal antibodies. Detergents of the Triton series are amphipathic
molecules composed of an aromatic, hydrophobic head and a repetitive
hydrophilic polyoxyethylene tail which determines the physical properties of
the molecule in solution (Figure 3.1). For example Triton X-100, which has
an average repeat of nine polyoxyethylene groups, forms micelles composed
of about 140 molecules at 0°C when at or above its critical micellar
concentration (cmc). Increasing the temperature of such a solution has no
visible effect until the characteristic "cloud-point" is reached when the
micelles aggregate and separate from the solution in a separate phase. For
Triton X-100, this occurs at 64°C, but the more hydrophobic detergent Triton
X-114, which has on average around seven polyoxyethylene groups, has its
cloud point at the more useful temperature of 20°C [Bordier, 1981; Pryde,
1986],
In 1981 Bordier, using Triton X-114, showed that a mixture of proteins
could be resolved into distinct groups depending on their hydrophobicities
and he applied this principle to extract the membrane proteins from human
erythrocytes. Biological membranes are composed of phospholipid bilayers
containing integral membrane proteins anchored by hydrophobic domains
and when they are treated with Triton X-114 at 0°C, micelles containing
detergent, phospholipids and membrane proteins are formed. At the cloud-
point these mixed micelles aggregate and precipitate, forming a detergent-rich
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Figure 3.1
Polyoxyethylene p-t octyl phenol: The Triton X-114 molecule.
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The average number of ethylene oxide units for Triton X-114 is between 7 and 9.
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phase enriched in intrinsic membrane proteins, distinct from an aqueous
phase containing extrinsic and soluble proteins.
The ease with which Triton X-114 resolves membrane proteins while
retaining their biological function has led to its application to other biological
membrane preparations, including chromaffin granule membranes
[Clementson et ai, 1984; Maher & Singer, 1985; Pryde & Phillips, 1986]. It soon
became apparent that, because of their extensive hydrophilic domains, some
membrane-bound glycoproteins partitioned anomalously, in that they
remained in solution after phase separation at 30°C [Pryde, 1986]. However, if
the Triton X-114 concentration of the aqueous phase (~700 pM), which is
about three times higher than the cmc, is reduced below the cmc by
exhaustive dialysis using Amberlite XAD-2 beads, the membrane
glycoproteins form insoluble aggregates and precipitate, leaving the truly
soluble proteins in solution. In the present study, this behaviour has been
exploited in producing a fraction enriched in membrane glycoproteins that
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3.2 Results & Discussion
[a] Generation of a membrane vlycoprotein-ricli fraction :
Figure 3.2(a) is a two-dimensional gel showing the protein
composition of chromaffin granule membranes; about half of these proteins
are glycoproteins which stain poorly with Coomassie blue and are better
visualised by lectin blotting (Figures 3.2(b) and (c); see also Pryde & Phillips,
1986). Among the chromaffin granule membrane glycoproteins which bind
the lectins concanavalin A and wheat germ agglutinin are the biosynthetic
enzyme dopamine /3-monooxygenase, glycoproteins J, H and K, as well as
glycoproteins II, III, IV and V. However, it is not possible to visualise some
other chromaffin granule membrane glycoproteins such as p65 with either
Coomassie blue-staining or with the above lectins.
Upon treatment with the non-ionic detergent Triton X-114 according
to the scheme shown in Figure 3.3(a), the proteins of the chromaffin granule
membrane are fractionated into distinct groups (Figure 3.3(b) ). The first of
these fractions is the "phospholipid-rich" pellet which contains the subunits
of the H+-translocating ATPase complex of the chromaffin granule as well as
other hydrophobic proteins (Figure 3.3(b), track 3) [Percy et al., 1985; Perez-
Castiniera & Apps, 1990]. The bulk of the Triton X-114 remains in the
supernatant but when the solution is warmed up to 30°C, the detergent
separates out into a distinct "detergent-rich" phase which contains several
intrinsic proteins such as cytochrome b561, ATPase II and the membrane-
associated form of the enzyme dopamine /3-monooxygenase (Figure 3.3(b),
track 4) [Percy et al., 1985; Pryde & Phillips, 1986]. Most intrinsic glycoproteins
of the chromaffin granule membrane remain in the aqueous phase (Figure
3.3(b), track 5 and Figure 3.4(a) ), but can be separated from soluble secretory
115
Chapter 3
The generation of polypeptides from chromaffin granule membranes for the production of monoclonal antibodies
Figure 3.2
Composition of adrenal chromaffin granule membranes.




300 gg of chromaffin granule membranes were separated by two-dimensional electrophoresis,
gels were either Coomassie-blue stained ((a)), or the proteins were transferred onto
nitrocellulose and were visualised by lectin blotting ((b) & (c)).
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Figure 3.2
Composition of adrenal chromaffin granule membranes.
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Figure 3.3
Triton X-114 fractionation of adrenal chromaffin granule membrane proteins.
(a) Scheme for the fractionation of chromaffin granule membranes using the non-ionic detergent
Triton X-114:"
Solubilised by Triton X-l 14
at 0 C with a detergent to
protein ratio of 5:1
Chromaffin granule
membranes at
4 mg of protein/ml
White precipitate
formation
Centrifugation: 412,000 gov, 10 min at 2 C
Supernatant
Supernatant placed
over a "cushion" of
0.25 M sucrose with
0.06% Triton X-114
Incubate solution
















Glycoproteins H, J, &
p65
Supernatant




" Adapted from Pryde (1986).
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Figure 3.3
Triton X-114 fractionation of adrenal chromaffin granule membrane proteins.
(b) Protein composition of Triton X-114 fractions derived from chromaffin granule membranes:
12 3 456 789 10
Track 1: Molecular weight markers; Track 2: chromaffin granule membranes;
Track 3: phospholipid-rich pellet; Track 4: detergent-rich pellet; Track 5: aqueous supernatant;
Track 6: glycoprotein-rich pellet; Track 7: soluble and extrinsic proteins of chromaffin granules;
Track 8: Na2C03-washed chromaffin granule membranes; Track 9: proteins released from
Na2C03-washed chromaffin granule membranes; Track 10: Molecular weight markers.
90 pg protein was loaded per lane of a large format gel.
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proteins such as chromogranins and most of the soluble dopamine
/3-monooxygenase (Figure 3.3(b), track 7) by the removal of the residual
detergent by exhaustive dialysis (Figure 3.3(b), track 6). Figure 3.4(b) is a
two-dimensional gel showing the composition of this "glycoprotein-rich"
fraction which was used to immunise mice.
[b] Generation of soluble peptides from integral membrane proteins :
The second approach to the production of suitable antigens has been
to generate tryptic peptides from integral membrane proteins, an approach
developed after experiences with the intrinsic membrane protein p65 (see
Chapter 5).
To ensure that antibodies were generated against only the integral
components of chromaffin granules membranes, the membranes were
washed free of peripheral and membrane-associated proteins with 100 mM
Na2C03 /10 mM EDTA at pH 11 as described in Chapter 2 [Howell & Palade,
1982; Higgins, 1984], This procedure breaks open vesicular structures and
removes adherent proteins from them. Figure 3.3 (b) (tracks 8 & 9) and
Figures 3.5(a) & (b) show the composition of the membranes after this
treatment and the polypeptides removed from them. The majority of the
proteins removed from chromaffin granule membranes by this procedure are
the lumenal chromogranins, enkephalin precursors and their proteolytic
products (see Chapter 1, Section 1.3[a] ). The composition of this fraction is
therefore very similar to the proteins released from intact granules by
hyperosmotic lysis [Apps et al., 1985]. This procedure also removes cytosolic
proteins which adhere to chromaffin granule membrane preparations but,
which because of the abundance of the lumenal proteins, are not easily
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Figure 3.4
Protein composition of fractions obtained by Triton X-114 phase-separation of adrenal
chromaffin granule membranes.
(a) Composition of the "aqueous-supernatant" derived from Triton X-114 fractionated
chromaffin granule membranes by Coomassie-blue staining (300 pg):
Basic Acidic
(b) Composition of the "glycoprotein-rich" pellet derived from Triton X-l 14 fractionated
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Figure 3.5
Intrinsic and extrinsic proteins of adrenal chromaffin granule membranes.
(a) Composition of Na2CC>3 (pH ll)-washed chromaffin granule membranes showing the
intrinsic membrane components (300 pg):
Basic Acidic
(b) Composition of the proteins removed from chromaffin granule membranes by Na2CC>3







The generation of polypeptides from chromaffin granule membranes for the production of monoclonal antibodies
identified by Coomassie blue-staining.
The washed membranes obtained by the above procedure were then
treated separately with three trypsin concentrations (0.1, 1.0 and 20.0 pg
trypsin per mg of membranes) to obtain a range of soluble peptides which
were separated from residual membranes and used to immunise mice. The
generation of tryptic peptides as an immunogen minimised the chances of
obtaining antibodies against the protease-resistant biosynthetic enzyme
dopamine /3-monooxygenase (Figure 5.4(f)). The composition of this mixture
can be seen in Figure 3.7 (tracks 3, 4, 5); it is not possible to identify any of
these peptides without specific antibodies.
[c] Isolation of chromaffin granule membrane-binding cytosolic proteins :
As reviewed in Chapter 1, Section 1.5, many of the peripheral proteins
of chromaffin granules membranes are of cytosolic origin but reversibly
associate with granules under defined conditions. Among these are the
annexins or chromobindins which bind to chromaffin granule membranes in
the presence of elevated Ca2+ levels and are thus implicated in the
mechanism of exocytosis [Geisow & Burgoyne, 1982; Creutz et al., 1983; Drust
et al., 1988]. A third approach to this study has been to use chromaffin
granule membranes as an affinity matrix, in order to isolate such families of
proteins for the production of monoclonal antibodies.
A fraction enriched in Ca2+-dependent chromaffin granule membrane-
binding proteins was prepared by incubating chromaffin granule membranes
with a cytosolic fraction in the presence of 10 pM CaCl2 and 1 mM MgATP as
described in Chapter 2. Figure 3.7 shows the polypeptides obtained during a
typical purification - although some 15 distinct polypeptides were eluted from
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Figure 3.6
Preparation of tryptic peptides from integral membrane protein of adrenal chromaffin granules.
- fl6kIU
Track 1 & 7: molecular weight markers; Tracks 2 & 6: Na2C03-washed chromaffin granule
membranes; Tracks 3, 4, 5: tryptic peptides liberated from Na2CC>3-washed chromaffin granule
membranes with 0.1,1.0 and 20.0 pig/ml trypsin respectively.
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Figure 3.7
Preparation of Ca2+-dependent adrenal chromaffin granule membrane-binding proteins.
1 2 3 4 5 6 7
Track 1: Adrenal medullary cytosol; Track 2: cytosolic proteins precipitated with 55%
ammonium sulphate; Track 3: cytosolic proteins remaining in solution in 55% ammonium
sulphate; Track 4: cytosolic proteins remaining in solution in 90% ammonium sulphate;
Track 5: cytosolic proteins precipitated between 55 - 90% ammonium sulphate;
Track 6: Ca2+-dependent chromaffin granule membrane-binding proteins; Track 7: proteins
remaining in solution after one round of incubation with chromaffin granule membranes to
remove Ca2+-dependent chromaffin granule membrane-binding proteins.
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chromaffin granule membranes by this procedure (Figure 3.6, Track 6), the
yield was only around 20 pig protein from 1 mg of membranes. The low yield
appeared to be a result of the low binding-capacity of the membranes since no
difference in the polypeptide composition of the cytosolic fraction was
observed by Coomassie blue-staining of gels after the incubation. Increasing
the concentration of chromaffin granule membranes to increase the yield
appeared to increase non-specific binding of soluble proteins. Therefore to
provide enough material for immunisation and screening, repetitive rounds
of incubations of a large amount of cytosol were performed. The Ca2+-
dependent chromaffin granule membrane binding proteins obtained in this
manner were concentrated by lyophilisation followed by resuspension in a
small volume for immunisation of mice.
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3.3 Conclusions
An important approach to the identification of the proteins involved
in regulated secretion is to use antibodies directed against those proteins
found in secretory vesicle membranes. Many of these proteins are present in
low amounts and the generation of monoclonal antibodies allows the
characterisation of such proteins that are otherwise inaccessible by standard
biochemical methods.
Despite the advantages of monoclonal antibodies, the chances of
obtaining them would be greatly enhanced if partially-purified preparations
of chromaffin granule membranes could be used as immunogens. In this
Chapter, I have described three different approaches that were used to prepare
such immunogens in order to raise mouse monoclonal antibodies. These
methods are:
(a) the fractionation of chromaffin granule membranes using phase
separation in the non-ionic detergent Triton X-114 to prepare a fraction
enriched in membrane glycoproteins.
(b) the preparation of soluble tryptic peptides from integral membrane
proteins of chromaffin granule.
(c) the preparation of cytosolic proteins that bind specifically to chromaffin
granule membranes in the presence of elevated Ca2+-concentrations.
All of the above fractions were used to immunise mice and their
spleens were used in the generation of hybridoma cell lines which were
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Chapter 4
Screening for hybridomas secreting monoclonal antibodies against
chromaffin granule membrane-specific and associated antigens.
4.1 Introduction
The production of monoclonal antibodies against a mixture of antigens
such as the chromaffin granule membrane is possible only if the lymphocyte
clones that are amplified by the immune system in response to individual
antigens are extracted for culturing and identified. The extraction of the
lymphocytes, their fusion to myeloma cells and their continuous culture are
standard procedures which have been perfected over the years, but the
methods used for identifying the hybridomas of interest depend on the
nature of the antigen and this is the most important step in obtaining
monoclonal antibodies. An important criterion for a method designed to
screen for monoclonal antibodies raised against a mixture of antigens is that it
must be sensitive enough to detect antibodies against any component of the
immunisation mixture. This means that the greater the number of
components in the immunising mixture, the more sensitive the screening
procedure has to be. This applies in particular to detecting monoclonal
antibodies against those components of the chromaffin granule membrane
which constitute only 0.5 - 5 % of the total membrane protein. This Chapter
will outline methods developed to identify monoclonal antibodies against
such antigens and shows how they have been applied to screen hybridomas
obtained from three different fusions.
Among the many available screening methods, the easiest to perform
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and the most reproducible are various antibody capture assays, in which
excess antigen is attached to a solid support. Table 4.1 outlines the assays
which have been used in this study. In all cases, the antibodies were allowed
to bind to the immobilised antigen mixture and the immune complexes were
then detected using either enzyme-linked or radioactively-labelled reporter
molecules. This was usually done using secondary antibodies raised against
the immunoglobulins of the species in which antibodies to the antigens were
made. Other possible methods use the immunoglobulin (IgG)-binding ability
of protein A or protein G. The secondary reagents used in most assays are
conjugated to enzymes such as horseradish peroxidase, alkaline phosphatase
or urease for which there are simple colorimetric assays. Colorimetric assays
which give soluble reaction products, such as those used for ELISAs, may be
quantified by spectrophotometry; insoluble products are used for blots and are
less easily quantified. Secondary reagents may also be radiolabelled with 125I
which can be detected by autoradiography or by y-counting. Biotinylated
secondary antibodies can also be used, the highly specific interaction between
biotin and labelled-streptavidin being used to detect immune complexes.
Multiple biotinylation of the secondary antibody results in the amplification
of the signal and increases the sensitivity of detection. The sensitivity can be
further increased if 125I-streptavidin is used. For this reason, this was the
method used to detect antibodies against minor components of the
chromaffin granule membrane by dot- and immunoblots. However the
biotin-streptavidin system was not successful in ELISAs or with the more
sensitive enhanced chemiluminescence detection (see later).
Another way of increasing the sensitivity of detection is to screen with
preparations that are enriched in the minor constituents of chromaffin
granule membranes, although this requires prior knowledge of the antigen
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itself. However in methods in which a large quantity of cruder antigen is
bound, there will be sufficient minor components available to bind
antibodies. This is possible with dot blots, using nitrocellulose to bind
antigen. The protein-binding capacity of nitrocellulose is about 500 gig/cm2
or around 50 pg per dot [Harlow & Lane, 1988]. On the other hand,
polyvinylchloride, used for ELISA plates, binds approximately 1000-fold less
but the method can be as sensitive as dot blots if the conditions of the assay
are optimised. The optimisation of this assay is discussed in detail in the
Result & Discussion section of this Chapter.
Other important factors to be considered in the choice of an
immunoassay for the detection of monoclonal antibodies are its speed and
capacity. Hybridoma supernatants are available for screening approximately
8 to 14 days after the fusion and the cells producing the required antibodies
must be identified and expanded within the next 24 hours while still in late
log growth. Failure to do so will result in the cells entering stationary phase,
making them increasingly difficult to culture. Successful fusion or cloning
plates can generate hundreds of cell colonies, so the primary screening
procedure must have the capacity as well as the speed to cope with such
numbers of samples. All the methods listed in Table 4.1 are capable of
identifying positive supernatants within 8 to 10 hours but only ELISAs and
dot blots also have the capacity to screen large number of samples. The latter
are also applicable to 100 pi or less of culture supernatant which is the
amount available from 96-well culture dishes. Despite its advantage in
defining the specificity of antibodies, immunoblotting of SDS-polyacrylamide
gels was not used as a primary screening procedure because it requires at least
2 ml of culture supernatant. It detects only those antibodies whose epitopes
are resistant to denaturation by SDS, and therefore is not suitable when
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native antigens are used for immunisation as they were in this study. This
technique and its two-dimensional counterpart were used only as a final
screen of hybridomas which were positive with ELISAs and dot-blots. Thus
the different methods listed in Table 4.1 have been used in combination to
prevent the possible limitations of one method from misidentifying
supernatants.
The recent development of enhanced chemiluminescence (ECL) kits
was an important breakthrough in the sensitivity of immunoassays. With
this system, the enzymatic activity of conventional enzyme-linked second
antibodies is converted to light emission which is detected using
autoradiography film. This system requires about ten-fold less antigen for a
given dilution of primary antibody, and also ten-fold less secondary antibody.
Furthermore it does not require the overnight autoradiography which was
used to detect 125I-streptavidin-labelled immune complexes, and because it is a
non-radioactive method it is safer.
Advances made in equipment have also made screening easier and
more efficient, for example, the BioRad Bio-Dot® system allows not only
uniform application of the antigen but also the incubation of 96 different
hybridoma supernatants in an ELISA-plate format. The combination of the
high antigen-binding capacity of dot blots, the advantages of the BioRad
Bio-Dot® system and the high sensitivity of ECL were important in screening
for monoclonal antibodies. Another advance has been the multiblotter from
Immunetics (Biometra). This apparatus only requires 200 pi of each culture
supernatant and can screen up to 25 samples by immunoblotting. The
combination of this and the ECL system allows the characterisation of
supernatants from as early as the 96-well stage.
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The Results and Discussion section of this Chapter will present how
the above screening procedures were adapted and used to identify
monoclonal antibodies from three different fusions. The first of these fusions
was for antibodies that were raised by immunising mice with a fraction
enriched in proteins that bind onto chromaffin granules in the presence of
elevated Ca2+ concentrations; this was initially screened using optimised
ELISAs. A second fusion was for antibodies that were raised against the
glycoprotein-rich fraction of chromaffin granule membranes and screened
using a combination of ELISAs and dot blots against two different antigens.
The final fusion which was to generate monoclonal antibodies against the
integral proteins of the chromaffin granules was screened using the
combination of dot-blots and ECL.
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4.2 Results & Discussion
[a] Development of ELISAs and Dot blots:
(i) ELISAs
The successful application of enzyme-linked immunosorbent assays
(ELISAs) depends primarily on the concentration at which the antigen is
immobilised and the choice of the detection system. However, the problem
facing attempts to set up any immunoassay to detect antibodies against
uncharacterised proteins is that it is not possible to know how it will perform
without the antibodies, yet the assay is required to obtain them.
A useful way of optimising immunoassays without the use of
antibodies is to non-specifically label the antigen with biotin and use the
specific interaction between biotin and streptavidin to assess the conditions.
To investigate the optimal conditions for ELISAs to screen monoclonal
antibodies, antigens were therefore biotinylated and incubated at a range of
concentrations in ELISA plates precoated with poly-L-lysine as described in
Chapter 2. The plates were processed by blocking the non-specific binding
sites for 1 hour followed by a 2 hour incubation in culture medium. At the
end of this incubation, the wells were washed three times with PBS/0.1%
Tween-20 and incubated for a further 1 hour with a 1:2000 dilution of
streptavidin-horseradish peroxidase (-HRP) to mimic antibody binding. The
plates were then washed as before and the bound antigen was measured by
monitoring the enzymatic conversion of the substrate ABTS into a
chromogenic product at 410nm. Figure 4.1 shows that the binding of
streptavidin-HRP to immobilised antigen was bell-shaped, indicating that the
detection signal was dependent on the concentration at which the antigen
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Figure 4.1
Optimisation of ELISAs to screen for monoclonal antibodies raised against antigens derived




CGM = chromaffin granule membranes;
Ca depn. CGMbps = Ca -dependent chromaffin granule membrane-binding proteins.
Table 4.2
The optimal concentration of antigen for coating ELISA plates for the detection of monoclonal
antibodies.
Antigen Coating Concentration (pg/ml)
Chromaffin granule membranes 20
Glycoprotein-rich fraction 10
Cytosol 5
Ca2+-dependent granule-binding proteins 10
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was attached to the ELISA plates. A possible explanation of this behaviour is
that if antigen is bound at concentrations above the capacity of the plastic
matrix, then during incubations it will leach off the walls of the wells and
bind to the streptavidin in solution. This will reduce the amount of
streptavidin available to bind to immobilised antigen and therefore reduce
the signal. Such would also be the case when hybridoma culture
supernatants are incubated. The above procedure was carried out for each of
the fraction that were to be used for the screening of monoclonal antibodies
in this study and the optimal concentration of each antigen is shown in Table
4.2.
The antigen-binding conditions were adapted from Grimaldi et al.
(1987) who coated ELISA plates with insulinoma granule membranes using
10 mM Mes-Tris at pH 6.5. Another method uses 100 mM carbonate/
bicarbonate at pH 9.5 [Harlow & Lane, 1988]. Poly-L-Lysine-precoating is also a
recommended method of binding antigens to ELISA plates, and is known to
increase the binding of some antigens. When binding of solubilised
chromaffin granule membranes were investigated using these different
conditions, it was found that poly-L-lysine precoating increased the detection
signal of ELISAs by about 10% at pH 6.5 and around 40% at pH 9.5. There was
no significant difference between the detection signal strengths when antigen-
binding to poly-L-lysine precoated plates were compared at pH 6.5 and 9.5,
although it appeared that at pH 9.5 maximal signal could be obtained with
antigen concentrations half that at pH 6.5 (i.e. lOgg/ml of chromaffin granule
membranes at pH 9.5, as compared to 20 |ig/ml at pH 6.5). As a consequence
of these experiments, poly-L-lysine-precoated ELISA plates were coated at
optimal antigen concentrations shown in Table 4.2 using 10 mM Mes-Tris at
pH 6.5. The more neutral pH was preferred to avoid possible anomalous
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Figure 4.2
Optimisation of ELISAs to screen for monoclonal antibodies raised against antigens derived
from adrenal medulla: The effects of poly-L-lysine precoating plates and antigen-binding pH.
+polyLys at pH6.5
-a- -polyLys at pH6.5
+polyLys at pH9.5
-o- -polyLys at pH9.5
Antigen concentration (pg/ml)
Optimisation of ELISAs for the screening of monoclonal antibodies:
Figure 4.1: The effect of the concentration at which EL1SA plates were coated with various
antigens on the detection signal: Biotinylated antigen fractions derived from adrenal
medullary chromaffin cells were incubated at the concentrations shown as described in Chapter
2, Section 2.7[a]. Antigen binding was detected using the enzymatic activity of horseradish
peroxidase-conjugated streptavidin, and monitored at 410nm.
Figure 4.2: The effect of poly-L-lysine precoating of ELISA plates, and the pH of antigen-
coating was investigated by incubating biotinylated solubilised chromaffin granule membranes
at the concentrations shown and signal strengths were determined by using the enzymatic
activity of horseradish peroxidase-conjugated streptavidin monitored at 410nm.
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behaviour of some antigens at extreme pH.
It was also found that the detection system used in ELISA drastically
effected the signal strength. This was not apparent until the monoclonal
antibody against dopamine /3-monooxygenase (dbhl) was raised and used to
validate the results obtained by the biotinylated antigen approach. Figure 4.3
shows the results when the biotin-streptavidin system was compared with
urease-conjugated second antibodies. Surprisingly, the signal strength of the
biotin-streptavidin system (which should give signal amplification) was less
than that of urease-conjugated second antibodies. This was probably because
the extra incubation and wash steps required by the biotin-streptavidin system
led to loss of immune complexes from the wells thus reducing the signal.
Therefore the urease system was adopted as the standard ELISA detection
system. This had the added advantage that the reaction product, ammonia,
changed the colour of the substrate solution from yellowish-amber to deep
purple, making the qualitative visualisation of the results easier. One
drawback of the system was that because the colour change was due to the
change of pEl of the unbuffered substrate solution, the wells had to be washed
free of PBS and care had to be taken so that ammonia from one well did not
affect neighbouring wells by incubating the plates on an orbital shaker.
(ii) Dot- and immunoblots
Immunoassays in which excess antigen is attached to nitrocellulose
can give a linear response [Harlow & Lane, 1988]. Useful antibodies are
generally revealed by as little as 1 - 5 gg of chromaffin granule membranes
loaded onto 0.75 mm thick minigels when the biotin-12°I-streptavidin
detection system is used. In order to screen by dot-blotting for antibodies
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Figure 4.3
Optimisation of ELISAs to screen for monoclonal antibodies raised against antigens derived
from adrenal medulla: Comparison of the immunoreactivity of the monoclonal antibody dbhl
detected using either the urease- or biotin-streptavidin-horseradish peroxidase-detection
systems.
Urease
Concentration of antigen (pg/ml)
The immunoreactivity of the monoclonal antibody dbhl against chromaffin granule membranes
attached to ELISA plates at a range of concentrations was determined using either urease-
conjugated or biotinylated secondary antibodies. Biotinylated second antibodies were detected
using streptavidin-horseradish peroxidase conjugate.
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which could be useful for immunoblotting, up to 30 pig of chromaffin granule
membranes were loaded per dot. This value is higher than that required for
immunoblots but within the binding capacity of nitrocellulose and was used
to increase the sensitivity of the detection. Despite the extra sensitivity of the
ECL system, to be able to detect the antibodies against the minor components
of chromaffin granule membranes, the same amount of antigen was loaded.
When immunoblots were used to screen culture supernatants, up to
1500 |ig of antigen was loaded as a single sample onto large-format gels (0.5
mm thick) or 300 gg onto 0.75 mm thick minigels. After electrophoresis, the
antigens were transferred onto nitrocellulose sheets which were then cut into
strips for incubation in separate supernatants; the multiblotter from
Immunetics did not require strips.
In all screening methods, a mixture of anti-mouse-IgG and -IgM
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lb] Screening of fusions :
(i) Monoclonal antibodies against calcium-dependent chromaffin granule
binding proteins
A fraction enriched in cytosolic proteins that show Ca2+-dependent
binding to chromaffin granule membrane (Chapter 3) was used to immunise
mice and their spleens were fused with NS-0 myeloma cells. After
approximately 8 days, 179 aminopterin-resistant colonies were tested by ELISA
using the same fraction that was used for the immunisation. A summary of
the positive colonies is given in Figure 4.4(a). These were expanded initially
in 24-well plates, then in flasks to obtain supernatants for immunoblotting
against cytosol. As seen in Figure 4.4(b), the immunoreactivities varied both
in terms of strength and specificity. Since at this stage none of the cell lines
were cloned, it was not surprising to find a range of polypeptides reacting
with the different supernatants. However with cell lines 13 and 83, there
were stronger immunoreactivities against proteins of -55- and ~85-kDa and
these were therefore selected for cloning by limiting dilution; all other cell
lines were frozen uncloned for storage in liquid nitrogen.
When the clones 13.10 and 83.6 were tested, there was no
enhancement of the 55- and 85-kDa bands. To investigate the specificity of the
immunoreactivities against the weaker bands, a dilution assay was
performed. As shown in Figure 4.4(c), diluting the antibody did not reduce its
immunoreactivity against the minor bands. One explanation could be that an
epitope which generates a monoclonal antibody may consist of only a few
aminoacids and consequently may be present in several proteins (see clone
13.10). Another explanation is that the different bands may be proteolytic
products of one protein. In such a case, as seen for clone 83.6 in Figure 4.4(c),
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Figure 4.4
The immunoreactivity of culture supernatants from hybridomas generated against Ca2+-
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Figure 4.4
The immunoreactivity of culture supernatants of hybridomas generated against Ca2+-
dependent chromaffin granule membrane-binding proteins.
(c) Specificity of monoclonal antibodies 13.10 & 83.6: Antibody dilution assay.
a 10
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The immunoreactivity of culture supernatants of hybridomas generated against
Ca2+-dependent chromaffin granule membrane-binding proteins.
Figure 4.4(a): Immunoreactivities of culture supernatants from hybridomas generated by
immunising mice with Ca2+-dependent chromaffin granule membrane-binding proteins
(numbers indicated) were assayed using ELISA against Ca2+-dependent chromaffin granule
membrane-binding proteins. Immunoreactivities were quantitated by the activity of
urease-conjugated anti-mouse-IgG and -IgM secondary antibodies at 510nm.
Figure 4.4(b): Immunoblot showing the immunoreactivities of culture supernatants from
hybridomas generated by immunising mice with Ca2+-dependent chromaffin granule
membrane-binding proteins (numbers indicated) against adrenal medullary cytosol.
Figure 4.4(c): The specificity of the immunoreactivities of culture supernatants from clonal
hybridomas 13.10 and 83.6 were investigated by serial dilution of culture supernatant:
Tracks 1: undiluted culture supernatant; Tracks 2: 1 in 5 dilution; Tracks 3: 1 in 10 dilution;
Tracks 4: 1 in 25 dilution; Tracks 5: 1 in 50 dilution; Tracks 6: 1 in 100 dilution;
Tracks 7: 1 in 200 dilution; Tracks 8: 1 in 400 dilution.
143
Chapter 4
Screening for hybridomas secreting McAbs against chromaffin granule membrane-specific and associatedantigens
the major immunoreactive band should be the one of highest molecular
weight. Because of the success of other fusions, these antibodies were not
investigated any further.
(ii) Monoclonal antibodies against glycoproteins of the chromaffin granule
membrane
As a strategy for obtaining monoclonal antibodies against the minor
membrane components of chromaffin granule membranes, a glycoprotein-
rich fraction of these membranes (see Chapter 3) was used to immunise mice.
Hybridomas were generated and their supernatants were tested using both
ELISAs and dot-blots. For ELISAs, plates were either coated with solubilised
chromaffin granule membranes or with the glycoprotein-rich fraction. To
overcome the possibility that some antigens were not able to attach to ELISA
plates and therefore were excluded from the assay, supernatants were also
tested against chromaffin granule membranes by dot-blotting. Urease-
conjugated second antibodies were used to detect mouse antibodies in ELISAs
and the biotin-125I-streptavidin system was used for dot-blots.
Figure 4.5(a) shows the results from ELISAs when hybridomas
generated from this fusion were tested. Using the glycoprotein-rich fraction
in ELISAs substantially increased the sensitivity of the assay as compared to
the reactivities against chromaffin granule membranes. The results obtained
from dot-blots were identical to those obtained by ELISAs but the reactivities
against chromaffin granule membranes of cell lines 6, 14 and 23 were much
more pronounced, probably because more antigen is available in dot-blots.
The cell lines that were positive were expanded into flasks and their
supernatants were tested by immunoblotting. Figure 4.5(b) shows the
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Figure 4.5
The immunoreactivities of culture supernatants from hybridomas generated against adrenal
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Figure 4.5
The immunoreactivities of culture supernatants from hybridomas generated against adrenal
chromaffin granule membrane glycoproteins.
(a) Immunoreactivities of culture supernatants from hybridomas generated by immunising mice
with a membrane glycoprotein-rich fraction derived from chromaffin granule membranes by
Triton X-114 fractionation using ELISAs against either solubilised chromaffin granule
membranes (CGM) or against glycoproteins (GP) derived from them. Immunoreactivities were
quantitated by the activity of urease-conjugated anti-mouse-IgG and -IgM antibodies at 510nm.
(b) Immunoblot showing the immunoreactivities of culture supernatants from hybridomas
generated by immunising mice with a membrane glycoprotein-rich fraction derived from
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immunoreactivities of these supernatants: only cell lines 6 and 14 were
reactive. These reacted against 67- and 75-kDa proteins respectively and the
reactivity of no. 14 was substantially more than that of no. 6. Since these
antibodies recognised both native and denatured epitopes, they were chosen
for cloning.
To further characterise supernatants 6 and 14, two-dimensional
immunoblots were carried out using chromaffin granule membranes. As
seen in Figure 4.6(a), the immunoreactivity from cell line 14 was characteristic
of the catecholamine biosynthetic enzyme dopamine /1-monooxygenase and
the antibody was termed dbhl. The immunoreactivity from cell line 6 was
less obvious (Figure 4.6(b)). It reacted with a protein of apparent molecular
weight 67-kDa and pi 5.4 - 6.2, and was therefore named cgm67. The
characterisation of the cgm67-reactive protein (p65) is the subject of Chapter 5.
Both cell lines were cloned by limiting dilution and used to generate ascites
tumours in mice.
The antibodies dbhl and cgm67 were identified as IgG and IgM type
mouse immunoglobulins respectively. This was carried out by ELISA in
which secondary antibodies against either mouse IgG or IgM were used to
measure the immunoreactivity of dbhl or cgm67 (Figure 4.7(a) ). The
monoclonal antibody dbhl was clearly an IgG-class immunoglobulin and
cgm67 appeared to be an IgM but the lower titer of this antibody prevented
firm conclusions being drawn. In order to establish if cgm67 was indeed an
IgM, the molecular mass of cgm67-immunoreactivity was determined by gel
filtration under non-reducing conditions using a TSK-G3000 SWXL column
with molecular weight cut off at 500-kDa. The molecular weight of IgM being
around 106-Da, its immunoreactivity would be expected in the void volume
of the column whereas IgG-immunoreactivity would appear in later
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Figure 4.6
Two-dimensional immunoblots showing the immunoreactivities of the monoclonal antibodies
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Figure 4.7








(a) To determine whether the monoclonal antibodies raised against chromaffin granule
membrane glycoproteins were IgGs or IgMs, the immunoreactivities of the culture supernatants
against the Triton X-114 "glycoprotein" fraction was determined using ELISAs with either
anti-mouse IgG or anti-mouse IgM secondary antibodies conjugated to urease.
Immunoreactivities were quantitated by monitoring the activity of urease at 570nm, as
described in Chapter 2, Section 2.71a].
Cell line 6 secretes cgm67, Cell line 14 secretes dbhl.
(b) To establish that cgm67 (the monoclonal antibody secreted from cell line 6) was indeed an
IgM, culture supernatant of cell line 6 was fractionated by gel filtration using a TSK-G3000
SWXL column with molecular weight cut off at 500-kDa. Immunoreactivity of each fraction
was determined by dot-blotting the column fractions against chromaffin granule membranes,
followed by probing the dot-blot with 125I-labelled anti-mouse IgM secondary antibodies.
Immunoreactivity was visualised by autoradiography. Fractions 1 -18 are the void volume of
the column; fraction numbers are indicated on the dot-blot.
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(b) Gel filtration profile of culture supernatant from cell line 6 (cgm67):
Void volume is collected in fractions 1-18.
Immunoreactivity of fractions derived from cell line 6 by gel filtration using a TSK-G3000
SWXL column:
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fractions. As seen in Figure 4.7(b), the cgm67-immunoreactivity eluted in the
void volume, confirming that cgm67 was indeed an IgM.
Although the aim of this project was to obtain monoclonal antibodies
against the uncharacterised proteins of the chromaffin granule membrane,
the anti-dopamine /3-monooxygenase antibody from cell line 14 (dbhl)
proved to be very useful as a positive control in the characterisation of other
monoclonal antibodies.
(iii)Monoclonal antibodies against intrinsic proteins of the chromaffin
granule membrane
As described in Chapter 3, one of the approaches to obtaining
monoclonal antibodies against only the intrinsic proteins of the chromaffin
granule membrane was to liberate tryptic peptides from membranes that had
been washed with 100 mM sodium carbonate (pH 11). The washing step
ensured that chromaffin granule membranes were free of extrinsic proteins
and mild trypsin treatment reduced the chances of obtaining antibodies
against the protease-resistant dopamine /3-monooxygenase. The mixture of
tryptic peptides was used to immunise mice and hybridomas were prepared as
usual. The hybridomas were screened against chromaffin granule
membranes using dot-blots, bound mouse antibodies being detected by
enhanced chemiluminescence.
Figure 4.8(a) shows the primary screen results of the hybridomas from
this fusion. The hybridomas secreting chromaffin granule membrane-specific
antibodies were expanded and their supernatants were tested against
chromaffin granule membranes by immunoblotting. Figure 4.8(b) shows that
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8 out of the 13 hybridomas tested secreted antibodies against an antigen of
~80-kDa. The immunoreactivities of the others varied but the most striking
feature of this fusion was that it was biased towards the larger antigens of the
chromaffin granule membrane.
The antibody secreted by cell lines 9 (cgm.80) was subsequently tested by
two-dimensional immunoblotting against chromaffin granule membranes
(Figure 4.8(c)). This antibody detected an antigen of 78 - 94-kDa with distinct
isoforms which had pi values around 4-5. The cgm80 cell line was cloned
and used to generate ascites tumours; the other cell lines were stored
uncloned in liquid nitrogen.
The molecular weight and the distinctive acidic pi suggested that
cgmSO could be against the previously identified, but biochemically
uncharacterised, glycoprotein II - a protein with a wide distribution in
secretory vesicles of both endo- and exocrine glands as well as in kidney
lysosomes [Obendorf et al., 1988; Weiler et al., 1990]. To establish whether
cgm80 was indeed against glycoprotein II, the immunoreactivities of cgm80
and a polyclonal antiserum against this protein (obtained from Dr.
Fischer-Colbrie, Innsbruck, Austria) were compared by two-dimensional
immunoblotting. To determine the precise position of the immunoreactive
spots of the two antibodies, the immunoreactivity of dbhl (a monoclonal
antibody against dopamine /i-monooxygenase) was used as an internal
marker of molecular weight and pi. As seen in Figure 4.9(a) and (b), the mono-
and polyclonal antibodies stained the same regions of the immunoblot
suggesting that the two antibodies recognised the same protein. To further
prove that these antibodies recognised the same protein, the anti-glycoprotein
II antiserum/dbhl blot was reincubated with cgm80. This resulted in the
intensification of the spots that were originally immuno-stained by the
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Figure 4.8
The immunoreactivities of culture supernatants from hybridomas generated against tryptic
peptides derived from integral proteins of adrenal chromaffin granule membrane.
(a) by dot-blots:
















Screening for hybridomas secreting McAbs against chromaffin granule membrane-specific and associatedantigens
Figure 4.8
The immunoreactivities of culture supernatants from hybridomas generated against tryptic
peptides derived from integral proteins of adrenal chromaffin granule membrane.






(a) Immunoreactivities of culture supernatants from hybridomas generated by immunising mice
with soluble tryptic peptides derived from integral membrane proteins of chromaffin granule
membranes using dot-blots against solubilised chromaffin granule membranes. Immuno¬
reactivities were detected by using enhanced chemi-luminescence followed by exposure to
autoradiography film.
(b) Immunoblot showing the immunoreactivities of culture supernatants from hybridomas
generated by immunising mice with soluble tryptic peptides derived from integral membrane
proteins of chromaffin granule membranes against chromaffin granule membrane proteins.
Immunoreactivities were detected by using enhanced chemi-luminescence followed by exposure
to autoradiography film.
(c) Two-dimensional immunoblots showing the immunoreactivity of the monoclonal antibody
cgmSO (secreted by cell line 9) against chromaffin granule membrane proteins.
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Figure 4.9
Identification of the cgm80-antigen as glycoprotein II.
Comparison of the immunoreactivities of the monoclonal antibody cgm80 and
glycoprotein II polyclonal antibody using two-dimensional immunoblotting:
(a) Two-dimensional immunoblots showing the position of the cgm80-reactive
to dopamine /Tmonooxygenase:




(b) Two-dimensional immunoblots showing the position of glycoprotein II relative to
dopamine /Tmonooxygenase:
~ pi 6.3 5.8 5.0
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anti-glycoprotein II antiserum. Furthermore, upon longer exposures of the
immunoblots, common degradation products were observed. An
independent approach taken to identify the cgm80-antigen was to compare its
fractionation using the detergent Triton X-114 with that of glycoprotein II.
Using concanavalin A-binding property of glycoprotein II, Pryde & Phillips
(1986) have shown that glycoprotein II fractionates predominantly into the
detergent-rich phase - this was confirmed using anti-glycoprotein II antisera
(Figure 4.9(c) ). As seen in Figure 4.9(c), the cgm80-antigen also fractionated
predominantly into the detergent-rich phase. Taken together, these results
therefore show that cgm80 is an anti-glycoprotein II monoclonal antibody.
Cgm80 immunoreactivity was detected only if anti-mouse IgG
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Figure 4.9
Identification of the cgm80-antigen as glycoprotein II.
(c) Immunoblot showing the distribution of cgm80 immunoreactivity on fractionation of
chromaffin granule membranes with the non-ionic detergent Triton X-114:
1 2 3 4 5 6 7 8
80 kDa - M |m . ^ ,
Track 1: chromaffin granule membranes; Track 2: phospholipid-rich pellet;
Track 3: detergent-rich pellet; Track 4: aqueous supernatant; Track 5: glycoprotein-rich pellet;
Track 6: soluble and extrinsic proteins of chromaffin granules; Track 7: Na2CC>3-washed
chromaffin granule membranes; Track 8: proteins released from Na2C03-washed chromaffin
granule membranes. 20 pg of each fraction was loaded per lane of a minigel.
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4.3 Conclusions
The most important part of producing monoclonal antibodies against
components of a mixture of antigens is the availability of screening
procedures that can identify hybridomas producing antibodies against the
individual components.
In this Chapter, I have outlined how immunological techniques for
the detection of monoclonal antibodies were set up and shown how these
have been used. Monoclonal antibodies 13.10 and 83.6 were raised against a
fraction enriched in cytosolic proteins that bind to chromaffin granules in the
presence of elevated Ca2+ concentrations. Three other monoclonal antibodies
against chromaffin granule membranes (cgm67, cgm80 and dbhl) were also
identified and characterised: they are directed against p65, glycoprotein II and
dopamine /3-monooxygenase respectively. These monoclonal antibodies will
be used initially in the characterisation of the proteins with which they react,
and ultimately to help to explore the molecular mechanisms that govern the
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CHAPTER 5
Characterisation of bovine chromaffin granule p65 using the
monoclonal antibody cgm67
5.1 Introduction
Among integral components of secretory vesicle membranes must be
those proteins that are responsible for its organisation and exocytic function,
but their study has been complicated by the complex composition of such
membranes. Production of monoclonal antibodies against components of
these membranes provides one way of overcoming this problem and
initiating such investigations. Using the chromaffin granules as a model
system, a membrane-derived glycoprotein-rich fraction was produced and
used to raise several monoclonal antibodies, among them dbhl and cgm67
(see Chapters 3 & 4). These monoclonal antibodies recognised the
biosynthetic enzyme dopamine /3-monooxygenase and a 67-kDa protein
respectively. The latter protein appeared to be novel and its characterisation is
the subject of this Chapter.
In view of the many extrinsic components present in preparations of
chromaffin granule membranes, the initial aim in the characterisation of the
cgm67-antigen was to define its subcellular localisation, by subcellular
fractionation of adrenal medulla and immunoblotting the fractions using
cgm67. The partitioning of the cgm67-reactive antigen during Triton X-114
fractionation of chromaffin granule membranes and its susceptibility to
oligosaccharide-cleaving enzymes were also explored to further analyse the
nature of this antigen.
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Studies on the position of the cgm67-epitope were performed by
partial trypsin digestion of chromaffin granules and their membranes. This
led to the isolation of a 39-kDa tryptic peptide containing the cgm67-epitope,
which was purified and partially sequenced.
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5.2 Results
[a] Localisation of cgm67-immunoreactivity :
The subcellular localisation of cgm67-immunoreactivity was
established by fractionation of bovine adrenal medulla by differential
centrifugation, and by continuous sucrose density gradients (as described in
Methods, Chapter 2), followed by immunoblotting. Figure 5.1(a) shows that
when the post-nuclear supernatant was fractionated on a continuous sucrose
gradient, cgm67-immunoreactivity was found in the same region of the
gradient as dopamine /3-monooxygenase, an established marker enzyme of
chromaffin granules, between 1.8 and 1.95 M sucrose. It has been shown for
some integral membrane proteins of secretory vesicles, such as
synaptophysin, that as well as being present in chromaffin granules, they are
also present in a vesicle population devoid of the typical granule markers
which band around 1.2 M sucrose [Obendorf et ai, 1988]. In comparison with
the immunoreactivity in the granule region of the sucrose gradient, no
appreciable amount of cgm67-immunoreactivity was present in any other
region of the gradient. Flowever, after longer periods of autoradiography,
weak cgm67-immunoreactivity was also observed in the 0.85 M sucrose
region of the gradient where broken chromaffin granule membranes are
present. As a consequence of the low sensitivity of the 125I-labelled second
antibody system which was used in this experiment (to avoid a problem
inherent in the more sensitive biotin-streptavidin system, namely detection
of naturally-occurring biotinyl proteins), firm conclusions about the apparent
dual distribution of the cgm67-antigen could not be drawn.
The cgm67-immunoreactivity was located in the membranes of
broken chromaffin granules by more conventional fractionation methods as
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Figure 5.1
Characterisation of the cgm67-antigen.
(a) Subcellular distribution of the cgm67-reactive antigen: Postnuclear supernatant of adrenal
medulla was separated by using a sucrose density gradient (0.5 to 2.4 M) and fractionated (12 x 1
ml). Equal volumes of each fraction (40 pi) were analysed by immunoblotting using first cgm67,
followed by dbhl on the same sheet of nitrocellulose in order to compare the distribution of the
cgm67-reactive antigen with that of dopamine /J-monooxygenase.
(b) Subcellular distribution of the cgm67-reactive antigen: Adrenal medullae were
fractionated by differential centrifugation and equal protein (100 pg; large format gel) from
each subcellular fraction was analysed by immunoblotting using the monoclonal antibody
cgm67.
(c) Fractionation of chromaffin granule membranes by Triton X-114: Immunoblot showing the
distribution of cgm67 immunoreactivity on fractionation of chromaffin granule membranes with
the non-ionic detergent Triton X-114. 20pg of each fraction was loaded per lane of a minigel.
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seen in Figure 5.1(b). Despite the large population of secretory granules in
chromaffin cells (Chapter 1, Section 1.3), the weak cgm67-immunoreactivity
in the post-nuclear supernatant suggested a much lower abundance of the
cgm67-antigen than of dopamine /3-monooxygenase. When chromaffin
granule membranes were extensively washed with Na2C03 at pH 11 to
remove extrinsic proteins, cgm67-antigen remained in the membrane
fraction, suggesting that it is an integral membrane protein (Figure 5.1(c)).
Further fractionation of membranes with the non-ionic detergent Triton
X-114 suggested that the cgm67-antigen was a membrane-bound glycoprotein
which is present in the "aqueous" phase but which precipitates out into the
"glycoprotein-rich" fraction once the residual Triton X-114 is removed by
dialysis (Figure 5.1(c)).
[b] Identification of cgm67-antigen as bovine p65 :
A 65-kDa antigen of synaptic vesicles termed "p65" has also been
shown to be the major calmodulin-binding protein of chromaffin granule
membranes [Matthew et al., 1981; Fournier & Trifaro, 1988] (see Chapter 1,
Section 1.4(b)(i) ). The apparent molecular weight of the cgm67-antigen was
similar to that of p65. To determine whether the protein recognised by cgm67
was p65, a calmodulin-binding fraction from solubilised chromaffin granule
membranes was prepared by calmodulin-agarose affinity chromatography (see
Methods, Chapter 2). The polypeptides in this fraction were separated by
two-dimensional electrophoresis, and blotted with both cgm67 and asv48, the
monoclonal antibody originally used in characterising p65 (Matthew et al.,
1981). A trace of dopamine /1-monooxygenase was added to the material
loaded onto the gel, and was used as an internal marker of pi and molecular
165
Chapter 5
Characterisation of bovine chromaffin granule membrane p65 using the monoclonal antibody cgm67
weight. It was detected with dbhl, an IgG-class anti-dopamine
/3-monooxygenase monoclonal antibody. The positions of the asv48- and
cgm67-immunoreactive spots were coincident, although that due to cgm67
was much stronger than that due to asv48 (Figures 5.2(a) & 5.2(b) ). As a
further proof of similarity, the asv48/dbhl blot was then incubated with
cgm67, which resulted in the intensification the spot previously stained by
asv48 (cf. Figures 5.2(a) ). As p65 has been shown to bind both asv48 and
calmodulin and to be present in bovine chromaffin granule membranes
[Fournier & Trifaro, 1988a], it was concluded that cgm67 bound to an epitope
on that protein, although its apparent molecular weight was 67-kDa, rather
than 65-kDa as has been reported in the rat brain [Matthew et al., 1981].
Another approach taken to establish whether the cgm67-antigen was
the same protein as p65 was to compare the immunoreactivities of tryptic
peptides derived from the cgm67-antigen using the monoclonal antibodies
asv48 and cgm67. Intact granules were treated (0, 2.5 and 600 pig/ml trypsin
for 60 minutes at 37°C) and the supernatant and residual membrane fractions
analysed separately. Figure 5.2(c) is an immunoblot showing the soluble and
membrane-bound asv48-reactive tryptic peptides. Comparison of these
peptides with those that are reactive with cgm67 (Figure 5.5) shows that the
two antibodies recognised the same tryptic peptides and were therefore almost
certainly directed against the same protein.
The cgm67-antigen was therefore the bovine homologue of the
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Figure 5.2
Comparison of the immunoreactivities of the monoclonal antibodies cgm67 and asv48 :










(a) Two-dimensional immunoblots showing the position of the cgm67-reactive protein relative
to dopamine /Tmonooxygenase.
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Figure 5.2
Comparison of the immunoreactivities of the monoclonal antibodies cgm67 and asv48:
(c) flsu48-reactive tryptic peptides derived from chromaffin granule membranes (refer to
Figure 5.6(b) & (d)):
Pure chromaffin granules were incubated with a range of trypsin concentrations
(Track 1: 0 |ig/ml; Track 2: 2.5 pg/ml; Track 3:600 pg/ml; Track 4: 2.5 |ig/ml; Track 5: 67 gg/ml)
and the soluble and insoluble fractions were examined separately (Tracks 1, 2,3: insoluble
peptides (membrane-bound); Tracks 4,5: soluble peptides). Track 6 is a control without trypsin,
containing chromaffin granule membrane proteins.
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[c] Glycosylation of bovine chromaffin granule p65 :
Bovine chromaffin granule membrane p65 behaved like several other
intrinsic membrane glycoproteins when fractionated in the non-ionic
detergent Triton X-114. To confirm that bovine p65 is indeed glycosylated, the
aqueous fraction from Triton X-114-treated chromaffin granule membranes
in which membrane glycoproteins were still in solution was treated with the
oligosaccharide-cleaving enzymes neuraminidase or endoglycosidase F, in the
presence of protease inhibitors as described in Chapter 2. The digestion
products were separated and immunoblotted with cgm67. Neuraminidase,
which removes terminal sialic acid residues, reduced the apparent molecular
weight of the protein by approximately 1-kDa (Figure 5.3(a) ). On the other
hand, treatment with endoglycosidase F, which removes N-glycans of the
high-mannose and complex types from core polypeptides, reduced the
molecular weight by approximately 5-kDa. Together these results indicate
that bovine p65 contains one or more N-linked oligosaccharide chains,
terminating in sialic acid and galactose. The oligosaccharide moiety of
bovine p65 does not bind concanavalin A or wheat germ agglutinin (see
Chapter 3, Figures 3.2(b) & (c) ) but does bind peanut agglutinin after
neuraminidase treatment (Figure 5.3(b)).
Recent publication of the cDNA sequence of the rat p65 [Perin et al.,
1990] has revealed only one putative N-linked glycosylation site in the
intragranular region of the protein. At this stage it is not possible "predict the
number of glycosylation sites on the bovine p65. Recently the rat p65 has also
been shown to be N-glycosylated [Perin et al., 1991b].
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Figure 5.3
Glycosylation of bovine chromaffin granule p65.
(a) Enzymatic degradation of the oligosaccharide chains of p65 using neuraminidase and
endoglycosidase F.
Neuraminidase E ndoglycosidase F
p67
(b) Peanut agglutinin-binding glycoproteins of chromaffin granule membranes before and after
digestion with neuraminidase:
67 kDa - I-
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[d] Subcellular orientation of the cgm67 epitope :
To establish the orientation of the cgm67 epitope in the chromaffin
granule membrane, crude intact granules were mixed with purified
chromaffin granule membranes and the mixture was incubated with cgm67
for 10 minutes at room temperature. The organelle/antibody mixture was
then loaded onto a continuous sucrose gradient (0.5 to 2.4 M) and centrifuged
to equilibrium. Since only bound monoclonal antibodies would enter the
gradient, if the cgm67 epitope was on the cytoplasmic side of the granules
bound antibody would be detected in the granule region (1.80 to 1.95 M
sucrose) as well as in the broken membrane region (around 0.85 M sucrose);
in the case of a lumenal epitope, cgm67 would only be present in the broken
membrane region. After centrifugation to equilibrium, the gradient was
fractionated and the distribution of cgm67 in the gradient was assayed by dot-
blotting the fractions onto a nitrocellulose membrane and probing them with
125I-anti-mouse IgM antibodies. The 125I bound to each dot was subsequently
quantitated by y-counting. Figure 5.4(a) shows that cgm67 was present in both
intact granule and in the broken granule membrane region of the gradient.
In a parallel experiment intact granules were first treated with 0.1 mg/ml
trypsin to establish if the cgm67 epitope in intact granules was accessible to
proteolysis and hence cytoplasmically oriented. After 1 hour, the trypsin was
inhibited with TLCK, PMSF and trypsin inhibitor. The unruptured
trypsin-treated granules were then mixed with broken chromaffin granule
membranes, incubated with cgm67, and processed as above. The added
broken chromaffin granule membranes served as a positive control to check
that cgm67 was not affected by any residual uninhibited trypsin. Treatment of
the granules with trypsin abolished the binding of cgm67 to them but not to
the untreated broken granule membranes, implying that the epitope is on the
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Figure 5.4
Subcellular orientation of the cgm67-epitope.
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Figure 5.4
Subcellular orientation of the cgm67-epitope.
I. Antibody/organelle sucrose gradients:
(a) To determine the subcellular orientation of the epitope of cgm67, crude chromaffin granule
fraction derived from the adrenal medulla (-150 pi; 5 mg) was mixed with -0.5 mg purified
chromaffin granule membranes in 0.3 M sucrose/10 mM Hepes (pH 7.2). To this mixture, 250 pi
of cgm67 culture supernatant was added and the mixture was incubated at room temperature for
5 minutes. The organelle/monoclonal antibody mixture was then loaded onto a continuous
sucrose gradient (0.5 to 2.4 M) which was centrifuged to equilibrium. After centrifugation to
equilibrium, the gradient was fractionated and the distribution of cgm67 in the gradient was
assayed by dot-blotting the fractions onto a nitrocellulose membrane and probing them with
125l-anti-mouse IgM antibodies. The bound to each dot was subsequently quantitated by
"/-counting. In a parallel experiment trypsin-treated chromaffin granules (see Chapter 2,
Section 2.3[e]) were loaded onto the gradient.
(b) The procedure described above was carried out using the monoclonal antibody dbhl
directed against dopamine /3-monooxygenase.
II. The effect of protease treatment of intact granules:
The effect of papain-, pronase- and trypsin-treatment of intact granule on bovine p65 ((c)),
dopamine /1-monooxygenase ( (d) & (f) ) and cytochrome b5^ ((e)) were investigated by
purifying membranes from protease-treated intact chromaffin granules and analysing them by
immunoblotting using the monoclonal antibodies cgm67, dbhl and a polyclonal antibody against
cytochrome b^^ obtained from Dr. D.K. Apps (Dept. of Biochemistry, Univ. of Edinburgh).
Tracks 1: granule incubated without protease for 60 minutes at room temperature; Track s 2:
papain-treated granules; Tracks 3; pronase-treated granules; Tracks 4: trypsin-treated
granules; Tracks 5: granules incubated for 60 minutes at 0°C; Track 6 (Fig. 5.4(f) only): intact
granule incubated without trypsin for 60 minutes at room temperature; Track 7 (Fig. 5.4(0 only):
intact granule incubated with 0.1 pg/ml trypsin for 60 minutes at room temperature with the
addition of 0.5 % Triton X-100; Track 8 (Fig. 5.4(f) only): as track 7, but incubated with 1 pg/ml
trypsin with the addition of 0.5 % Triton X-100; Track 9 (Fig. 5.4(f) only): as track 7, but
incubated with 20 pg/ml trypsin with the addition of 0.5 % Triton X-100; Track 10 (Fig. 5.4(f)
only): as track 7, but incubated with 100 pg/ml trypsin with the addition of 0.5 % Triton X-100;
Track 11 (Fig. 5.4(f) only): intact granules incubated with 100 pg/ml trypsin for 60 minutes at
room temperature without the addition of 0.5 % Triton X-100.
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cytoplasmic side of the granule membranes. In a similar experiment, the
monoclonal antibody against dopamine /3-monooxygenase (dbhl) was only
detected in the broken membrane region showing that as expected its epitope
was lumenal (Figure 5.4(b) ).
Another approach to investigating the orientation of the cgm67
epitope was to determine its susceptibility to protease treatment. Intact
chromaffin granules were therefore treated with 0.1 mg/ml trypsin, papain or
pronase for 60 minutes at room temperature, and membranes were purified
from them. These membranes were immunoblotted with cgm67 to establish
the fate of its epitope following such treatment. As with the organelle/
antibody gradients described above, protease treatment resulted in the
complete loss of the cgm67 epitope from the granules (Figure 5.4(c) ). In
contrast, dopamine /3-monooxygenase, which is not exposed to the cytoplasm,
was unaffected by these extragranular reagents (Figure 5.4(d) ). Cytochrome
i>561, a transmembrane protein with extragranular N- and C- termini [Perin et
al., 1988] was found, as expected, to be protease-sensitive (Figure 5.4(e) ). The
addition of 0.5 % Triton X-100 to the granules to lyse them before protease
treatment made dopamine/3-monooxygenase protease-sensitive (Figure 5.4(f)).
These experiments confirm that the cgm67 epitope is extragranular and that
the granules remain unruptured during the protease treatments.
[e] Epitope mapping and transmembrane topology of bovine p65 :
To establish the membrane topology of bovine p65, intact granules or
their broken membranes were treated with a range of trypsin concentrations.
This resulted in the concentration-dependent release of the cgm67-reactive
peptides (Figure 5.5). A major soluble cgm67-reactive peptide of 39-kDa was
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Figure 5.4
Subcellular orientation of the cgm67-epitope.
(c) The effect of protease treatment of intact granules on the epitope of cgm67:
12 3 4 5
p£S -
(d) The effect of protease treatment of intact granules on the epitope of cibhl:
12 3 4 5
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Figure 5.4
Subcellular orientation of the cgm67-epitope.
(e) The effect of protease treatment of intact granules on cytochrome b551:
1 2 3 4 5
- dinners
cqkchfW)£_ b
(f) The effect of protease- and detergent-treatment of intact granules on dopamine
/Tmonooxygenase:
6 7 8 9 10 11
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released from both intact granules and their broken membranes with as little
as 0.01 gig/ml trypsin apparently by cleavage at a trypsin-hypersensitive site.
As the trypsin concentration was increased from 0.01 to 25 pg/ml more of the
39-kDa fragment was released (Figures 5.5(c) & (d), tracks 4-10), but at higher
concentrations (>25 pg/ml) this fragment began to be degraded to a 27-kDa
soluble fragment (tracks 9-11). As the detection of the fragments depends
upon their immunoreactivities, p65-derived polypeptides that do not contain
the cgm67 epitope are not seen in these blots.
As well as these soluble products, trypsin treatment of broken
membranes also generated membrane-bound cgm67-reactive peptides
(Figures 5.5(b) ). As with intact granules, on trypsin treatment of broken
membranes the amount of residual (intact) p65 decreased as the trypsin
concentration was increased from 0.01 to 2.5 (ig/ml (Figures 5.5(b) tracks 1-6),
and a new membrane-bound form of apparent molecular weight 45-kDa
appeared. This 45-kDa species was not seen when intact granules were
incubated with trypsin (Figure 5.5(a) ), nor was any other membrane-bound
cgm67-immunoreactive product. At higher trypsin concentrations, the
45-kDa peptide was converted to a 28-kDa form (Figure 5.5(b), tracks 8-10).
These results are consistent with the release of a large (39-kDa,
immunoreactive) domain of p65 into the soluble fraction from both broken
membranes and intact granules, and the release of a smaller, lumenal
domain (22-kDa, and non-immunoreactive) from broken membranes only.
The cgm67 epitope is present on the larger domain which is cytoplasmically
oriented, as it is released from intact chromaffin granules by protease
treatment, and no membrane-bound degradation product can then be
detected (Figures 5.6(a) ). The 39-kDa cytoplasmically oriented tryptic peptide
has a single isoelectric point of 6.4 (Figure 5.6).
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Figure 5.5
Trypsin degradation of bovine p65:




(a) Granule pellet (c) Granule supernatant
123456789 10 11 + 123456789 10 11
67 kDa
45 kDa 40 kDa
27 kDa
28 kDa
(b) Ruptured Membrane Pellet (d) Ruptured membrane supernatant
Intact chromaffin granules or chromaffin granule membranes were incubated with a range of
trypsin concentrations (Tracks 1: 0.01 gg/ml: Tracks 2: 0.03 gg/ml; Tracks 3: 0.09 pg/ml;
Tracks 4: 0.27 pg/ml; Tracks 5: 0.81 pg/ml; Tracks 6: 2.5 gg/ml; Tracks 7: 7.4 gg/ml;
Tracks 8: 22 pg/ml; Tracks 9: 67 gg/ml; Tracks 10:200 pg/ml; Tracks 11: 600 pg/ml) and the
soluble and insoluble (membrane-bound) fractions were examined separately by immunoblotting
with the monoclonal antibody cgm67. Tracks "+" are controls without trypsin.
(a) & (b) show the insoluble (membrane-bound) tryptic peptides generated;
(c) & (d) show the soluble tryptic peptides generated.
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Figure 5.6
The 39-kDa cytoplasmic domain of bovine p65.
dhbl
cgm67 -
Soluble peptides derived from limited trypsin treatment of chromaffin granule membranes (1 pg
trypsin per mg/ml of membranes) were separated by two-dimensional electrophoresis and
immunoblotted using the monoclonal antibody cgm67. The cgm67 immunoblot was reincubated
with the monoclonal antibody dbhl to establish the isoelectric point of the 39-kDa tryptic
peptide of bovine p65. rfW;2-immunoreactivity is resistant to trypsin treatment at 1 pg trypsin
per mg/ml of membranes (see Figure 5.4(d)). The 39-kDa tryptic peptide of bovine p65 has a
single isoelectric point of 6.4.
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[f] Purification and partial aminoacid sequence of the cytoplasmic domain
of bovine p65 :
The presence of the large cytoplasmic domain of bovine p65 suggested
that this domain may be important in its in vivo function. Since this domain
could be solubilised by mild trypsin treatment of chromaffin granule
membranes, its purification was undertaken so that its biochemical
characterisation and studies of its function could be initiated. The
purification of this domain would also allow a partial aminoacid sequence to
be obtained which would permit oligonucleotide primers to be made for use
in the polymerase chain reaction, so that the corresponding DNA sequence
could be obtained from a bovine adrenal cDNA library.
The results in Figure 5.5(d) show that the optimal amount of trypsin
required to solubilise the 39-kDa cytoplasmic domain of bovine p65 was
around 1 pg in a lmg/ml solution of chromaffin granule membranes. Using
these conditions, the yield of the cytoplasmic domain from chromaffin
granule membranes was maximal between 40 and 60 minutes of incubation at
37°C at which times little resiciual 39-kDa fragment remained in the
membranes (Figures 5.7(a) & (b) ). At the end of the incubation, the trypsin
treatment was inhibited with 50 pM TLCK and 200pM PMSF. The soluble
tryptic peptides were separated from the membranes by centrifugation and the
supernatant was adjusted to 1.25 M ammonium sulphate with ice cold 3 M
ammonium sulphate in 10 mM phosphate (pH 7.0) and loaded on a
phenyl-5PW-TSK hydrophobic interaction column.
Under these conditions the 39-kDa fragment bound to phenyl-5PW,
whereas most other polypeptides did not. It was eluted from the column at a
concentration of ammonium sulphate of 700 mM (Figure 5.8(a) ). The
presence of this polypeptide was assayed by dot-blotting the fractions and
180
Chapter 5
Characterisation of bovine chromaffin granule membrane p65 using the monoclonal antibody cgm67
Figure 5.7
Generation of the cytoplasmic domain of bovine chromaffin granule p65.
(a) Time-course of p65 cytoplasmic domain generation:
12 3 4 5 6 7 8
Chromaffin granule membranes were incubated with 1 gg/ml trypsin as described in Chapter 2,
Section 2.3[e] and the soluble peptides generated were analysed by immunoblotting using the
monoclonal antibody cg>n67. Track 1: 0 min.; Track 2:10 min.; Track 3: 20 min.; Track 4: 30 min.;
Track 5: 40 min.; Track 6:50 min.; Track 7: 60 min.; Track 8:120 min.
(b) Generation of p65 cytoplasmic domain by multiple rounds of trypsin-treatment:
Chromaffin granule membranes were incubated with 1 pg/ml trypsin for 60 minutes at 37°C.
The digestion was terminated by incubation on ice and the soluble tryptic peptides were
separated from the chromaffin granule membranes by centrifugation. The membranes were then
reincubated with 1 pg/ml fresh trypsin for 60 more minutes at 37°C. The generation of the
cytoplasmic domain of bovine p65 was analysed by immunoblotting using the monoclonal
antibody cgm67. Track 1: p65 cytoplasmic domain generated after one round of trypsin-
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Figure 5.8
Purification of the cytoplasmic domain of bovine p65.
(a) Hydrophobic interaction chromatography profile:
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Figure 5.8
Purification of the cytoplasmic domain of bovine p65.






Purification of the cytoplasmic domain of bovine p65:
(a) Soluble tryptic peptides obtained from bovine chromaffin granule membranes were applied
to a phenyl-5PW-TSK hydrophobic interaction chromatography column at an ammonium
sulphate concentration of 1.25 M (in 50 mM phosphate buffer, pH 7.0). Unbound peptides were
washed off the column with 1.25 M ammonium sulphate/ 50 mM phosphate buffer (pH 7.0) and
the bound peptides were eluted with a 30 ml linear gradient of ammonium sulphate. The
protein concentration of the column eluate was monitored at 220 nm.
(b) The eluted peptides were assayed for the cgm67 epitope by immuno-dot-blotting. The
cgm67-reactive peptides eluted from the column at around 750 - 700 mM ammonium sulphate.
(c) The cgm67-reactive fractions were pooled and extensively dialysed to remove ammonium
sulphate, concentrated by rotary evaporation for further purification using a C18 reverse-
phase HPLC column. The polypeptide composition of the cgm67-reactive fractions were
determined by SDS-PAGE.
(d) The pooled cgm67-reactive fractions were further fractionated using a CI8 reverse-phase
HPLC column and the composition of each protein peak was determined by SDS-PAGE ( (e) );
*marks cgm67-reactive peak; "+" marks pooled active fraction from (c).
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Figure 5.8
Purification of the cytoplasmic domain of bovine p65.
(d) C 18 reverse-phase HPLC profile:
(d) Polypeptide composition of the fractions obtained from C 18 reverse-phase HPLC:
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probing with the monoclonal antibody cgm67 (Figure 5.8(b) ).
The cgm67-reactive fractions were pooled and extensively dialysed
against 0.1 mM phosphate buffer (pH 7.0) to remove ammonium sulphate.
Figure 5.8(c) shows that the 39-kDa cytoplasmic domain was free of most other
polypeptides at this stage and was immunoreactive. The dialysed fraction was
concentrated by rotary evaporation and bound to a C18 reverse-phase column
in 10% acetonitrile/0.1% trifluoroacetic acid in water. In contrast to the
composition shown on gels, the HPLC profile of the pooled fraction suggested
a complex mixture of peptides (Figure 5.8(d)). The 39-kDa polypeptide eluted
from the column as a single peak at 45% acetonitrile. When this fraction was
checked for purity by SDS-PAGE, it appeared as a doublet (Figure 5.8(e)). Both
polypeptides were immunoreactive with cgm67 and were therefore
sequenced together by automated Edman degradation. Table 5.1 shows the
N-terminal aminoacid sequence of the 39-kDa polypeptide.
[g] Calmodulin binding site of bovine p65 is cytoplasmically oriented :
The putative role of calmodulin in secretion has been discussed in
Chapter 1. It has been shown that calmodulin binds to chromaffin granule
membrane proteins of apparent molecular weights 50-53 and 65-69-kDa
[Burgoyne & Geisow, 1981; Hikita et ah, 1984]. Although the latter protein has
been identified as p65 by immunological methods, the techniques used by
these authors to determine calmodulin-binding were not able to resolve the
orientation of the calmodulin binding site, nor determine whether the
calmodulin receptors were integral membrane components. If calmodulin is
indeed involved in exocytosis, it must bind specifically only to the
cytoplasmic domains of the above proteins.
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Table 5.1
N-terminal aminoacid sequence of the 39-kDa tryptic peptide of bovine p65.
Cycle 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Aminoacid TMKDQA LKDD D A E T GLTD7GE
Yield (pmol) 28 19 17 14 28 26 28 11 8 10 6 17 9 9 15 7 5 2 7 8
Rat p65 TMKDQALKDD D AE T G LT D GE
About 32 pmol of peptide was loaded on to the sequencer, and the aminoacid recoveries are
corrected for background. In each case the aminoacid quoted is that with the highest recovery
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Figure 5.9
Binding of bovine p65 and its cytoplasmic domain to calmodulin.
1 2 3 4 5 6
67 kDa
- 39 kDa
The aqueous phase derived from Triton X-114 fractionated chromaffin granule membranes
(Tracks 1 and 6) was incubated with immobilised calmodulin in the presence of 100 pM (total)
Ca^+ and eluted with 5 mM EGTA. Track 2: eluate; Track 3: eluate when when 2 mM EGTA was
included during the incubation. Track 4 and Track 5 show a similar experiment in which the
cytoplasmic domain of p65, liberated by treatment of chromaffin granule membranes with
trypsin (see Figures 5.5 & 5.6) was incubated with immobilised calmodulin. Proteins eluted
were visualised by immunoblotting with the monoclonal antibody cgm67.
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In previous sections of this Chapter it was shown that the cytoplasmic
domain of bovine p65 could be solubilised by protease treatment, and that
cgm67 recognises an epitope on this domain. To investigate the position of
the calmodulin-binding site of p65, both the "aqueous" fraction of Triton
X-114-treated chromaffin granule membranes (containing intact p65) and
trypsin-solubilised peptides from these membranes were applied to
calmodulin-agarose in the presence of 100 pM (total) Ca2+. Following
extensive washing with 10 mM Hepes-NaOH (pH 7.2) containing the same
total calcium ion concentration, the bound proteins were eluted with 5 mM
EGTA in 10 mM Hepes-NaOH (pH 7.2). Analysis of the EGTA-eluate by
immunoblotting with cgm67 (Figure 5.9) showed that both p65 and its 39-kDa
cytoplasmic domain bound to immobilised calmodulin. The binding of both
polypeptides was abolished if 2 mM EGTA was included in the binding buffer.
A 40-kDa cgm67-immunoreactive peptide present in the aqueous fraction also
bound to immobilised calmodulin but that of ~50-kDa did not.
[h] p65 from sources other than bovine chromaffin granule membranes :
The monoclonal antibody cgm67 reacted with p65 from both human
and rat sources. Figure 5.10 shows an immunoblot with cgm67 against
secretory vesicle membranes prepared from bovine adrenal medulla, human
phaeochromocytomas and synaptosomes from rat forebrain. The human and
bovine p65 migrated with an apparent molecular weight of 67-kDa in contrast
to rat p65 which was at 65-kDa, in agreement with previous reports [Matthew
et al, 1981],
When secretory vesicle membranes were fractionated with the
non-ionic detergent Triton X-114 at 30°C, human p65 fractionated
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Figure 5.10
p65 from sources other than the bovine adrenal medulla.
Comparison of the molecular weights of p65:
Preparations of bovine chromaffin granule (Track 1), rat synaptic vesicles (Track 2) and
chromaffin granule membranes from human phaeochromocytoma (Track 3) were separated by
SDS-PAGE and immunoblotted with the monoclonal antibody cgm67.
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predominantly into the "detergent-rich" phase in contrast to bovine p65
which fractionated in the "aqueous" phase (Figure 5.11(a) ). The endogenous
50-kDa cgm67-reactive peptide derived from human p65 also fractionated like
the intact protein but an endogenous 40-kDa cgm67-reactive peptide
(presumably the cytoplasmic domain) behaved as a soluble protein and
fractionated into the aqueous phase. When rat forebrain synaptosomes were
fractionated with the detergent Triton X-114 using the same protocol as that
for chromaffin granule membranes, p65 appeared in all fractions (Figure
5.11(b) ). This result and the high protein content of the "phospholipid-rich"
fraction suggested that fractionation was incomplete under the conditions
used. Further studies to optimise the conditions for Triton X-114
fractionation of synaptosomes were not done.
The partitioning pattern of human p65 in Triton X-114 implies that it
is less hydrophilic than its bovine counterpart. This behaviour and the
molecular weight difference between the species could be because of sequence
divergence or different glycosylation of the intralumenal domain since the
aminoacid sequence of the cytoplasmic domain of p65 is highly conserved
[Perin et al., 1991 a\ (see later).
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Figure 5.11
Fractionation of p65 from sources other than the bovine adrenal medulla by Triton X-114.
Immunoblots showing the distribution of cgm67 immunoreactivity (p65) on fractionation of
chromaffin granule membranes from human phaeochromocytomas (a) or synaptic vesicles from
rat fore-brain (b) with the non-ionic detergent Triton X-114. 20pg of each fraction was loaded
per lane of a minigel. Track 1: bovine chromaffin granule p65; Track 2: human chromaffin
granule p65; Track 3: PI fraction from Triton X-114 treated human chromaffin granule p65;
Track 4: detergent phase from Triton X-114 treated human chromaffin granule p65; Track 6:
aqueous phase from Triton X-114 treated human chromaffin granule p65; Track 7 & 12: bovine
p65; Track 8: rat synaptic vesicles; Track 9: PI from Triton X-114 treated rat synaptic vesicles;
Track 10: detergent phase from Triton X-114 treated rat synaptic vesicles; Track 11: aqueous
phase from Triton X-114 treated rat synaptic vesicles.
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Figure 5.11
Fractionation of p65 from sources other than the bovine adrenal medulla by Triton X-114.
(a) p65 from human phaeochromocytomas:
1 2 3 4 5
(b) p65 form rat synaptic vesicles:
7 8 9 10 11 12
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5.3 Discussion & Conclusions
Experiments with the monoclonal antibody cgm67 have revealed a
67-kDa transmembrane glycoprotein of chromaffin granules which binds
calmodulin. This protein appears to be homologous to p65, the protein from
rat synaptic vesicles described by Matthew et al. (1981). The epitope recognised
by cgm67 was localised to the cytoplasmic domain of the protein both by
protease treatment and subcellular fractionation of intact granules on
granule/antibody gradients.
The structure of bovine p65 was analysed by limited trypsin digestion
of both intact granules and their ruptured membranes followed by the
analysis of the fragments which continued to bind cgm67. These results are
summarised in Figure 5.12 which shows a schematic structure of bovine
chromaffin granule membrane p65. The trypsin cleavage sites shown in this
figure are numbered according to their apparent distance (in kDa) from the
N-terminus. The membrane-bound 45-kDa fragment is produced by cleavage
of p65 at T22; that of 28-kDa by a further cleavage at T50. The soluble 39-kDa
fragment is produced by cleavage at T28, and the soluble 27-kDa fragment is
produced from this by removal of a 12-kDa fragment, either from its
N-terminus (cleavage at T40) or its C-terminus (cleavage at T55), assuming it
is generated by a single cut. The hypersensitivity of sites T22 and T28 to
trypsin means that no membrane-bound tryptic fragment of molecular
weight greater that 45-kDa is detected by cgm67. The 39-kDa fragment
includes most of the cytoplasmic domain of p65 and contains the cgm67
epitope between T28 and T50; more precise location is not possible without
further fragmentation and sequencing. The epitope recognised by asv48, the
monoclonal antibody used in the original identification of p65, was also
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Figure 5.12
Schematic diagram of bovine chromaffin granule p65:
Epitope of cgm 67






T22, T28, T40, T50 and T54 are trypsin cleavage sites; boxes A and B indicate regions which in
rat p65 contain sequence similarity (39 %) to the C2 regulatory domain of protein kinase C. This
diagram has been constructed from the data shown in Figure 5.5.
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analysed in a similar manner. This antibody was able to bind to the same
cgm67-immunoreactive tryptic peptides, however, asv48 did not react as
strongly with the 27-kDa soluble and the 28-kDa membrane-bound tryptic
peptides. This implies that the epitopes recognised by the two antibodies are
not the same, but are localised to a common tryptic peptide. The structure
predicted from the data above is consistent with the recently published cDNA
sequence of rat brain p65 [Perin et al., 1990], and is identical to the
independent work of Perin et al. (1991b).
The biological function of p65 is unknown but it presumably involves
its large cytoplasmic domain. Previous studies have shown that p65 binds
calmodulin, an ubiquitous Ca2+-binding protein which modulates the
function of many proteins in response to the intracellular level of Ca2+, and
which has been implicated in the mechanism of exocytosis. In this Chapter,
using the monoclonal antibody cgm67, it was confirmed that bovine p65
binds to immobilised-calmodulin. It was also shown that the calmodulin-
binding site is located on the cytoplasmic of domain p65, and therefore
accessible to calmodulin in vivo. It was found that an endogenous 40-kDa
peptide of p65 also binds to immobilised calmodulin, but that one of ~50-kDa
does not. The identity of the 40- and 50-kDa peptides are not established but
the Triton X-114 fractionation of the 40-kDa peptide and its molecular weight
are both consistent with its being the cytoplasmic domain of p65, probably
generated by proteolytic cleavage at the hypersensitive site at T28. The
~50-kDa fragment partitions as a membrane-bound polypeptide and may be
generated by proteolytic cleavage near T55, within the cytoplasmic domain of
p65. If this is so, it implies that the calmodulin-binding site may be at the
C-terminus of p65; however, using only cgm67 and without further
fragmentation of the cytoplasmic domain of p65, it is not possible to
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determine the exact location of this calmodulin-binding site. Using
"125I-calmodulin overlay" of SDS-gels, Trifaro and his co-workers were unable
to find calmodulin-binding peptides of p65. This could either be because the
calmodulin-binding site of p65 might be denatured and no longer able to bind
125I-calmodulin when chromaffin granule membrane proteins are separated
on SDS-gels and also because there may simply be not enough proteolytic
peptides of p65 in their preparations.
The significance of the calmodulin binding is presumably to activate a
specific, but as yet unknown, function of p65. One of the properties of rat p65
is the ability of its cytoplasmic domain to bind acidic phospho- and
sphingolipids, and to agglutinate rabbit erythrocytes [Perin et al., 1990]. The
cDNA sequence of this domain has shown the presence of a tandem repeat
homologous to the C2 regulatory domain of protein kinase C [Perin et al.,
1990]. The function of these domains are not clear, nor is whether or how
these activities are linked to calmodulin-binding.
To study the cytoplasmic domain of p65, it was purified to
homogeneity by hydrophobic interaction and reverse-phase chromatography.
The N-terminal aminoacid sequence of this 39-kDa domain was determined
by automated Edman degradation. The sequence of the first 20 aminoacids,
which is shown in Table 5.2, was identical with residues 112 - 131 of the rat
p65 sequence, following the potential trypsin cleavage site at lysine-111. This
sequence lies between the proposed transmembrane span and the first region
with homology to the C2 regulatory domain of protein kinase C (Figure 5.13).
A minor peptide of molecular weight slightly less than 39-kDa which
co-purified with the 39-kDa peptide was also sequenced - its sequence was
identical but 3 aminoacids shorter at the N-terminus than that of the 39-kDa
peptide and was probably generated by cleavage of p65 at the next lysine, i.e. 3
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residues closer to the C-terminus. The aminoacid sequence data thus
provided direct confirmation of the membrane orientation and the identity of
the cgm67-reactive protein.
This aminoacid sequence identity between part of bovine and rat p65
and the fact that the monoclonal antibodies cgm67 and asv48 recognise p65
from different species suggests this protein is highly conserved. That this
indeed is the case is shown in the recently-published p65 cDNA sequences
from human and Drosophila [Perin et al., 1991 a\. When human and rat
sequences are compared, within the 343 aminoacid cytoplasmic domain, only
two residues are different. Sequence diversity in p65 is found only in the
intragranular domain, which probably explains the differences in molecular
weight and Triton X-114 fractionation patterns observed. The molecular
weight of bovine and human p65 was determined as 67-kDa, and that of rat as
65-kDa by immunoblotting with the monoclonal antibody cgm67 - these
values are much larger than the polypeptide molecular weight calculated
from the rat sequence, which is 47,576 Da [Perin et al.r 1990].
The sequence homology of p65 from different sources as diverse as
human and Drosophila, its calmodulin- and phospholipid-binding
properties, its ability to agglutinate red blood cells and the fact that the
cytoplasmic domain may be phosphorylated in vitro all suggest that p65
performs an essential function in vivo [Perin et al., 1990, 199la, 1991 b;
Petrenko et al., 1991; Tugal et al., 1991]. Ultimately, it is hoped that the
characterisation of p65 in this study, together with the use of the monoclonal
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Chapter 6
Summary, conclusions and perspectives
In cells such as those present in the adrenal medulla, the pituitary or
in the nervous system which export their products through the regulated
secretory pathway, these products are taken up, concentrated and stored in
organelles called "secretory granules" (see Chapter 1). The secretory products
remain within these granules until an external stimulus triggers their release
out of the cell. The pharmacology of secretion and the intracellular events
that lead up to exocytosis have been the subject of many studies and are
reasonably well understood, however, the mechanisms by which these
signals are translated into the movement of secretory granules to the plasma
membrane, and by which the granules dock and fuse with it are not
understood. Our lack of understanding of these events is because of our
limited knowledge about the proteins that are involved in these processes. It
is assumed that at least part of this "exocytic machinery", together with other
proteins involved in the organisation and trafficking of secretory vesicles are
integral components of their membranes. Within the last decade, such an
hypothesis has led to an increasing number of studies being carried out on
secretory vesicle membrane proteins, including studies of their
phosphorylation states, their ability to bind either Ca2+ or Ca2+-calmodulin
and their ability to interact with intracellular components such as cytosolic
proteins, the cytoskeleton and other organelles (see Chapter 1). Another, and
particularly successful approach, has been the immunological characterisation
of secretory vesicle membrane proteins, in particular those present in synaptic
vesicle membranes. The success of these studies has greatly depended on the
development of the hybridoma technology by Kohler & Milstein (1975),
because it allows the generation of specific monoclonal antibodies against
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components of secretory vesicles which are otherwise inaccessible by standard
biochemical techniques.
The aim of the present study was the immunological characterisation
of the membranes of chromaffin granules, the secretory vesicles of adrenal
chromaffin cells, in order to identify proteins which might mediate the
process of exocytosis or organisation of the granule.
The immunological characterisation was initiated by raising
monoclonal antibodies against the membrane proteins of bovine chromaffin
granules, and in particular, against those components which are not
obviously involved in the biosynthesis of secretory material. As stressed in
Chapters 3 and 4, the success of this approach depended on the combination
of using membrane-derived fractions capable of generating useful antibodies,
and on the development of sensitive immunoassays which could identify
them.
The two fractions successfully used as immunogens in raising
monoclonal antibodies against chromaffin granule membrane proteins were
first, a fraction enriched in membrane glycoproteins derived from chromaffin
granule membranes by fractionating them with the non-ionic detergent
Triton X-114, and second, a fraction of soluble tryptic peptides derived only
from integral membrane components (see Chapter 3). Hybridomas generated
as a result of immunising mice with these antigens were screened using
immunoassays developed to be sensitive enough to identify any antibody
raised against a component of the immunisation mixture. These immuno¬
assays were in the form of ELISAs and dot-blots (see Chapter 4).
As a result of these approaches three monoclonal antibodies (cgm67,
cgm80 and dbhl) were obtained. These monoclonal antibodies were directed
against the integral membrane proteins p65, glycoprotein II and against the
biosynthetic enzyme involved in the synthesis of catecholamines, dopamine
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/3-monooxygenase (Chapter 4). As well as these, the monoclonal antibodies
13.10 and 83.6 were raised by using a fraction enriched in a group of cytosolic
proteins that bound to chromaffin granule membranes in the presence of
elevated Ca2+ concentrations.
The cgm67-reactive antigen was characterised in detail (Chapter 5). It
was established that cgm67 bound to an integral membrane protein of
molecular weight 67-kDa and pi 5.4 - 6.2 present in adrenal chromaffin
granule membranes of both cow and humans. The cgm67-antigen was also
present in rat synaptic vesicle membranes. It was also established that
cgm67-antigen was the bovine homologue of the rat synaptic vesicle protein
p65 which had been identified previously by Matthew et al. (1981).
The structure of bovine p65 was analysed by using proteases and
oligosaccharide-cleaving enzymes. The results showed that p65 was an
integral membrane glycoprotein of chromaffin granules which spanned the
membrane once with its C-terminal two-thirds exposed to the cytoplasm (see
Figure 5.13). It was found that the cytoplasmic domain of bovine p65 could be
solubilised by mild trypsin digestion as a 39-kDa peptide, and that this domain
bound both cgm67 and Ca2+-calmodulin (Chapter 5). This domain was
purified and its N-terminus was partially sequenced by automated Edman
degradation; the 20-aminoacid stretch was found to be identical to the
corresponding region of rat p65 as determined from its cDNA sequence [Perin
et al., 1990].
Recently, rat p65 has also been characterised by Perin et al. (1991b). Its
structure is identical to that of bovine p65, and furthermore its sequence is
97% identical to human p65 [Perin et al., 1991^]. The high degree of sequence
homology of p65, particularly in the cytoplasmic domain, suggests that it
mediates an important function mediated by this domain which is conserved
across species, even down to Drosophila [Perin et al., 1991<?]. One striking
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feature of the cytoplasmic domain of p65 is that it contains two regions in
tandem showing 39% homology to the C2 regulatory domain of protein
kinase C [Perin et al., 1990]. This region has been shown been shown to bind
acidic phospholipids [Perin et al., 1991b]. Other in vitro activities of the
cytoplasmic domain of p65 are its ability to bind Ca2+-calmodulin [Tugal et al.r
1991] and to form homodimers [Perin et al., 199b']. It has also been suggested
that this domain could bind Ca2+ directly, however no evidence has been
presented for this claim [Perin et al., 1991b].
Although the physiological relevance of Ca2+-calmodulin binding by
p65 has been dismissed by Siidhof & Jahn (1991) without direct evidence, the
fact that p65 binds Ca2+ (either directly, or indirectly as Ca2+-calmodulin)
implies that its activity could be responsive to changes in the intracellular
levels of Ca2+.
It has recently been shown that p65 is phosphorylated in vitro, and
that this event is inhibited by the receptor for the black widow spider venom
neurotoxin, a-latrotoxin [Petrenko et al., 1991]. Since the physiological effect
of this toxin is to enhance neurotransmitter release, Petrenko et al. have
concluded that exocytosis could be mediated by the dephosphorylated form of
p65. Such observations fit in with the requirement of ATP as a "primer" of
exocytosis and the importance of dephosphorylation as a step preceding
exocytosis (see Chapter 1, Section 1.6[b] ). If p65 does have an in vivo role in
mediating exocytosis, this function whatever it may be, must be regulated
such that p65 is only functional under conditions which trigger exocytosis.
The combination of the in vitro activities displayed by p65 suggests that it
may indeed have a role in exocytosis and it has been suggested by Fournier &
Trifaro (1988b) and Siidhof & Jahn (1991) that this role could be in the docking
of secretory vesicles to the plasma membrane (see Section 1.4[b](a) ).
The ultimate aim in the characterisation of p65 is to establish whether
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p65 is involved in exocytosis, and for this its biochemistry must be studied
using a functional assay which reconstitutes exocytosis. A suitable and a
well-characterised assay to study the role of p65 in exocytosis is the
permeabilised chromaffin cell system (see Section 1.8[a] ). Since the function
of p65 appears to be through its cytoplasmic domain, in such a system, this
domain is accessible to manipulation. Such studies should proceed along the
following routes:
(1) Using the N-terminal partial aminoacid sequence of the cytoplasmic
domain of p65, oligonucleotide probes should be designed so that the
corresponding cDNA may be isolated from a bovine adrenal cDNA library
using the polymerase chain reaction. The isolated cDNA for the
cytoplasmic domain of p65 could then be cloned into a vector so as to
express a fusion protein (e.g. a protein A/p65 chimera) which would allow
the purification of the this domain. Similarly, the cDNA for the
cytoplasmic domain could be used to dissect this domain into "functional"
units which could also be expressed and purified. These peptides could
then be introduced into permeabilised chromaffin cells either as fusion
proteins, or after proteolytic cleavage from the chimeras to determine
their effects on Ca2+-dependent exocytosis. Inhibition of exocytosis would
mean that the recombinant cytoplasmic domain is competing with the
endogenous p65 and by using the smaller recombinant portions of this
domain, the important sections of p65 may be established.
(2) Another approach to determine the role of p65 in exocytosis could be
through making polyclonal antibodies against both the recombinant
cytoplasmic domain of p65 and its peptides and determining their effects
(and of cgm67) on Ca2+-dependent exocytosis in the permeabilised
chromaffin cell system.
(3) Whether p65 is phosphorylated in vivo, and whether such an event
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controls its function must be determined. These studies could be carried
out on 32P-labelled intact chromaffin cells. By using mild trypsin digestion
followed by immunoprecipitation, the phosphorylation state of the
cytoplasmic domain of endogenous p65 could be analysed using one- and
two-dimensional gels in cells before and after stimulation.
(4) To determine whether phosphorylation controls the function of p65, the
effect of introducing recombinant phospho- and dephospho-p65
cytoplasmic domains into permeabilised chromaffin cells could be studied
by determining whether they alter the Ca2+-dependence of secretion.
(5) Finally the kinase(s) and phosphatase(s) which control the phos¬
phorylation state of p65 in vivo should be established in order to
determine the how exocytic signals are transmitted to the exocytic
machinery of the cell. Initially this could be tackled by fractionating
cytosol and assaying for its ability to phosphorylate the recombinant
cytoplasmic domain of p65 or smaller recombinant portions of this
domain. To establish the physiological relevance of the phosphorylation,
the phospho-cytoplasmic domains could be assayed for their effect on
Ca2+-dependency of exocytosis as suggested in point (4) above. Establishing
the residues that are phosphorylated would also determine whether p65 is
serine- or tyrosine-phosphorylated.
The studies on the structure and in vitro activities of p65 in this study
and by others have implicated its possible role in exocytosis. It is hoped that
using this knowledge, the above aims can be investigated so that the possible
role of p65 in mediating exocytosis can be discovered. It is also hoped that
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Aminoacid codes and data
AminoAcid Abbreviations m.w. Property
Alanine Ala A 89 Alliphatic
Arginine Arg R 174 Basic
Asparagine Asn N 132 Amide
Aspartate Asp D 133 Acid
Cysteine Cys C 121 Thiol
Glutamine Gin Q 146 Amide
Glutamate Glu E 147 Acidic
Glycine Gly G 75 Alliphatic
Histidine His H 155 Basic
Isoleucine lie I 131 Alliphatic
Leucine Leu L 131 Alliphatic
Lysine Lys K 146 Basic
Methionine Met M 165 Thiol
Phenylalanine Phe F 165 Aromatic
Proline Pro P 115 Amide
Serine Ser S 105 Alliphatic alcohol
Threonine Thr T 119 Alliphatic alcohol
Tryptophan Trp W 204 Aromatic
Tyrosine Tyr Y 181 Aromatic alcohol
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Glycosylation and transmembrane topography of bovine chromaffin
granule p65
H. Biilent TUGAL,* Fred van LEEUWEN, David K. APPS, Jeff HAYWOOD and John H. PHILLIPS
Department of Biochemistry, University of Edinburgh Medical School, George Square, Edinburgh EH8 9XD, Scotland, U.K.
The bovine homologue of p65, a calmodulin-binding protein located in the membranes of synaptic vesicles and endocrine
secretory granules, has been studied by the use of monoclonal antibodies directed against this antigen and against
dopamine /(-mono-oxygenase. The protein (apparent molecular mass 67kDa; pi = 5.5-6.2) is partially degraded by
treatment with neuraminidase or endoglycosidase F. Trypsin treatment of intact adrenal chromaffin granules or of granule
membranes releases a soluble 39 kDa fragment of p65 which corresponds to the whole of its cytoplasmic domain. This
domain contains both the epitope for the monoclonal antibody cgm67 and the calmodulin-binding site. The 20 amino
acids at the V-terminus of this fragment are identical to part of the rat p65 sequence.
INTRODUCTION
Although the process of regulated secretion is reasonably well
characterized in pharmacological terms, its molecular details
have yet to be elucidated. One approach is to use monoclonal
antibodies, raised against secretory granule membranes, in the
biochemical characterization of proteins on the granule surface.
By this means several granule antigens have been recognized,
although their functions have yet to be fully defined; these
include p38 (synaptophysin; Wiedenmann & Franke, 1985), SV2
(Buckley & Kelly, 1985) and p65 (Matthew et al., 1981).
This last protein was first identified as a component of rat
brain synaptic vesicles, and monoclonal antibodies against it
were found to precipitate chromaffin granules from bovine
adrenal medulla (Lowe et al., 1988). Subsequently p65 was shown
to be identical with a 65 kDa calmodulin-binding protein that
had already been identified in the membranes of chromaffin
granules (Fournier & Trifaro. 1988; Fournier et al., 19896). The
amino acid sequence of rat p65, deduced by sequencing a cDNA
clone (Perin et al., 1990), suggested that the protein had a single
membrane-spanning sequence; its V-terminal domain contained
a single putative A-glycosylation site and was predicted to lie
within the lumen of the granule, whereas the cytoplasmic C-
terminal domain contained two related sequences with sequence
similarity to a regulatory domain of protein kinase C.
We now report some studies on the structure and topography
of p65, using a monoclonal antibody (cgm67) raised against
bovine chromaffin granules. Our results provide direct bio¬
chemical evidence in support of the structural model of Perin
et al. (1990).
MATERIALS AND METHODS
Triton X-114 was obtained from Fluka AG, Buchs, Switzer¬
land, and purified by the method of Bordier (1981). All other
reagents were of AnalaR grade. Monoclonal antibody asv48 was
kindly given by Dr. John Bixby (University of Miami, Miami,
FL, U.S.A.).
Preparation of chromaffin granule membranes
Chromaffin granules were isolated from fresh bovine adrenal
glands (obtained from the local slaughterhouse) by the method
ofPhillips (1974), and purified granule membranes were prepared
from them according to Apps & Schatz (1979). All procedures
were carried out at 4 °C in media buffered with 10 mM-Hepes/
NaOH, pH 7.2, and containing 2 mM-EGTA, 1 mM-benzamidine
and 0.2 mM-phenylmethanesulphonyl fluoride (PMSF). The
membranes were finally resuspended in 10 mM-Hepes/NaOH
(pH 7.2)/5 mM-dithiothreitol (DTT) to a protein concentration
of 10 mg/ml.
Triton X-114 fractionation of chromaffin granule membranes
Chromaffin granule membranes were resuspended to 4 mg of
protein/ml in Tris-buffered saline (20 mM-Tris/150 mM-NaCl),
pH 7.4, with 2% (w/v, final) Triton X-114, and fractionation
was carried out according to Pryde & Phillips (1986). Most
experiments were carried out using the 'aqueous' phase, which
contains residual Triton X-114. Removal of this detergent
precipitated the chromaffin granule membrane glycoproteins,
producing the 'glycoprotcin-rich' fraction.
pH 11 treatment of membranes
Chromaffin granule membranes (approx. 1 mg/ml) were sus¬
pended in 0.1 M-Na2C03, pH 11, containing 10 mM-EDTA. After
30 min at 0 °C the membranes were separated from solubilized
proteins by centrifugation.
Preparation of antibodies
cgm67 and dbhl monoclonal antibodies were prepared es¬
sentially as described by Bastin et al. (1982). Mice were
immunized with the glycoprotein-rich Triton X-114 fraction of
chromaffin granule membranes. Hybridomas were screened
against the immunogen.
Calmodulin-affinity chromatography of chromaffin granule
membrane glycoproteins
The aqueous fraction from Triton X-114 fractionation of
chromaffin granule membranes was incubated for 20 min with
calmodulin-agarose gel (Sigma) in 10 mM-Hepes/NaOH
(pH 7.2)/0.1 mM-CaCl2. After extensive washing in the same
buffer, bound proteins were eluted by replacing CaCl2 by 5 mM-
EGTA. Controls were performed with the addition of 2 mM-
EGTA during the binding incubation.
Abbreviations used: PMSF, phenylmethanesulphonyl fluoride; Tos-Lys-CH2Cl, A'-a-/)-tosyl-2-lysine chloromethyl ketone ('TLCK'); DTT,
dithiothreitol.
* To whom correspondence should be addressed.
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Enzymic deglycosylation of gp67
TV-Deglycosylation was carried out using endoglycosidase F
(EC 3.2.1.96; Boehringer) and desialylation was carried out with
neuraminidase (sialidase, EC 3.2.1.18; Sigma, type VI). For
deglycosylation, 100 fig of the aqueous fraction from Triton X-
114 fractionation of chromaffin granule membranes was lyo-
philized and resuspended with the following reagents to give a
final protein concentration of 1.6mg/ml: 50 mM-Mes/NaOFI,
pH 6.5, 0.5% deoxycholate, 1% Triton X-100, 5 mM-DTT,
15 mM-EDTA, pH 6.5, and 33 units of endoglycosidase F/ml.
The digestion was carried out at 30 °C for 6 h in the presence of
5 mM-benzamidine, 200 /tm-PMSF, 5 jug of leupeptin/ml, 5 fig of
pepstatin/ml and 50 jug of Tos-Lys-CH2Cl (TV-a-p-tosyl-2-lysine
chloromethyl ketone; TLCK)/ml. For digestion with neur¬
aminidase, 100 //g of the Triton X-114 aqueous fraction was
lyophilizcd and resuspended in 50 mM-Mes/NaOH, pH 6.0, to a
final concentration of 1.6 mg/ml in the presence of 0.2 % Triton
X-100, 5 mM-DTT and the above proteinase inhibitors. Neur¬
aminidase was added to a final concentration of 1 unit/ml and
the reaction mixture was incubated at 30 °C for 6 h. The samples
were lyophilized and dissolved in SDS sample buffer with 5 mM-
DTT for analysis by gel electrophoresis and immunoblotting.
Proteinase digestion of chromaffin granule membranes
Chromaffin granule membranes were resuspended to 1 mg/ml
and incubated with various concentrations of trypsin for 60 min
at 20 °C in the presence of 2 mM-DTT. The digestions were
stopped by the addition of 50 /tg of Tos-Lys-CH.,Cl and 200 ftM-
PMSF. The soluble peptides were separated from the membranes
by centrifugation (412000 j»ov , 15 min, 2 °C). The resulting pellet
was washed twice by resuspension and centrifugation in 10 mM-
Hepes/NaOH, pH 7.2, containing the same inhibitors. The
supernatant fraction was recentrifuged as above to remove any
residual membrane fragments. The membrane fractions were
resuspended and then denatured by the addition of 0.25 vol.
of hot (100 °C) pH 4.6 SDS sample buffer [0.2 M-potassium
biphthalate, pH 4.6, 0.2 mM-EDTA, 20 % (w/v) SDS, 40 % (v/v)
glycerol, 0.015% (w/v) Bromophenol Blue] in the presence of
5 mM-DTT. The soluble fractions were lyophilized and taken up
in one-tenth of the original volume of 4-fold diluted SDS sample
buffer (pH 4.6, as above). The samples were then analysed by
electrophoresis and immunoblotting.
Electrophoresis and immunoblotting
One- and two-dimensional gel electrophoresis was performed
as described by O'Farrell (1975) and by Gavine et al. (1984), with
the exception that samples were lyophilized before use. Electro-
phoretic transfer to nitrocellulose was done according to Towbin
et al. (1979). Incubation with primary antibody was carried out
overnight, with bound antibody being detected either with 125I-
labelled second antibody or with biotinylated second antibody
followed by 125I-streptavidin.
Purification and partial amino acid sequencing of the cytosolic
domain of p65
Chromaffin granule membranes (10 mg of protein in 10 ml of
10 mM-Hepes/NaOH, pH 7.2, 5 mM-DTT) were incubated with
10 /zg of trypsin for 60 min at 20 °C, and the reaction was
stopped by the addition of 50 fig of Tos-Lys-CH2Cl/ml and
200 //m-PMSF. The membranes were pelleted and the super¬
natant was removed and made 1.25 M in ammonium sulphate
and 50 mM in sodium phosphate, pH 7.0. This sample was
applied to a hydrophobic interaction column (Pheny!-5PW;
TSK) equilibrated in the same medium, washed with this medium
and eluted with a 30 ml linear gradient of 1.25-0 M-ammonium
H. B. Tugal and others
sulphate in 50 mM-phosphate buffer, pH 7.0. Fractions were
assayed for the cgm67 epitope by immunodotting, and active
fractions containing an immunoreactive 39 kDa peptide were
pooled, dialysed against distilled water and concentrated by
rotary evaporation. Samples from six such runs were combined.
The dialysed sample was made 10% in acetonitrile and 0.1 % in
trifluoroacetic acid, applied to a C18 reverse-phase h.p.l.c. column
and eluted with a linear gradient of 10-70 % acetonitrile in water
containing 0.1% trifluoroacetic acid. The peak containing the
cgm67-immunoreactive 39 kDa peptide was checked for purity
by gel electrophoresis and Coomassie Blue staining, and was
sequenced on an Applied Biosystems type 477 microsequencer by
automated Edman degradation.
RESULTS AND DISCUSSION
The cgm67 epitope is on p65
The non-ionic detergent Triton X-114 may be used to frac¬
tionate membrane proteins according to their hydrophobicities
(Pryde & Phillips, 1986). After fractionation of bovine chromaffin
granule membranes by this method, the glycoprotein-rich frac¬
tion was used as the immunogen in the preparation of a class
IgM mouse monoclonal antibody, which was named cgm67.
This antibody recognizes an epitope on a bovine chromaffin
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Fig. 1. Detection of cgm67-reactive epitopes in chromaffin granule
membranes
(a) Immunoblot of a two-dimensional electrophoretogram of
chromaffin granule membranes using the monoclonal antibody
cgm67. (b) Immunoblot showing the distribution of cgm67
immunoreactivity on fractionation of chromaffin granule
membranes with Triton X-114 (tracks 1-6) or washing at pH 11
(tracks 7 and 8). Track 1, chromaffin granule membranes; track 2,
phospholipid-rich fraction; track 3, detergent-rich fraction; track 4,
aqueous fraction; track 5, glycoprotein-rich fraction; track 6,
supernatant remaining after removal of glycoproteins from aqueous
fraction; tracks 7 and 8, pellet and supernatant obtained on washing
chromaffin granule membranes at pH 11. In each track 15 /zg of
protein was loaded.
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(a) pH ... 6.3 5.8
D/JH
p65
(b) pH ... 6.3 5.8
D/?H
p65
Fig. 2. Two-dimensional immunoblots
(a) and (b) show the position of protein p65 relative to that of
dopamine /?-mono-oxygenase (D/TH, 75 kDa), and were developed
with monoclonal antibodies cgm67 (a) and asv48 (b), together with
dbhl, a monoclonal antibody directed against dopamine /?-mono-
oxygenase.
1 2 3 4
Fig. 3. Enzymic degradation of the oligosaccharide chains of p65
The aqueous fraction from Triton X-114 treatment of chromaffin
granule membranes was treated with neuraminidase (track 2) or
endoglycosidase F (track 3); the product was analysed by immune
blotting with cgm67. Tracks 1 and 4 are controls, incubated without
enzyme.
granule membrane protein of apparent molecular mass 67 kDa
and pi 5.5-6.2 (Fig. la). The antigen was shown to be located in
the granule fraction by subcellular fractionation, and its distri¬
bution paralleled that of dopamine /T-mono-oxygenase (results
not shown).
When chromaffin granule membranes were fractionated with
Triton X-114, immunoreactivity with cgm67 appeared pre¬
dominantly in the aqueous phase (Fig. 1 b, track 4). Removal of
residual Triton X-114 from this fraction concentrated the
immunoreactivity in the insoluble glycoprotein-rich fraction (Fig.
lb, track 5), leaving the supernatant, which contained secretory
proteins, devoid of immunoreactivity (Fig. lb, track 6). The
immunoreactive protein also remained membrane-bound on
treatment with 100 mM-Na2C03, consistent with it being an
integral membrane protein (Fig. lb, track 7).
The apparent molecular mass of the cgm67-reactive protein is
similar to that of p65, a 65 kDa protein of rat synaptic vesicle
membranes (Matthew et al., 1981) also shown to be one of the
calmodulin-binding proteins of bovine chromaffin granule mem¬
branes (Fournier & Trifaro, 1988). To determine whether the
protein recognized by cgm67 was indeed p65, we obtained a
calmodulin-binding fraction from solubilized chromaffin granule
membranes by calmodulin-agarose affinity chromatography (see
the Materials and methods section), separated the proteins by
two-dimensional electrophoresis and blotted them both with
cgm67 and with asv48, the monoclonal antibody originally used
in characterizing p65 (Matthew et al., 1981). A trace ofdopamine
/(-mono-oxygenase was added to the material loaded on to the
gel, and was used as an internal pi and molecular mass marker
by detection with dbhl, a class IgG anti-(dopamine /?-mono-
oxygenase) monoclonal antibody. The positions of the asv48-
and cgm67-immunoreactive spots were coincident, although that
due to cgm67 was much stronger than that due to asv48 (Figs. 2a
and 2b). As p65 has been shown to bind both asv48 and
calmodulin and to be present in bovine chromaffin granule
membranes (Fournier & Trifaro, 1988), we conclude that cgm67
binds to an epitope on this protein, although we found an
apparent molecular mass of 67 kDa rather than the 65 kDa
reported in the rat (Matthew et al., 1981). Both of these values
are much larger than the peptide molecular mass calculated from
the rat sequence, which is 47 576 Da.
Bovine chromaffin granule p65 is TV-glycosylated
Incubation of the aqueous fraction of chromaffin granule
membranes with endoglycosidase F or neuraminidase produced
partial degradation of p65, as shown by SDS/PAGE.
Neuraminidase, which removes terminal sialic acid residues from
oligosaccharides, decreased the molecular mass of p65 by about
1 kDa (Fig. 3, tracks 1 and 2), whereas endoglycosidase F, which
completely removes TV-linked high-mannose and complex
oligosaccharides, produced a greater decrease, of about 5 kDa
(Fig. 3, tracks 3 and 4). We also found that p65 did not bind the
lectins concanavalin A or wheatgerm agglutinin, but that it did
bind peanut agglutinin after neuraminidase treatment (results
not shown). Together, these results indicate that bovine p65
contains one or more TV-linked oligosaccharide chains,
terminating in sialic acid and galactose. The decrease in molecular
mass on deglycosylation is not large enough to account for the
discrepancy between the calculated molecular mass and that
determined by SDS/PAGE (see above).
Isolation and partial amino acid sequencing of the cytosolic
domain of bovine p65
Treatment of intact chromaffin granules or of their broken
membranes with low concentrations of trypsin released soluble
cgm67-reactive cleavage products, the major one being a frag¬
ment ofabout 39 kDa. As the trypsin concentration was increased
from 0.1 to 20 /<g/ml, more of the 39 kDa fragment was released
(Figs. 4c and Ad, tracks 4-10), but at higher concentrations
(>20 /<g/ml) this began to be degraded to a 27 kDa fragment
(tracks 9-11). As the detection of the fragments depends upon
their immunoreactivities, p65-derived polypeptides that do not
contain the cgm67 epitope are not seen in these blots.
On trypsin treatment of broken membranes the amount of
residual intact p65 decreased as the trypsin concentration was
increased from 0.01 to 2.5 /<g/ml (Fig. 4b, tracks 1-6), and a new
membrane-bound form of molecular mass 45 kDa appeared,
with a smaller amount of a 28 kDa form being seen at trypsin
concentrations around 200 /tg/ml (Fig. Ab, tracks 5-11). This
45 kDa species was not seen when intact granules were incubated
with trypsin (Fig. 4a), nor was any other membrane-bound
cgm67-immunoreactive product.
These results are consistent with the release of a large (39 kDa)
domain of p65 into the soluble fraction from both broken
membranes and intact granules and with the release of a smaller,
luminal domain (22 kDa; non-immunoreactive) from broken
membranes only. The cgm67 epitope is present on the larger
domain, and this must be cytosolic, as it is released from intact
chromaffin granules by trypsin, and no membrane-bound degra¬
dation product can then be detected (Fig. 4a). According to the
structure prediction by Perin et al. (1990), this cytosolic domain
is C-terminal to the membrane-spanning sequence (see Fig. 6).
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Fig. 4. Trypsin degradation of p65
Intact chromaffin granules or chromaffin granule membranes were
incubated with a range of trypsin concentrations (/tg/ml: track 1,
0.01; track 2, 0.03; track 3, 0.09; track 4. 0.27; track 5, 0.81; track
6, 2.5; track 7, 7.4; track 8, 22; track 9, 67; track 10, 200; track 11,
600) and the insoluble and soluble fractions were examined sep¬
arately by immune blotting with cgm67. Tracks marked + are
controls without trypsin. (a) and (b) show insoluble fractions from
intact granules and granules membrane respectively; (c) and (d)
show soluble fractions from intact granules and granule membranes
respectively.
Epitope of cgm67







Fig. 6. Diagram of the structure of bovine p65
T22, T28, T40, T50 and T55 are trypsin cleavage sites; boxes A and
B indicate regions which in rat p65 contain sequences similar to
protein kinase C. For the amino acid sequence, see Table 1.
Molecular 1 2 3 4 5 6
mass (kDa) *
Fig. 5. Binding of p65 and its cytoplasmic domain to calmodulin
The aqueous fraction from Triton X-114 treatment of chromaffin
granule membranes (tracks 1 and 6) was incubated with immobilized
calmodulin in the presence of 100 /tM-Ca2+ (total) and eluted with
5 mM-EGTA. Track 2, eluate; track 3, eluate when 2 mM-EGTA was
included during the incubation. Tracks 4 and 5 show a similar
experiment in which the cytoplasmic domain of p65, liberated by
treatment of chromaffin granule membranes with trypsin (see Fig.
4d), was incubated with immobilized calmodulin. Proteins were
visualized by immunoblotting with cgm67.
The 39 kDa tryptic fragment showed Ca2+-dependent binding
to immobilized calmodulin, from which it was eluted by EGTA
(Fig. 5, track 4). An endogenous 39 kDa degradation product
which was present in the aqueous phase from Triton X-114
fractionation (Fig. 5, track 1) behaved similarly (Fig. 5, track 2).
A small amount of another (approx. 50 kDa) endogenous
degradation product that was detectable in this fraction failed to
bind to calmodulin (Fig. 5, tracks 1 and 2).
The 39 kDa tryptic fragment of p65 bound to a phenyl-5PW
hydrophobic interaction chromatography gel in the presence of
1.25 M-ammonium sulphate (at which concentration most other
peptides were not bound), and was eluted at about 700 mM-
ammonium sulphate. Further purification of this fraction by
reverse-phase h.p.l.c. on a Clg column gave a fraction containing
only immunoreactive peptides, a major one having a molecular
mass of 39 kDa and a minor one of slightly lower molecular
mass. These peptides were sequenced together by automated
Edman degradation (Table 1). The sequence of the first 20 amino
acids of the major peptide is identical with residues 112-131 of
the rat p65 sequence, which follow the potential trypsin-cleavage
Table 1. A-Terminal amino acid sequence of the 39 kDa soluble fragment derived from bovine p65 by proteolytic cleavage
About 32 pmol of peptide was loaded on to the sequencer, and the amino acid recoveries are corrected for background. In each case the amino
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site at lysine- 111. This sequence lies between the proposed
transmembrane span and the first region, with sequence similarity
with the CI regulatory domain of protein kinase C (Fig. 6). The
minor peptide was probably generated by cleavage of p65 at the
next lysine (i.e. three residues closer to the C-terminus), as
suggested by partial TV-terminal sequencing.
The cleavage by trypsin of chromaffin granule p65 is consistent
with results reported elsewhere (Fournier et al., 1989a; Trifaro
et al., 1989) and with the sequence data for rat p65 (Perin et al.,
1990), and puts some restrictions on the location of the cgm67
epitope. The trypsin-cleavage sites shown in Fig. 6 are numbered
according to their apparent distance (in kDa) from the TV-
terminus. The membrane-bound 45 kDa fragment (Fig. 4b, tracks
6-11) is produced by cleavage of p65 at site T22, and that of
28 kDa (Fig. 4b, tracks 10 and 11) by a further cleavage at T50.
The soluble 39 kDa fragment (Figs. 4c and 4d, tracks 4—9) is
produced by cleavage at T28, and the soluble 27 kDa fragment
(Fig. 4d, tracks 9 and 10) is produced from this by removal of a
12 kDa fragment, from either its TV-terminus (cleavage at T40) or
its C-terminus (cleavage at T55), assuming that it is generated by
a single cut. The cgm67 epitope must lie between T28 and T50;
more precise location is not possible without further fragment¬
ation and sequencing. In view of the large discrepancy between
the molecular mass values determined by electrophoresis and by
sequencing, the values quoted only give a rough idea of the
relative sizes of these fragments. The extreme sensitivity of sites
T22 and T28 to trypsin means that no membrane-bound tryptic
fragment of molecular mass greater than 45 kDa is detected by
cgm67.
The amino acid sequence data provide direct confirmation of
the membrane orientation of p65. The sequence obtained is close
to the start of the two regions similar in sequence to protein
kinase C, which encompass most of the 39 kDa fragment. The
calmodulin-binding domain lies within this fragment (Fig. 6),
although it was not detected using the calmodulin overlay
technique (Fournier et al., 1989b; Trifaro et al., 1989). The
complete identity of the rat and bovine sequences for 20 amino
acids indicates a strong pressure for conservation in this region,
which suggests some role in the function of p65.
Note added in proof (received 27 August 1991)
The results reported here are in agreement with those of a
recently published study on the domain structure of p65 (Perin
et al., 1991).
This work was supported by a grant from the Medical Research
Council. We thank Dr. John Bixby for a gift of antibodies, and the
Welmet Protein Characterization Facility for amino acid sequence
determinations.
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The vacuolar H+-translocating ATPase of renal tubules contains a
115-kDa glycosylated subunit
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Kidney microsomes were fractionated with Triton X-114, to give a fraction enriched in the renal tubule H+-translocating ATPase, as judged by
the sensitivity of its ATPase activity to bafilomycin A,, and its content of two polypeptides recognized by antibodies directed against subunits
of plant tonoplast ATPases. This fraction contained a polypeptide of apparent molecular mass of 115 kDa, that was recognized by an antibody
to the largest (120 kDa) subunit of chromaffin-granule membrane H + -ATPase, and, like this subunit, was reduced in molecular weight on treatment
with glycopeptidase F. We conclude that, like other mammalian vacuolar Fl+-ATPases, the kidney H+-ATPase contains a large, glycosylated sub-
unit.
Kidney; Proton translocation; ATPase; Glycoprotein
1. INTRODUCTION
Three classes of H + -translocating ATPase have been
recognized [1]: F-type (the ATP-synthases of energy-
transducing membranes), P-type (proton pumps,
located in the plasma membranes of plant, fungal and
some specialized animal cells), and V-type (endomem-
brane proton pumps). The V-type ATPases have a wide
distribution, occurring in the membranes of most (pro¬
bably all) types of acidic intracellular compartments in
sukaryotic cells [2], In renal tubular cells, ATP-driven
proton transport is carried out by V-type ATPases that
are inserted into the apical plasma membrane by fusion
of exocytotic vesicles, in response to changes in
acid/base status [3,4].
V-\ype ATPases are of high molecular weight
[400-600 kDa) and complex subunit composition,
rhere is now a consensus that they have a minimum of
3 subunit types: (i) 66-73 kDa; (ii) 55-62 kDa; and (iii)
13-17 kDa, as judged by SDS-polyacrylamide gel elec-
irophoresis. These subunits have been implicated in
ATP hydrolysis, regulatory nucleotide-binding and
H +-translocation, respectively [5-8], Subunits of in-
ermediate size (20-40 kDa) are also present in most
preparations. In some cases up to 5 polypeptides in this
'ange have been reported, but none has yet been
iharacterized functionally.
An interesting controversy surrounds the largest
100-120 kDa) subunit. This was originally found in
ust two types of mammalian V-ATPase [9-11], but a
Correspondence address: D.K. Apps, Department of Biochemistry,
Jniversity of Edinburgh Medical School, Hugh Robson Building,
jeorge Square, Edinburgh EH8 9XD, Scotland, UK
polypeptide of comparable size has now been reported
to occur in V-ATPases from beet and yeast vacuoles
[12,13], although most groups working with plant or
fungal V-type ATPases do not find it in their prepara¬
tions. A subunit of this size was not found in
immunoaffinity-purified ATPase of bovine renal cortex
and medulla [14], and it was not detected by immune
blotting of liver lysosomal membranes and kidney
microsomes [15]. We now report the immunochemical
detection of a 115 kDa N-glycosylated component in
partially-purified kidney microsomal V-ATPase and in
the ATPase of chromaffin granules isolated from
human phaeochromocytoma.
2. MATERIALS AND METHODS
Kidney microsomes were prepared by an adaptation of a published
procedure [16]. All solutions contained 10 mM Tris-HCl, 1 mM
NaHCOj, 1 mM EDTA, 1 mM DTT (pH 8.0, 0°C), plus sucrose at
the required concentration. Bovine renal medullary tissue was minced
anc] homogenized in 0.25 M sucrose, and centrifuged for 10 min at ga»
= 1600. After centrifugation of the supernatant for 60 min at ga» =
41 000, crude microsomes were removed from the surface of the pellet
by swirling, collected by centrifugation, resuspended in 0.25 M
sucrose, overlaid onto step gradients of 0.7, 1.0 and 1.5 M sucrose,
and centrifuged for 5 h at 35 000 rpm in a swingout rotor (Beckman
SW41). The microsomal fraction was collected from the 0.7 M/l .0 M
sucrose interface, diluted, centrifuged and finally resuspended in 0.25
M buffered sucrose containing benzamidine (2 mM), pepstatin (5
lig/ml), leupeptin (5 /xg/ml).
Triton X-l 14 (Fluka) was precondensed as described [17], It was us¬
ed to fractionate kidney microsomes essentially as described for
chromaffin-granule membranes [18,19], except that the final concen¬
tration of detergent was 17.5 mg/ml. The Triton-insoluble fraction
was used for immune blotting as described below. Chromaffin
granule membranes were prepared from bovine adrenal medulla and
human phaeochromocytoma as described [20] and fractionated with
Triton X-l 14 [19]. Antiserum to chromaffin granule H + -ATPase was
Published by Elsevier Science Publishers B. V. 69
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raised by injecting reconstituted holo-ATPase [18] into rabbits. Rab¬
bit antisera to individual subunits of the tonoplast H + -ATPase of
Kalanchoe daigremontiana were raised by injection of proteins elec-
troeluted from gels. Immune blots were developed using the ECL
system (Amersham). Deglycosylation of proteins in the Triton-
insoluble fraction was carried out by incubation (8 h, 20°C) of 100 /ig
protein with 1 unit endoglycosidase F (Boehringer) in 50 mM HEPES-
NaOH, pH 7.0, containing 2 mM benzamidine, 5 ng/ml pepstatin, 5
;tg/ml leupeptin, 0.2 mM PMSF, 0.5% deoxycholate, 1.0% Triton
X-100, 20 mM EDTA and 10 mM dithiothreitol (total volume 105 /d).
3. RESULTS
The purified kidney microsomes had a specific ATP-
ase activity of 0.37 /xmol/min/mg protein, and this
could be inhibited 15% by 2 /xM bafilomycin Ai, a
specific inhibitor of V-type ATPases [21]. We establish¬
ed that the optimal concentration of Triton X-114 for
fractionating kidney microsomes was 1.75% (w/v); the
Triton-insoluble fraction had only a slightly higher
specific ATPase activity than did the membranes (0.48
/xmol/min/mg protein), but it was inhibited about 80%
by bafilomycin, indicating an enrichment in vacuolar
ATPase.
This enrichment is confirmed by the immune blots
shown in Fig. 1. Rabbit antisera directed against the 57
kDa and 67 kDa subunits of the tonoplast H + -ATPase
of Kalanchoe daigremontiana recognize polypeptides of
similar molecular weight in bovine chromaffin granule
membranes and kidney microsomes, and in each case
the immunoreactive polypeptides appear in the Triton-
insoluble fraction. The anti-57 kDa serum recognizes a
doublet in the kidney fraction (Fig. lb, track 4); a
similar result was obtained with antiserum directed
against the 57 kDa subunit of beet tonoplast













Fig. 2. Silver-stained gel showing unfractionated membranes (tracks
1, 3 and 5) and Triton-insoluble fractions (tracks 2, 4 and 6). (Tracks
1 and 2) Bovine chromaffin granules; (tracks 3 and 4) human
phaeochromocytoma granules; (tracks 5 and 6) bovine kidney
microsomes. Each track contained 3 /ig protein. The positions of
marker proteins are shown at the side; major bands in tracks 2 and 4
are at 120, 72, 57, 40, 19 and 16 kDa.
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Fig. 1. Immunoblots showing the enrichment in vacuolar ATPase ob¬
tained by fractionating membranes with Triton X-114 (Track 1)
Chromaffin granule membranes (60 gg protein). (Track 2) Kidney
microsomes (60 jtg). (Track 3) Triton-insoluble fraction from
chromaffin granule membranes (10 ng). (Track 4) Triton-insoluble
fraction from kidney microsomes (30 ;ig). Antibodies were against the
67 kDa (a) and 57 kDa (b) subunits of a plant tonoplast ATPase; note
that in animals these recognize proteins of 72 and 57 kDa, respective¬
ly. In each case only the relevant part of the blot is shown, but there
is no significant immunoreactivity elsewhere.
Although fractionation of chromaffin granule mem¬
branes with Triton X-114 purifies the H + -ATPase to
near-homogeneity [18], the Triton X-l 14-inscruble
fraction from kidney microsomes contains many
polypeptides besides those identified as H + -ATPase
subunits (Fig. 2).
The antiserum produced by immunization of rabbits
with reconstituted chromaffin-granule H+ -ATPase
vesicles [18] reacted with the 120 kDa subunit of this
ATPase, and (more weakly) with dopamine @-
monooxygenase (Fig. 3a, track 1). In unfractionated
kidney microsomes, immunoreactivity was barely
detectable (track 2), but the Triton X-l 14-insoluble
fraction contained a protein of about 115 kDa that was
clearly recognized by this serum (track 4).
Digestion of the Triton X-l 14-insoluble fraction with
endoglycosidase F converted the diffuse immunoreac¬
tive band at 115 kDa into a sharper one at about 100
kDa (Fig. 3b, tracks 5 and 6). This is similar to the ef¬
fect of deglycosylation on the 120 kDa H+-ATPase
subunit in both bovine and human chromaffin granules
(Fig. 3b, and [10]).
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Fig. 3. Immunoblots showing that an antibody to the 120 kDa subunit
of chromaffin granule membrane H + -ATPase recognizes a similar
component in kidney membranes, (a) Fractionation with Triton
X-114. (Track 1) Chromaffin granule membranes (20 gg protein);
(track 2) kidney microsomes (20 gg); (track 3) chromaffin granule
membrane Triton-insoluble fraction (5 gg); (track 4) kidney
microsome Triton-insoluble fraction (28 gg). The immunoreactive
band at 75 kDa is dopamine /3-monooxygenase. (b) Digestion with en-
doglycosidase F; Triton-insoluble fractions from: (tracks 1 and 2)
human phaeochromocytoma granule (5 gg protein); (tracks 3 and 4)
bovine chromaffin granule (5 gg); (tracks 5 and 6) bovine kidney
microsomes (25 gg). Tracks 1, 3 and 5 are controls; tracks 2, 4 and 6
are endoglycosidase F-treated.
4. DISCUSSION
Fractionation with Triton X-114 [16,18] has proved
useful in purifying V-type H + -ATPases from chromaf¬
fin granule membranes [18] and plant tonoplasts [22],
essentially in one step. When applied to kidney
microsomes, it produces a Triton-insoluble fraction
that is enriched about 5-fold in V-ATPase, as judged by
its sensitivity to bafilomycin, but which contains many
other polypeptides (Fig. 2). The activity of this prepara¬
tion can be increased by the addition of phospholipids
(cf. [18]) but the conditions have not yet been op¬
timized.
Our attempts to raise antibodies to chromaffin
granule membrane H + -ATPase by immunization with
individual subunits have proved unsuccessful; however,
antibodies to the 57 kDa and 67 kDa subunits of plant
tonoplast H + -ATPases crossreact with the mammalian
counterparts [23], and antisera raised against individual
subunits of the tonoplast H +-ATPase from the
crassulacean plant Kalanchoe daigremontiana have
been used to follow the kidney Fl +-ATPase during
Triton X-114 fractionation. Immunoblotting using
these antisera confirms the results obtained, using
bafilomycin-sensitive ATPase activity as an assay.
Immunization of rabbits with reconstituted
chromaffin-granule H +-ATPase produced an an¬
tiserum that reacted with the largest (120 kDa) subunit.
Its slight reactivity with dopamine /3-monooxygenase, a
contaminant of the purified H+ -ATPase, was not a
nuisance in these experiments, since this enzyme is ab¬
sent from kidney; it could in any case be overcome by
absorption of the serum with purified dopamine /?-
monooxygenase, without affecting the reactivity of the
serum with the larger component. The antiserum
recognizes a polypeptide in kidney microsomes that has
an electrophoretic mobility close to that of the 120 kDa
subunit of chromaffin-granule H +-ATPase, and is
glycosylated to a similar extent. In fact, the bovine
kidney polypeptide is slightly smaller than that in
bovine chromaffin granules, with an apparent
molecular weight of about 115 kDa; this is reduced by
about 15 kDa on treatment with endoglycosidase F
(specific for N-linked oligosaccharide chains). It is
established that the 120 kDa subunit is a component of
the H +-ATPase of chromaffin granules and clathrin-
coated vesicles [9-11] and this result suggests that the
kidney H +-ATPase is similar, this polypeptide having
previously been undetected by protein staining and im¬
mune blotting. Several of the properties of this subunit
make it difficult to detect: it is glycosylated, so appears
as a diffuse band in electrophoretograms; it stains poor¬
ly with Coomassie blue; it is extremely sensitive to pro¬
teolysis; and it aggregates when heated in SDS.
Interestingly, the antibody raised against bovine
H+ -ATPase fails to recognize any antigen in plant
tonoplasts [22], although the presence of a 100 kDa
subunit in beet H + -ATPase has been reported [13]. The
question of whether a polypeptide of 100-120 kDa is a
necessary component of all V-type ATPases, or is a
species- or tissue-specific subunit, remains open.
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